
<html lang="en"     class="pb-page"  data-request-id="d376a9bf-3ed1-4216-9f0a-01954c7b2d8d"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";article:article:10.1021/jm4008906;requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;issue:issue:10.1021/jmcmar.2013.56.issue-18;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Optimization of Activity, Selectivity, and Liability Profiles in 5-Oxopyrrolopyridine DPP4 Inhibitors Leading to Clinical Candidate (Sa)-2-(3-(Aminomethyl)-4-(2,4-dichlorophenyl)-2-methyl-5-oxo-5H-pyrrolo[3,4-b]pyridin-6(7H)-yl)-N,N-dimethylacetamide (BMS-767778)" /></meta><meta name="dc.Creator" content="Pratik  Devasthale" /></meta><meta name="dc.Creator" content="Ying  Wang" /></meta><meta name="dc.Creator" content="Wei  Wang" /></meta><meta name="dc.Creator" content="John  Fevig" /></meta><meta name="dc.Creator" content="JianXin  Feng" /></meta><meta name="dc.Creator" content="Aiying  Wang" /></meta><meta name="dc.Creator" content="Tom  Harrity" /></meta><meta name="dc.Creator" content="Don  Egan" /></meta><meta name="dc.Creator" content="Nathan  Morgan" /></meta><meta name="dc.Creator" content="Michael  Cap" /></meta><meta name="dc.Creator" content="Aberra  Fura" /></meta><meta name="dc.Creator" content="Herbert E.  Klei" /></meta><meta name="dc.Creator" content="Kevin  Kish" /></meta><meta name="dc.Creator" content="Carolyn  Weigelt" /></meta><meta name="dc.Creator" content="Lucy  Sun" /></meta><meta name="dc.Creator" content="Paul  Levesque" /></meta><meta name="dc.Creator" content="Frederic  Moulin" /></meta><meta name="dc.Creator" content="Yi-Xin  Li" /></meta><meta name="dc.Creator" content="Robert  Zahler" /></meta><meta name="dc.Creator" content="Mark S.  Kirby" /></meta><meta name="dc.Creator" content="Lawrence G.  Hamann" /></meta><meta name="dc.Description" content="Optimization of a 5-oxopyrrolopyridine series based upon structure–activity relationships (SARs) developed from our previous efforts on a number of related bicyclic series yielded compound 2s (BMS-..." /></meta><meta name="Description" content="Optimization of a 5-oxopyrrolopyridine series based upon structure–activity relationships (SARs) developed from our previous efforts on a number of related bicyclic series yielded compound 2s (BMS-..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="September 9, 2013" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm4008906" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2013 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm4008906" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm4008906" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm4008906" /></link>
        
    
    

<title>Optimization of Activity, Selectivity, and Liability Profiles in 5-Oxopyrrolopyridine DPP4 Inhibitors Leading to Clinical Candidate (Sa)-2-(3-(Aminomethyl)-4-(2,4-dichlorophenyl)-2-methyl-5-oxo-5H-pyrrolo[3,4-b]pyridin-6(7H)-yl)-N,N-dimethylacetamide (BMS-767778) | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm4008906" /></meta><meta property="og:title" content="Optimization of Activity, Selectivity, and Liability Profiles in 5-Oxopyrrolopyridine DPP4 Inhibitors Leading to Clinical Candidate (Sa)-2-(3-(Aminomethyl)-4-(2,4-dichlorophenyl)-2-methyl-5-oxo-5H-pyrrolo[3,4-b]pyridin-6(7H)-yl)-N,N-dimethylacetamide (BMS-767778)" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-18/jm4008906/production/images/large/jm-2013-008906_0015.jpeg" /></meta><meta property="og:description" content="Optimization of a 5-oxopyrrolopyridine series based upon structure–activity relationships (SARs) developed from our previous efforts on a number of related bicyclic series yielded compound 2s (BMS-767778) with an overall activity, selectivity, efficacy, PK, and developability profile suitable for progression into the clinic. SAR in the series and characterization of 2s are described." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm4008906"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm4008906">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm4008906&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm4008906&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm4008906&amp;href=/doi/10.1021/jm4008906" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2013</span><span class="cit-fg-volume">, 56</span><span class="cit-fg-issue">, 18</span><span class="cit-fg-pageRange">, 7343-7357</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/56/18" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm400792m" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/jm400919p" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Optimization of Activity, Selectivity, and Liability Profiles in 5-Oxopyrrolopyridine DPP4 Inhibitors Leading to Clinical Candidate (<i>Sa</i>)-2-(3-(Aminomethyl)-4-(2,4-dichlorophenyl)-2-methyl-5-oxo-5<i>H</i>-pyrrolo[3,4-<i>b</i>]pyridin-6(7<i>H</i>)-yl)-<i>N</i>,<i>N</i>-dimethylacetamide (BMS-767778)</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Pratik++Devasthale">Pratik Devasthale</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Ying++Wang">Ying Wang</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Wei++Wang">Wei Wang</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=John++Fevig">John Fevig</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=JianXin++Feng">JianXin Feng</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Aiying++Wang">Aiying Wang</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Tom++Harrity">Tom Harrity</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Don++Egan">Don Egan</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Nathan++Morgan">Nathan Morgan</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Michael++Cap">Michael Cap</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Aberra++Fura">Aberra Fura</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Herbert+E.++Klei">Herbert E. Klei</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Kevin++Kish">Kevin Kish</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Carolyn++Weigelt">Carolyn Weigelt</a></span><span class="author-xref-symbol author-aff-symbol"><sup>⊥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Lucy++Sun">Lucy Sun</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Paul++Levesque">Paul Levesque</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Frederic++Moulin">Frederic Moulin</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Yi-Xin++Li">Yi-Xin Li</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Robert++Zahler">Robert Zahler</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Mark+S.++Kirby">Mark S. Kirby</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Lawrence+G.++Hamann">Lawrence G. Hamann</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-text"><sup>†</sup>Metabolic Diseases Chemistry, <sup>‡</sup>Metabolic Diseases Biology, <sup>§</sup>Pharmaceutical Candidate Optimization, <sup>∥</sup>Protein Science and Structure, <sup>⊥</sup>Computer-Assisted Drug Design, Bristol-Myers Squibb Research and Development, Princeton, New Jersey 08543-5400, United States</span></div><div class="corresp-info"><strong>*</strong>Telephone: 609-818-4974. Fax: 609-818-3550. E-mail: <a href="/cdn-cgi/l/email-protection#cfbfbdaebba6a4e1abaab9aebcbba7aea3aa8fada2bce1aca0a2"><span class="__cf_email__" data-cfemail="f3838192879a98dd9796859280879b929f96b3919e80dd909c9e">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm4008906&amp;href=/doi/10.1021%2Fjm4008906" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2013</span></span><span class="cit-volume">, 56</span><span class="cit-issue">, 18</span><span class="cit-pageRange">, 7343–7357</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">August 21, 2013</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>17 June 2013</li><li><span class="item_label"><b>Published</b> online</span>9 September 2013</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 26 September 2013</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm4008906" title="DOI URL">https://doi.org/10.1021/jm4008906</a></div><div class="article_header-article-copyright"><strong>Copyright © 2013 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D7343%26pageCount%3D15%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DPratik%2BDevasthale%252C%2BYing%2BWang%252C%2BWei%2BWang%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D56%26issueNum%3D18%26contentID%3Djm4008906%26title%3DOptimization%2Bof%2BActivity%252C%2BSelectivity%252C%2Band%2BLiability%2BProfiles%2Bin%2B5-Oxopyrrolopyridine%2BDPP4%2BInhibitors%2BLeading%2Bto%2BClinical%2BCandidate%2B%2528Sa%2529-2-%25283-%2528Aminomethyl%2529-4-%25282%252C4-dichlorophenyl%2529-2-methyl-5-oxo-5H-pyrrolo%255B3%252C4-b%255Dpyridin-6%25287H%2529-yl%2529-N%252CN-dimethylacetamide%2B%2528BMS-767778%2529%26numPages%3D15%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D7357%26publicationDate%3DSeptember%2B2013">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm4008906"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">1938</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">18</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm4008906" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Optimization of Activity, Selectivity, and Liability Profiles in 5-Oxopyrrolopyridine DPP4 Inhibitors Leading to Clinical Candidate (Sa)-2-(3-(Aminomethyl)-4-(2,4-dichlorophenyl)-2-methyl-5-oxo-5H-pyrrolo[3,4-b]pyridin-6(7H)-yl)-N,N-dimethylacetamide (BMS-767778)&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Pratik&quot;,&quot;last_name&quot;:&quot;Devasthale&quot;},{&quot;first_name&quot;:&quot;Ying&quot;,&quot;last_name&quot;:&quot;Wang&quot;},{&quot;first_name&quot;:&quot;Wei&quot;,&quot;last_name&quot;:&quot;Wang&quot;},{&quot;first_name&quot;:&quot;John&quot;,&quot;last_name&quot;:&quot;Fevig&quot;},{&quot;first_name&quot;:&quot;JianXin&quot;,&quot;last_name&quot;:&quot;Feng&quot;},{&quot;first_name&quot;:&quot;Aiying&quot;,&quot;last_name&quot;:&quot;Wang&quot;},{&quot;first_name&quot;:&quot;Tom&quot;,&quot;last_name&quot;:&quot;Harrity&quot;},{&quot;first_name&quot;:&quot;Don&quot;,&quot;last_name&quot;:&quot;Egan&quot;},{&quot;first_name&quot;:&quot;Nathan&quot;,&quot;last_name&quot;:&quot;Morgan&quot;},{&quot;first_name&quot;:&quot;Michael&quot;,&quot;last_name&quot;:&quot;Cap&quot;},{&quot;first_name&quot;:&quot;Aberra&quot;,&quot;last_name&quot;:&quot;Fura&quot;},{&quot;first_name&quot;:&quot;Herbert&quot;,&quot;last_name&quot;:&quot;E. Klei&quot;},{&quot;first_name&quot;:&quot;Kevin&quot;,&quot;last_name&quot;:&quot;Kish&quot;},{&quot;first_name&quot;:&quot;Carolyn&quot;,&quot;last_name&quot;:&quot;Weigelt&quot;},{&quot;first_name&quot;:&quot;Lucy&quot;,&quot;last_name&quot;:&quot;Sun&quot;},{&quot;first_name&quot;:&quot;Paul&quot;,&quot;last_name&quot;:&quot;Levesque&quot;},{&quot;first_name&quot;:&quot;Frederic&quot;,&quot;last_name&quot;:&quot;Moulin&quot;},{&quot;first_name&quot;:&quot;Yi-Xin&quot;,&quot;last_name&quot;:&quot;Li&quot;},{&quot;first_name&quot;:&quot;Robert&quot;,&quot;last_name&quot;:&quot;Zahler&quot;},{&quot;first_name&quot;:&quot;Mark&quot;,&quot;last_name&quot;:&quot;S. Kirby&quot;},{&quot;first_name&quot;:&quot;Lawrence&quot;,&quot;last_name&quot;:&quot;G. Hamann&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2013&quot;,&quot;month&quot;:&quot;09&quot;,&quot;day&quot;:&quot;09&quot;,&quot;issue&quot;:&quot;18&quot;,&quot;volume&quot;:&quot;56&quot;,&quot;pages&quot;:&quot;7343-7357&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm4008906&quot;},&quot;abstract&quot;:&quot;Optimization of a 5-oxopyrrolopyridine series based upon structure–activity relationships (SARs) developed from our previous efforts on a number of related bicyclic series yielded compound 2s (BMS-767778) with an overall activity, selectivity, efficacy, PK, and developability profile suitable for progression into the clinic. SAR in the series and characterization of 2s are described.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm4008906&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm4008906" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm4008906&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm4008906" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm4008906&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm4008906" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm4008906&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm4008906&amp;href=/doi/10.1021/jm4008906" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm4008906" /></input><a href="/doi/pdf/10.1021/jm4008906" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (2 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm4008906&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm4008906%26sid%3Dliteratum%253Aachs%26pmid%3D23964740%26genre%3Darticle%26aulast%3DDevasthale%26date%3D2013%26atitle%3DOptimization%2Bof%2BActivity%252C%2BSelectivity%252C%2Band%2BLiability%2BProfiles%2Bin%2B5-Oxopyrrolopyridine%2BDPP4%2BInhibitors%2BLeading%2Bto%2BClinical%2BCandidate%2B%2528Sa%2529-2-%25283-%2528Aminomethyl%2529-4-%25282%252C4-dichlorophenyl%2529-2-methyl-5-oxo-5H-pyrrolo%255B3%252C4-b%255Dpyridin-6%25287H%2529-yl%2529-N%252CN-dimethylacetamide%2B%2528BMS-767778%2529%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D56%26issue%3D18%26spage%3D7343%26epage%3D7357%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292288" title="X-rays">X-rays</a>,</li><li><a href="/action/doSearch?ConceptID=290658" title="Amides">Amides</a>,</li><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a>,</li><li><a href="/action/doSearch?ConceptID=291793" title="Inhibition">Inhibition</a>,</li><li><a href="/action/doSearch?ConceptID=291711" title="Selectivity">Selectivity</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/56/18" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-18/jmcmar.2013.56.issue-18/production/jmcmar.2013.56.issue-18.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-18/jm4008906/production/images/medium/jm-2013-008906_0015.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-18/jm4008906/production/images/large/jm-2013-008906_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4008906&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Optimization of a 5-oxopyrrolopyridine series based upon structure–activity relationships (SARs) developed from our previous efforts on a number of related bicyclic series yielded compound <b>2s</b> (BMS-767778) with an overall activity, selectivity, efficacy, PK, and developability profile suitable for progression into the clinic. SAR in the series and characterization of <b>2s</b> are described.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_32866" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_32866" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Dipeptidylpeptidase (DPP4) inhibitors,<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> such as sitagliptin,<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> saxagliptin,<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> vildagliptin,<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> and linagliptin,<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> have emerged as a favorable class of agents constituting an effective therapeutic option in the treatment of diabetes mellitus, a debilitating condition that afflicts about 347 million people worldwide (WHO Fact Sheet No. 312, Sep 2012). This is due in part to their ability to control hyperglycemia alone or in combination with other agents and with reduced risk of hypoglycemia and weight gain, side effects that are common to several other oral antidiabetic therapies. During our efforts to identify backup candidates to saxagliptin, a number of novel chemotypes were discovered that less closely resemble substrate mimetic scaffolds.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> Compounds that were being evaluated in the clinic at the time had varied selectivities versus DPP8 and DPP9, the significance of which was unknown. A report<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> from Merck on the potential liabilities of DPP8/9 inhibition using a DPP8/9-selective inhibitor in preclinical species suggested that it may be desirable to maximize selectivity versus DPP8 and DPP9. While a number of studies have subsequently suggested that inhibition of DPP8/9 is not associated with adverse events in humans, these data were not published at the time.<a onclick="showRef(event, 'cit7b cit7c cit7d'); return false;" href="javascript:void(0);" class="ref cit7b cit7c cit7d">(7b-7d)</a> We decided to include selectivity as a criterion in our backup program to mitigate against any potential issues even if the significance of DPP selectivity was unclear. Additionally, a greater placebo-subtracted HbA1c-lowering (>0.7 versus 0.4 that was achieved with 5 mg dose of saxagliptin) was observed in a 6-week phase II clinical trial with saxagliptin at 100 mg (unpublished data). However, because of potential concerns about using suprapharmacological doses, it was decided not to explore this dose in the clinic. It was therefore desirable to identify a potent, selective, and efficacious DPP4 inhibitor, optimally in a novel chemotype, with a high margin of safety to test the hypothesis in the clinic that greater HbA1c lowering could be achieved with continuous maximal DPP4 inhibition. This paper describes the culmination of those efforts with the identification of <b>2s</b> (BMS-767778), an optimized candidate from the 5-oxopyrrolopyridine series that was advanced into the clinic.</div><div class="NLM_p">The design and rationale for arriving at a variety of substituted bicyclic scaffolds have been recently described<a onclick="showRef(event, 'cit6c cit8a cit8b'); return false;" href="javascript:void(0);" class="ref cit6c cit8a cit8b">(6c, 8a, 8b)</a> and are summarized in Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>. Earlier work from our laboratories<a onclick="showRef(event, 'cit6a cit6b cit6c'); return false;" href="javascript:void(0);" class="ref cit6a cit6b cit6c">(6a-6c)</a> had identified the optimal point of attachment of the R group on a number of these scaffolds as indicated in Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>. X-ray structures from earlier series had suggested that this R group was exposed to solvent. The rationale for having a nitrogen atom on these bicyclic cores at this point of attachment was to allow facile and rapid functionalization in this solvent-exposed region for optimization of activity and liability profiles.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-18/jm4008906/production/images/medium/jm-2013-008906_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-18/jm4008906/production/images/large/jm-2013-008906_0002.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Design of novel bicyclic cores.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-18/jm4008906/production/images/large/jm-2013-008906_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4008906&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Our previous X-ray analyses of compounds from multiple bicyclic series related to <b>1</b> had established that the more active atropisomer in every case was <i>Sa</i> with the 2-Cl atom in <b>2</b> pointing below the plane.<a onclick="showRef(event, 'cit6b cit6c cit6d'); return false;" href="javascript:void(0);" class="ref cit6b cit6c cit6d">(6b-6d)</a> On the basis of previous work on closely related series in our group,<a onclick="showRef(event, 'cit6c cit6d'); return false;" href="javascript:void(0);" class="ref cit6c cit6d">(6c, 6d)</a> the 2,4-dichlorophenyl group was retained as an optimized aryl substitution at the 4-position of the pyridine.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_00403" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_00403" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Schemes <a class="ref internalNav" href="#sch1" aria-label="1">1</a>–<a class="ref internalNav" href="#sch4" aria-label="4">4</a> outline the synthesis of 5-oxopyrrolopyridines with aryl, heteroaryl, and alkyl substituents on the lactam.</div><figure id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-18/jm4008906/production/images/medium/jm-2013-008906_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-18/jm4008906/production/images/large/jm-2013-008906_0006.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 1. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-18/jm4008906/production/images/large/jm-2013-008906_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4008906&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) 2,4-dichlorobenzaldehyde, BnNH<sub>2</sub>, AcOH, IPA, 100%; (b) IPA, 79% <b>7a</b>, 65% <b>7b</b>; (c) AcOH, HNO<sub>3</sub>/H<sub>2</sub>O, 57% <b>8a</b>, 68% <b>8b</b>; (d) R<sub>2</sub>NH<sub>2</sub>, EtOH, microwave 150 °C, 71% <b>9a</b>, 53% <b>9b</b>, 71% <b>9s</b>; (e) LiOH, THF, H<sub>2</sub>O, 19% for <b>9a</b> or 10% Pd/C, H<sub>2</sub>, EtOAc, 100% for <b>9b</b>–<b>s</b>; (f) ClCO<sub>2</sub>Et, Et<sub>3</sub>N, THF, then NaBH<sub>4</sub>, THF, H<sub>2</sub>O; (g) MsCl, Et<sub>3</sub>N, CH<sub>2</sub>Cl<sub>2</sub>, 33% two steps <b>10a</b>, 7% two steps <b>10b</b>, 66% two steps <b>10s</b>; (h) 7 M NH<sub>3</sub> in MeOH, microwave 100 °C, 79% <b>1b</b>; (i) Boc<sub>2</sub>O, NaHCO<sub>3</sub>, THF; (j) ClCO<sub>2</sub>Et, Et<sub>3</sub>N, DMAP, CH<sub>2</sub>Cl<sub>2</sub>, 39% two steps; (k) TFA, CH<sub>2</sub>Cl<sub>2</sub>, 91% <b>1g</b>; (l) chiral separation (Chiralcel OJ 5 cm × 50 cm column; 20 μm; mobile phase, isocratic gradient of 15% EtOH–MeOH (50%) in heptane); (m) supercritical fluid chromatography (Chiralpak AD-H 250 mm × 30 mm i.d.; 5 μm; flow rate, 120 mL/min; mobile phase, CO<sub>2</sub>/EtOH 75/25 with 0.1% DEA).</p></p></figure><div class="NLM_p">Dihydropyrrolopyridinones <b>1</b>, <b>2</b>, <b>3</b> could be prepared according to the general synthesis outlined in Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>. Knoevenagel condensation of ethyl chloroacetoacetate <b>4</b> with 2,4-dichlorobenzaldehyde gave styrene <b>5</b>. The dihydropyridyl ring was closed by further condensation of styrene <b>5</b> with enamine <b>6</b> to yield diester <b>7</b>. Oxidation of the dihydro species to the fully aromatic pyridine diester <b>8</b> was accomplished with nitric acid.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a>  Closure of the pyrrolidone ring by treatment with primary amine under microwave heating condition gave 5-oxopyrrolidinopyridine <b>9</b>. Debenzylation of <b>9b</b>–<b>g</b> and <b>9s</b> by hydrogenolysis or hydrolysis of methyl ester <b>9a</b> afforded the corresponding acid, which was subsequently reduced to primary alcohol via anhydride formed by treatment with ethyl chloroformate followed by reduction with NaBH<sub>4</sub>. The alcohol was then converted into the corresponding chloride <b>10</b> by treatment with methanesulfonyl chloride. The desired primary amines <b>1</b>, <b>2</b>, and <b>3</b> were obtained by reaction of the chloride with NH<sub>3</sub>/MeOH under microwave heating conditions. Homochiral analogues <b>3e</b>, <b>2a</b>, and <b>3a</b> were isolated by using chiral supercritical fluid chromatography (SFC) from the corresponding racemic precursors. The primary amine <b>1f</b> was protected with Boc<sub>2</sub>O, and the resulting lactam was converted into the carbamate via treatment with ClCO<sub>2</sub>Et/Et<sub>3</sub>N/DMAP followed by deprotection with TFA to afford <b>1g</b>.</div><figure id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-18/jm4008906/production/images/medium/jm-2013-008906_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-18/jm4008906/production/images/large/jm-2013-008906_0007.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 2. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-18/jm4008906/production/images/large/jm-2013-008906_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4008906&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) supercritical fluid chromatography (Chiralpak AD 250 mm × 4.6 mm i.d.; 10 μm; 35 °C; flow rate, 2.0 mL/min; mobile phase, CO<sub>2</sub>/IPA 82/18; injection volume, 5 μL; detector wavelength, 220 nm); (b) R<sub>2</sub>NH<sub>2</sub>, EtOH, microwave 150 °C; (c) 10% Pd/C, H<sub>2</sub>, EtOAc, 100%; (d) ClCO<sub>2</sub>Et, Et<sub>3</sub>N, THF, then NaBH<sub>4</sub>, THF, H<sub>2</sub>O; (e) MsCl, Et<sub>3</sub>N, CH<sub>2</sub>Cl<sub>2</sub>; (f) 7 M NH<sub>3</sub> in MeOH, microwave 100 °C; (g) TFA, CH<sub>2</sub>Cl<sub>2</sub>, 46%; (h) Boc<sub>2</sub>O, NaHCO<sub>3</sub>, THF, H<sub>2</sub>O; (i) Et<sub>2</sub>NH, PyBOP, DIEA, THF, 100% two steps.</p></p></figure><div class="NLM_p">The racemic intermediate <b>8b</b> was resolved to homochiral <b>11a</b> and <b>11b</b> using chiral supercritical fluid chromatography (SFC). Following the sequence described in Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>, a number of homochiral analogues <b>2</b> and <b>3</b>, specified in Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>, were synthesized using resolved atropisomeric intermediates <b>11a</b> and <b>11b</b>. Stereochemistry of intermediates <b>11a</b> and <b>11b</b> was assigned on the basis of inhibitory activities of pairs of enantiomers generated individually from <b>11a</b> and <b>11b</b>. The intermediate yielding the more active antipode was assigned the stereochemistry indicated in <b>11a</b>. In addition, in every case in this and other related bicyclic series for which we have X-ray cocrystal structure data (seven compounds from three different series 5-oxopyrrolopyridines, 7-oxopyrrolopyridines, and imidazolopyrimidines), the more active atropisomer invariably had the <i>Sa</i> stereochemistry.</div><figure id="sch3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-18/jm4008906/production/images/medium/jm-2013-008906_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-18/jm4008906/production/images/large/jm-2013-008906_0008.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 3. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-18/jm4008906/production/images/large/jm-2013-008906_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4008906&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) H<sub>2</sub>, 10% Pd/C, 100%; (b) CCl<sub>3</sub>CN, Ph<sub>3</sub>P resin, CH<sub>2</sub>Cl<sub>2</sub>; (c) LiAl(OBu)<sub>3</sub>H, THF, 0 °C, 80% two steps; (d) supercritical fluid chromatography (Chiralpak AD 250 mm × 4.6 mm i.d.; 10 μm; 35 °C; flow rate, 2.0 mL/min; mobile phase, CO<sub>2</sub>/IPA 82/18; injection volume, 5 μL; detector wavelength, 220 nm); (e) MsCl, Et<sub>3</sub>N, CH<sub>2</sub>Cl<sub>2</sub>, 0 °C, >90%; (f) 7 M NH<sub>3</sub> in MeOH, 50 °C; (g) TFA, CH<sub>2</sub>Cl<sub>2</sub>; (h) Boc<sub>2</sub>O, NaHCO<sub>3</sub>, THF, H<sub>2</sub>O, 73% three steps; (i) HOBt·H<sub>2</sub>O, EDCI, NH<sub>4</sub>Cl, DIEA, DMF, <b>2q</b>; amine, PyBOP, DIEA, THF, <b>2n</b>, <b>2r, 2s, 2t, 2u, 2v</b>; (j) TFA, CH<sub>2</sub>Cl<sub>2</sub>, 12–74% two steps.</p></p></figure><div class="NLM_p">Scheme <a class="ref internalNav" href="#sch3" aria-label="3">3</a> describes the general synthesis of amide-containing 5-oxopyrrolopyridines. Debenzylation of <b>9i</b> by hydrogenolysis afforded acid <b>15</b>, which was subsequently reduced to the primary alcohol <b>16</b> via acid chloride prepared in situ with a combination of trichloroacetonitrile and triphenylphosphine<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> followed by treatment with lithium tri-<i>tert</i>-butoxyaluminum hydride.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> The racemate <b>16</b> was resolved by chiral supercritical fluid chromatography to give the desired atropisomer, which was converted to the corresponding chloride <b>17</b> by treatment with methanesulfonyl chloride. The acid <b>18</b> was obtained in an uneventful three-step sequence in 73% overall yield as shown in Scheme <a class="ref internalNav" href="#sch3" aria-label="3">3</a>. Coupling of <b>18</b> with appropriate amines followed by deprotection yielded the target amides. The atropisomerically pure amino acid pair of <b>2l</b> and <b>3d</b> was derived from <b>10h</b> via conversion to the primary amine, chiral chromatographic separation, and deprotection.</div><figure id="sch4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-18/jm4008906/production/images/medium/jm-2013-008906_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-18/jm4008906/production/images/large/jm-2013-008906_0009.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 4. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-18/jm4008906/production/images/large/jm-2013-008906_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4008906&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) KNBoc<sub>2</sub>, THF/DMF (15:5), 60 °C, 60%; (b) supercritical fluid chromatography (Chiralpak AD 250 mm × 4.6 mm i.d.; 10 μm; 35 °C; flow rate, 2.0 mL/min; mobile phase, CO<sub>2</sub>/IPA 82/18; injection volume, 5 μL; detector wavelength, 220 nm); (c) 4 N HCl, dioxane; (d) 1 N NaOH, CH<sub>2</sub>Cl<sub>2</sub>, 86% two steps.</p></p></figure><div class="NLM_p">An optimized, scalable protocol for the synthesis of <b>2s</b> is described in Scheme <a class="ref internalNav" href="#sch4" aria-label="4">4</a>. Chloride <b>10s</b> was converted to the bis-Boc-protected amino intermediate <b>19</b> by treatment with KNBoc<sub>2</sub>. The racemate <b>19</b> was resolved using SFC to obtain the desired atropisomeric intermediate <b>20</b>, which after removal of the Boc protecting groups under acidic conditions followed by basification afforded <b>2s</b> as a free base whose absolute stereochemistry was confirmed by X-ray analysis (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>). In general, the stereochemistry of individual atropisomers was assigned on the basis of X-ray cocrystal structures of about a dozen analogues in the 5-oxo and multiple other bicyclic series.<a onclick="showRef(event, 'cit6b cit6c'); return false;" href="javascript:void(0);" class="ref cit6b cit6c">(6b, 6c)</a> The more active atropisomer was invariably significantly more potent than the less active atropisomer (for example, see <b>2f</b> vs <b>3c</b> and <b>2g</b> vs <b>3b</b> in Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a> and <b>2l</b> vs <b>3d</b> in Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>).</div><div class="NLM_p">Analogous to our observations in the related 7-oxopyrrolopyridine series,<a onclick="showRef(event, 'cit6c'); return false;" href="javascript:void(0);" class="ref cit6c">(6c)</a> hERG, sodium channel, and CYP3A4 liabilities were evident in the 5-oxopyrrolopyridine series when the R group was aryl (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>). Mitigation of these liabilities was a major goal of the program. Additionally, though not clearly demonstrated to be a significant issue, we also sought to mitigate against any potential concerns associated with DPP8/9 inhibition by maximizing DPP4 specificity. Ortho substitution on the phenyl group (<b>1c</b>) resulted in a 5-fold increase in potency at DPP4 and >1000-fold selectivity versus DPP8/9. X-ray structure analysis of the analogous homochiral 7-oxodihydropyrrolopyridinone (compound (+)-<b>3f</b> in ref <a onclick="showRef(event, 'cit6c'); return false;" href="javascript:void(0);" class="ref cit6c">6c</a>, PDB entry <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3SX4">3SX4</a>) was consistent with two conformations of the ortho-methoxy group. In one orientation, the oxygen of the MeO group as well as the carbonyl oxygen of the 7-oxo group showed electrostatic interactions with Arg125. While an X-ray structure of <b>2a</b> is not available, one could speculate that a similar additional interaction with the ortho-MeO group may have contributed to the enhanced potency in the 5-oxo series as well. Essentially all phenyl- and benzyl-substituted analogues in Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a> showed significant inhibition of CYP3A4. Introducing heteroaromatic groups to reduce clogP helped reduce the CYP3A4 liability to only a modest extent. For example, oxazole <b>2d</b>, with the lowest clogP in the table, showed an IC<sub>50</sub> against CYP3A4 of 8 μM. Alkyl-substituted analogues shown in Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>, with the exception of <b>2k</b>, were relatively weaker inhibitors of CYP3A4. The hERG liability was greatly minimized by alkyl substitution (<b>1e</b>, <b>2g</b>, <b>3b</b>). Cyclic ethers (<b>2h</b>, <b>2i</b>) as well as basic groups (<b>2j</b>) were well-tolerated. However, the cyclic ethers were metabolically less stable while the pyrrolidine <b>2j</b> was about 10-fold less potent than our desired goal. The most potent DPP4 inhibitor from this series was <b>2k</b> with a <i>K</i><sub>i</sub> of 0.4 nM and DPP8/9 selectivity of 9500/7250, respectively. However, its IC<sub>50</sub> vs CYP3A4 of 3 μM and poor metabolic stability made it nonprogressible. A significant finding was that the unsubstituted lactam <b>1f</b> retained modest DPP4 inhibitory activity and good DPP8/9 selectivity and had minimal hERG and CYP3A4 liabilities (Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>). The goal at this point was to improve upon its DPP4 potency while retaining the beneficial overall profile. Previous SAR findings in our group as well as examination of several X-ray cocrystal structures of earlier analogous compounds had suggested that the substituent on the lactam nitrogen was exposed to solvent and hence an optimal position to explore functionalities that would potentially retain DPP4 activity and selectivity versus DPP8/9 and mitigate hERG and CYP3A4 liabilities. We were pleased to find that homochiral acids such as <b>2l</b> and <b>2m</b> and homochiral amides such as <b>2n</b>, <b>2o</b>, and <b>2p</b>, which lent themselves to facile SAR exploration, exhibited potent DPP4 inhibition. While the acids showed superior CYP3A4 profiles compared with the amides, they were also generally more potent at DPP9 (for example, <b>2m</b>, <i>K</i><sub>i</sub> = 300 nM). On the other hand, amides had IC<sub>50</sub> values of 7–10 μM against CYP3A4. The most potent compound from Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>, <b>2n</b>, suffered from poor metabolic stability in mouse liver microsomes. However, the finding triggered a concerted search, driven by structure–activity and structure–liability data analysis, for an optimal amide substituent with a superior profile. None of the compounds in Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a> displayed any hERG flux activity up to 80 μM. In general, lactam substituents containing a free acid, nitrogen-containing basic groups, and primary and secondary amide groups showed poor PAMPA permeability (data not shown). PAMPA permeability at pH 7.4 for most neutral aliphatic and aromatic substituents as well as for tertiary amides was high. Further optimization of the amide functionality (Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>) yielded compound <b>2s</b> with an overall profile that was suitable for progression into efficacy studies. Other close analogues that were of comparable potency, selectivity, and CYP3A4 profile to <b>2s</b> had inferior metabolic stability or poor permeability. For example, <b>2r</b> had a PAMPA permeability of 87 nm/s at pH 7.4 versus 330 nm/s for <b>2s</b>. Compound <b>2t</b>, while more potent and comparably selective versus DPP8/9, had a worse CYP3A4 and metabolic stability profile than <b>2s</b>. The more active atropisomer <b>2s</b>, with the <i>S</i> stereochemistry (confirmed by X-ray analysis, Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>), was 14-fold more potent than the less active atropisomer <b>3e</b> at inhibiting DPP4 and also showed a bigger therapeutic window versus CYP3A4. Compound <b>2s</b> had a DPP4 <i>K</i><sub>i</sub> of 0.9 nM and a DPP8/9 selectivity of 5400 and 3600, respectively. The atropisomeric integrity was unchanged after incubation of <b>2s</b> in human and rat plasma for 3 h at 37 °C.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. <i>N</i>-Aryl- and <i>N</i>-Benzyl-5-oxopyrrolopyridines</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-18/jm4008906/production/images/medium/jm-2013-008906_0010.gif" alt="" id="fx1" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-18/jm4008906/production/images/medium/jm-2013-008906_0011.gif" alt="" id="fx2" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>Table a</sup><p class="last"><i>n</i> = 1–3.</p></div><div class="footnote" id="t1fn2"><sup>Table b</sup><p class="last">Versus substrate 7-benzyloxy-4-trifluoromethyl coumarin.</p></div><div class="footnote" id="t1fn3"><sup>Table c</sup><p class="last">ND = not determined.</p></div><div class="footnote" id="t1fn4"><sup>Table d</sup><p class="last">Incubation in mouse liver microsomes for 10 min at 3 μM compound and 1 mg/mL protein.</p></div></div><div></div></div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. <i>N</i>-Alkyl-5-oxopyrrolopyridines</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-18/jm4008906/production/images/medium/jm-2013-008906_0012.gif" alt="" id="fx3" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup>Table a</sup><p class="last"><i>n</i> = 1–3.</p></div><div class="footnote" id="t2fn2"><sup>Table b</sup><p class="last">Versus substrate 7-benzyloxy-4-trifluoromethyl coumarin.</p></div><div class="footnote" id="t2fn3"><sup>Table c</sup><p class="last">ND = not determined.</p></div><div class="footnote" id="t2fn4"><sup>Table d</sup><p class="last">Incubation in mouse liver microsomes for 10 min at 3 μM compound and 1 mg/mL protein.</p></div></div><div></div></div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Acid-, Ester-, and Amide-Containing 5-Oxopyrrolopyridines</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-18/jm4008906/production/images/medium/jm-2013-008906_0013.gif" alt="" id="fx4" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup>Table a</sup><p class="last"><i>n</i> = 1–3.</p></div><div class="footnote" id="t3fn2"><sup>Table b</sup><p class="last">Versus substrate 7-benzyloxy-4-trifluoromethyl coumarin.</p></div><div class="footnote" id="t3fn3"><sup>Table c</sup><p class="last">ND = not determined.</p></div><div class="footnote" id="t3fn4"><sup>Table d</sup><p class="last">Incubation in mouse liver microsomes for 10 min at 3 μM compound and 1 mg/mL protein.</p></div></div><div></div></div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Acetamide-Substituted 5-Oxopyrrolopyridines</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-18/jm4008906/production/images/medium/jm-2013-008906_0014.gif" alt="" id="fx5" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup>Table a</sup><p class="last"><i>n</i> = 1–3, except for <b>2s</b> (<i>n</i> = 32).</p></div><div class="footnote" id="t4fn2"><sup>Table b</sup><p class="last">Versus substrate 7-benzyloxy-4-trifluoromethylcoumarin.</p></div><div class="footnote" id="t4fn3"><sup>Table c</sup><p class="last">Incubation in mouse liver microsomes for 10 min at 3 μM compound and 1 mg/mL protein.</p></div></div><div></div></div><div class="NLM_p">Compound <b>2s</b> was further characterized by cocrystallization within the active site of DPP4 (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>).<a onclick="showRef(event, 'cit12a'); return false;" href="javascript:void(0);" class="ref cit12a">(12a)</a> As with previous X-ray structures resolved for earlier analogues within this chemotype, the dominant nonhydrophobic interactions were between the basic primary amine of <b>2s</b> and the two glutamate residues E206/E207 of DPP4. As was observed in the 7-oxo series,<a onclick="showRef(event, 'cit6c'); return false;" href="javascript:void(0);" class="ref cit6c">(6c)</a> the amide functionality on the lactam was exposed to solvent. There were no interactions detected with the catalytic Ser630. The amide carbonyl appeared to have a stacking interaction with Tyr547, which may have contributed to DPP4 potency. Similar π–π interactions were observed in X-ray structures of phenyl-substituted lactams as well. Overall, there were fewer interactions in the S630-containing α/β-hydrolase domain relative to saxagliptin,<a onclick="showRef(event, 'cit12b'); return false;" href="javascript:void(0);" class="ref cit12b">(12b)</a> consistent with the hypothesis that greater selectivity could be achieved by taking advantage of a lower homology among DPP members in the β-propeller domain.</div><figure id="fig2" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-18/jm4008906/production/images/medium/jm-2013-008906_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-18/jm4008906/production/images/large/jm-2013-008906_0003.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. X-ray cocrystal structure of <b>2s</b> bound to the DPP4 active site at 2.35 Å resolution.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-18/jm4008906/production/images/large/jm-2013-008906_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4008906&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. Permeability and Plasma Protein Binding Profile of <b>2s</b></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"><i>P</i><sub>c</sub>, nm/s (PAMPA) (<i>n</i> = 3)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">pH 5.5</td><td class="colsep0 rowsep0" align="left">19.7 ± 3.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">pH 6.5</td><td class="colsep0 rowsep0" align="left">129.7 ± 12.9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">pH 7.4</td><td class="colsep0 rowsep0" align="left">330 ± 49</td></tr></tbody></table><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"><i>P</i><sub>c</sub>, nm/s (Caco-2)<a class="ref internalNav" href="#t5fn1" aria-label="a">a</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">apical to basolateral</td><td class="colsep0 rowsep0" align="left">26 ± 1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">basolateral to apical</td><td class="colsep0 rowsep0" align="left">131 ± 18</td></tr></tbody></table><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center">plasma protein binding, % free</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">human</td><td class="colsep0 rowsep0" align="left">18</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">mouse</td><td class="colsep0 rowsep0" align="left">14</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">rat</td><td class="colsep0 rowsep0" align="left">28</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">dog</td><td class="colsep0 rowsep0" align="left">27</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">monkey</td><td class="colsep0 rowsep0" align="left">16</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t5fn1"><div class="footnote" id="t5fn1"><sup>a</sup><p class="last">Measured at pH 7.4.</p></div></div></div><div class="NLM_p">The permeability (<i>P</i><sub>c</sub>) in the PAMPA model was pH-dependent and, at pH ≥ 6.5 (typical pH range in human intestine), was similar to <i>P</i><sub>c</sub> values of compounds that exhibit good (>80%) absorption in humans (Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>). The basolateral-to-apical permeability of <b>2s</b> was ≥5-fold higher versus apical-to-basolateral permeability in Caco-2 cells (pH ≥ 6.5; data shown are at pH 7.4), suggesting that it is a substrate of efflux transporters. The percent of <b>2s</b> bound to serum proteins was low in all species tested. The rate of <b>2s</b> metabolism in vitro (liver microsomes and hepatocytes) was low to moderate, and a low hepatic clearance in humans was predicted. In vivo, the total blood clearance of <b>2s</b> was low to intermediate in rats, dogs, and monkeys but high in mice (Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a>). Overall, the elimination of <b>2s</b> appeared to be mediated by both hepatic metabolism and renal excretion, with a minor contribution from biliary excretion. Compound <b>2s</b> had a favorable pharmacokinetic profile and good absorption properties with an absolute oral bioavailability ranging from 41% to 95% across animal species.</div><div class="NLM_table-wrap" id="tbl6"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 6. Pharmacokinetic Profile of <b>2s</b><a class="ref internalNav" href="#tbl6-fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center">mouse</th><th class="colsep0 rowsep0" align="center">rat</th><th class="colsep0 rowsep0" align="center">dog</th><th class="colsep0 rowsep0" align="center">monkey</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">iv dose (mg/kg)</td><td class="colsep0 rowsep0" align="left">0.82</td><td class="colsep0 rowsep0" align="left">0.82</td><td class="colsep0 rowsep0" align="left">3</td><td class="colsep0 rowsep0" align="left">3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">po dose (mg/kg)</td><td class="colsep0 rowsep0" align="left">0.82</td><td class="colsep0 rowsep0" align="left">0.82</td><td class="colsep0 rowsep0" align="left">3</td><td class="colsep0 rowsep0" align="left">3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CL (mL min<sup>–1</sup> kg<sup>–1</sup>)</td><td class="colsep0 rowsep0" align="left">137</td><td class="colsep0 rowsep0" align="left">40.9</td><td class="colsep0 rowsep0" align="left">10.6</td><td class="colsep0 rowsep0" align="left">19.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>V</i><sub>ss</sub> (L/kg)</td><td class="colsep0 rowsep0" align="left">6.3</td><td class="colsep0 rowsep0" align="left">2.9</td><td class="colsep0 rowsep0" align="left">2.7</td><td class="colsep0 rowsep0" align="left">2.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>T</i><sub>1/2</sub> (h)</td><td class="colsep0 rowsep0" align="left">1.8</td><td class="colsep0 rowsep0" align="left">1.5</td><td class="colsep0 rowsep0" align="left">7.8</td><td class="colsep0 rowsep0" align="left">5.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">bioavailability (%)</td><td class="colsep0 rowsep0" align="left">41</td><td class="colsep0 rowsep0" align="left">48</td><td class="colsep0 rowsep0" align="left">95</td><td class="colsep0 rowsep0" align="left">84</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl6-fn1"><div class="footnote" id="tbl6-fn1"><sup>a</sup><p class="last">Vehicle used in iv and po studies in all species: water.</p></div></div></div><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i9" class="anchor-spacer"></div><h3 class="article-section__title" id="_i9"> Oral Glucose Tolerance in ob/ob Mice</h3><div class="NLM_p">On the basis of its in vitro potency, selectivity, PK, and a favorable profile in in vitro liability assays, compound <b>2s</b> was selected for detailed evaluation in in vivo models of efficacy and safety. When tested in vivo in insulin resistant high fat fed (HFD) ob/ob mice, which were given an oral glucose tolerance test (oGTT) 1 or 4 h after dose, <b>2s</b> demonstrated an insulinotropic effect at all doses, with insulin AUCs increasing 2-, 3.8-, 2.5-, and 3.1-fold over the vehicle response at the 0.3, 1, 3, and 10 μmol/kg dose levels, respectively (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>). The 0.3 and 3 μmol/kg dose treatment groups did not achieve statistical significance in this study. In a separate mouse PK study, <i>C</i><sub>max</sub> and <i>T</i><sub>max</sub> for <b>2s</b> were determined to be 56 nM and 1 h after an oral dose of 0.82 mpk, respectively. With a mouse plasma free fraction of 14%, coverage over DPP4 <i>K</i><sub>i</sub> would be expected during the efficacy study.</div><figure id="fig3" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-18/jm4008906/production/images/medium/jm-2013-008906_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-18/jm4008906/production/images/large/jm-2013-008906_0004.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Insulin response and effects on plasma insulin AUC during an oGTT in an ob/ob mouse model, following treatment with <b>2s</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-18/jm4008906/production/images/large/jm-2013-008906_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4008906&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">These effects on insulin translated into decreases in peak glucose concentrations (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>). All doses of <b>2s</b> above 0.3 μmol/kg gave maximal decreases in peak glucose, similar to that seen with the 3 μmol/kg dose of BMS-538305.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a></div><figure id="fig4" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-18/jm4008906/production/images/medium/jm-2013-008906_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-18/jm4008906/production/images/large/jm-2013-008906_0005.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Glucose response and effects on glucose AUC during an oGTT in an ob/ob mouse model, following treatment with <b>2s</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-18/jm4008906/production/images/large/jm-2013-008906_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4008906&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The selection of <b>2s</b> as the clinical candidate was arrived at after an extensive analysis of all available in vitro and in vivo activity and liability data for advanced leads from multiple distinct chemotypes. In particular, differentiating areas among advanced leads pertained to metabolism, reactive intermediate formation, pharmacokinetic properties, and overall target potency. A desirable profile of the candidate included having a DPP4 potency comparable to that of saxagliptin (∼1 nM) and in vitro selectivity ratios versus DPP8/9 that were significantly higher than those for saxagliptin. Although the 7-oxopyrrolidinone series described earlier<a onclick="showRef(event, 'cit6c'); return false;" href="javascript:void(0);" class="ref cit6c">(6c)</a> was the most potent series with <i>K</i><sub>i</sub> values for leads in the 300–600 pM range, the series suffered from the poorest pharmacokinetic properties and was therefore not advanced. In the imidazopyrimidine<a onclick="showRef(event, 'cit6a cit6b'); return false;" href="javascript:void(0);" class="ref cit6a cit6b">(6a, 6b)</a> and the 5-oxopyrrolidinone series, a number of compounds showed evidence of mild time-dependent CYP3A4 inhibition. After analysis of over 100 analogues in this assay, candidates were advanced on the basis of a lack of time dependency and weakest overall inhibition potency. Additionally, several analogues showed evidence of reactive intermediate formation in glutathione trapping studies, presumably through the intermediacy of an oxime group arising from the benzylamine functionality. Only compounds that showed acceptable profiles in this reactive intermediate assays were advanced further. Further detailed comparative analysis of the full profiles of the best leads from each series resulted in the selection of <b>2s</b> as a candidate for toxicological evaluation in cynomolgous monkeys, where <b>2s</b> was determined to be acceptable for advancement to the clinic.</div><div class="NLM_p last">The toxicology profile of <b>2s</b> was evaluated in a battery of in vitro safety tests as well as in vivo tests in rats and dogs. No adverse effects were identified after single (up to 500 mg/kg) or repeated (up to 300 mg/kg) oral dosing for up to 14 days in rats. No clinical chemistry or hemotology changes were seen with <b>2s</b>. In the dog, administration of <b>2s</b> once daily for 5 days produced no significant dose-related changes at doses up to 25 mg/kg. At 50 mg/kg, a softening of stools was noted. Compound <b>2s</b> did not demonstrate any potential for undesirable cardiovascular activity at an oral dose of 50 mg/kg. On the basis of the results of human in vitro assays and allometrically scaled animal data, <b>2s</b> was predicted to be a low clearance compound in human with a projected human efficacious dose of 13–33 mg q.d. Because of the absence of any significant dose-limiting toxicities in preclinical toxicology studies, <b>2s</b> was considered to have demonstrated an overall efficacy, safety, and developability profile suitable for advancement to the clinic, allowing for exploring a hypothesis that higher sustained exposures above what are required for maximal DPP4 inhibition of a potent and selective DPP4 inhibitor with an acceptable safety margin would achieve greater HbA1c reductions in humans.</div></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i10">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_40046" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_40046" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">All reactions were carried out under a static atmosphere of argon or nitrogen, and mixtures were stirred magnetically unless otherwise noted. All reagents used were of commercial quality and were obtained from Aldrich Chemical Co., Sigma Chemical Co., Lancaster Chemical Co., or Acros Chemical Co. <sup>1</sup>H (400 MHz) and <sup>13</sup>C (100 MHz) NMR spectra were recorded on a JEOL GSX400 spectrometer using Me<sub>4</sub>Si as an internal standard unless otherwise noted. <sup>1</sup>H (500 MHz) and <sup>13</sup>C (125 MHz) NMR spectra were recorded on a JEOL JNM-ECP500 spectrometer. Chemical shifts are given in parts per million (ppm) downfield from internal reference Me<sub>4</sub>Si in δ units, and coupling constants (<i>J</i>) are given in hertz (Hz). Selected data are reported in the following manner: chemical shift, multiplicity, coupling constants. All reactions were carried out using commercially available anhydrous solvents from Aldrich Chemical Co. or EM Science Chemical Co. unless otherwise noted. All flash chromatographic separations were performed using E. Merck silica gel (particle size, 0.040–0.063 mm). Reactions were monitored by TLC using 0.25 mm E. Merck silica gel plates (60 F<sub>254</sub>) and were visualized with UV light, with 5% phosphomolybdic acid in 95% EtOH or by a sequential treatment with 1 N HCl/MeOH followed by ninhydrin staining. LC/MS data were recorded on a Shimadzu LC-10AT equipped with a SIL-10A injector, a SPD-10AV detector normally operating at 220 nm, and interfaced with a Micromass ZMD mass spectrometer. HPLC retention times, unless otherwise noted, are reported using a Zorbax SB C18 4.6 mm × 75 mm column. The gradient solvent system was from 100% A/0% B to 0% A/100% B (A = 90% H<sub>2</sub>O/10% MeOH + 0.2% H<sub>3</sub>PO<sub>4</sub>) (B = 90% MeOH/10% H<sub>2</sub>O + 0.2% H<sub>3</sub>PO<sub>4</sub>) for 8 min. Detection was at 220 nm. All solvents were removed by rotary evaporation under vacuum using a standard rotovap equipped with a dry ice condenser. All filtrations were performed with a vacuum unless otherwise noted. All final compounds were purified to >95% purity by HPLC analysis.</div><div id="sec3_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i11" class="anchor-spacer"></div><h3 class="article-section__title" id="_i11"> (<i>Z</i>)-Ethyl 4-Chloro-2-(2,4-dichlorobenzylidene)-3-oxobutanoate (<b>5</b>)</h3><div class="NLM_p last">A solution 2,4-dichlorobenzaldehyde (4.6 g, 26.1 mmol), ethyl 4-chloro-3-oxobutanoate (4.5 g, 27.4 mmol), benzylamine (165 mg, 1.5 mmol), and acetic acid (118 mg, 2.0 mmol) in isopropyl alcohol (30 mL) was stirred at ambient temperature for 96 h. The mixture was diluted with isopropyl alcohol to give a total volume of 50 mL and was saved as a stock solution (0.52 mmol/mL).</div></div><div id="sec3_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12"> (<i>E</i>)-Benzyl 3-Aminobut-2-enoate (<b>6b</b>)</h3><div class="NLM_p last">A mixture of benzyl acetoacetate 4.6 g, 24 mmol) and ammonium acetate (9.2 g, 119.5 mmol) in methanol (30 mL) was allowed to stir at ambient temperature for 72 h. The solvent was evaporated, and the residue was taken up in CHCl<sub>3</sub>/H<sub>2</sub>O. The combined organic layer was washed with brine, dried (Na<sub>2</sub>SO<sub>4</sub>), and evaporated to give <b>6b</b> (4.3 g, 90% yield) as a golden oil. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 91 (s, 3H), 4.60 (s, 1H), 5.12 (s, 2H), 7.24–7.40 (m, 5H).</div></div><div id="sec3_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13"> Ethyl 2-(Chloromethyl)-4-(2,4-dichlorophenyl)-5-(2-methoxy-2-oxoethyl)-6-methyl-1,4-dihydropyridine-3-carboxylate (<b>7a</b>)</h3><div class="NLM_p last">A mixture of 2,4-dichlorobenzaldehyde (2.3 g, 12.9 mmol), ethyl 4-chloro-3-oxobutanoate (2.2 g, 12.9 mmol), benzylamine (80.0 mg, 0.8 mmol), and acetic acid (55.0 mg, 0.9 mmol) in isopropyl alcohol (15 mL) was stirred at ambient temperature for 65 h. <b>6a</b> (1.6 g, 14.4 mmol) was added to the reaction mixture, and stirring continued at ambient temperature for 24 h. The reaction was quenched with concentrated HCl (1 mL), and the mixture was stirred at ambient temperature for 2 h. The reaction mixture was then concentrated in vacuo, diluted with diethyl ether, filtered, and evaporated. The residue was purified by flash chromatography (120 g column, 0–100% EtOAc/hexanes) to yield <b>7a</b> (4.2 g, 79% yield) as a yellow sticky oil. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 1.22 (t, <i>J</i> = 7.5 Hz, 3H), 2.36 (s, 3H), 3.63 (s, 3H), 4.11 (q, <i>J</i> = 7.2 Hz, 2H), 4.86 and 4.97 (AB<sub>q</sub>, <i>J</i> = 14.0 Hz, 2H), 5.40 (s, 1H), 6.40 (broad s, 1H), 7.13 (dd, <i>J</i> = 8.4, 2.2 Hz, 1H), 7.26–7.31 (m, 2H). <i>m</i>/<i>z</i> = 418 [M + H]<sup>+</sup>.</div></div><div id="sec3_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> 3-Benzyl 5-Ethyl 6-(chloromethyl)-4-(2,4-dichlorophenyl)-2-methyl-1,4-dihydropyridine-3,5-dicarboxylate (<b>7b</b>)</h3><div class="NLM_p last">A mixture of stock solution <b>5</b> (25 mL, 13 mmol) and <b>6b</b> (2.8 g, 14.5 mmol) in isopropyl alcohol (3 mL) was allowed to stir at ambient temperature for 18 h. The reaction was quenched with concentrated HCl (8 mL), and the mixture was stirred at ambient temperature for 2 h. The mixture was concentrated in vacuo, diluted with diethyl ether, filtered, and evaporated. The residue was purified by flash chromatography (120 g column, EtOAc/hexanes) to give <b>7b</b> (4.2 g, 65% yield) as a yellow sticky oil. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 1.19 (t, <i>J</i> = 7.0 Hz, 3H), 2.35 (s, 3H), 4.05–4.15 (m, 2H), 4.82 and 4.97 (AB<sub>q</sub>, <i>J</i> = 14.1 Hz, 2H), 5.07 and 5.11 (AB<sub>q</sub>, <i>J</i> = 12.3 Hz, 2H), 5.41 (s, 1H), 6.37 (broad s, 1H), 7.07 (dd, <i>J</i> = 8.4, 2.2 Hz, 1H), 7.16–7.32 (m, 5H), 7.35–7.38 (m, 2H).</div></div><div id="sec3_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> 3-Ethyl 5-Methyl 2-(chloromethyl)-4-(2,4-dichlorophenyl)-6-methylpyridine-3,5-dicarboxylate (<b>8a</b>)</h3><div class="NLM_p last"><b>7a</b> (3.4 g, 8.1 mmol) was dissolved in acetic acid (15 mL) and 70% nitric acid/water (15 mL). The reaction mixture was stirred at ambient temperature for 72 h. The crude product (3.7 g) was purified by flash chromatography (120 g column, 0–100% EtOAc/hexanes) to give <b>8a</b> (1.9 g, 57% yield) as a pale yellow oil. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 1.02 (t, <i>J</i> = 7.7 Hz, 3H), 2.66 (s, 3H), 3.60 (s, 3H), 4.10 (q, <i>J</i> = 7.0 Hz, 2H), 4.80 and 4.93 (AB<sub>q</sub>, <i>J</i> = 11.0 Hz, 2H), 7.13 (d, <i>J</i> = 7.0 Hz, 1H), 7.26–7.33 (m, 1H), 7.45 (s, 1H). <i>m</i>/<i>z</i> = 416 [M + H]<sup>+</sup>.</div></div><div id="sec3_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> 3-Benzyl 5-Ethyl 6-(chloromethyl)-4-(2,4-dichlorophenyl)-2-methylpyridine-3,5-dicarboxylate (<b>8b</b>)</h3><div class="NLM_p last"><b>7b</b> (4.1 mg, 8.2 mmol) was dissolved in acetic acid (30 mL) and 70% nitric acid/water (25 mL). The reaction mixture was allowed to stir at ambient temperature for 18 h. The crude product (4.2 g) was purified by flash chromatography (120 g column, 0–100% EtOAc/hexanes) to give <b>8b</b> (2.7 g, 68% yield) as a pale yellow oil. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 0.98 (t, <i>J</i> = 7.3 Hz, 3H), 2.65 (s, 3H), 4.05 (q, <i>J</i> = 7.0 Hz, 2H), 4.77 and 4.92 (AB<sub>q</sub>, <i>J</i> = 11.0 Hz, 2H), 5.04 (s, 2H), 7.01 (d, <i>J</i> = 8.35 Hz, 1H), 7.07 (dd, <i>J</i> = 8.4, 2.2 Hz, 1H), 7.10–7.14 (m, 2H), 7.21 (d, <i>J</i> = 2.2 Hz, 1H), 7.28–7.28 (m, 3H). <i>m</i>/<i>z</i> = 492 [M + H]<sup>+</sup>.</div></div><div id="sec3_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> (<i>S</i>)-3-Benzyl 5-Ethyl 6-(chloromethyl)-4-(2,4-dichlorophenyl)-2-methylpyridine-3,5-dicarboxylate (<b>11a</b>) and (<i>R</i>)-3-Benzyl 5-Ethyl 6-(chloromethyl)-4-(2,4-dichlorophenyl)-2-methylpyridine-3,5-dicarboxylate (<b>11b</b>)</h3><div class="NLM_p last"><b>8b</b> was separated into individual atropisomers using supercritical fluid chromatography (SFC). Conditions: Whelk O-1 SS, 500 mm × 20 mm, 10 μm; 35 °C; 5% IPA with 0.1% DEA in SFC–CO<sub>2</sub>; 100 bar; 60 mL/min; 220 nm. Faster-eluting isomer: <b>11a</b>. [α]<sub>D</sub><sup>25</sup> +54.45° (<i>c</i> 10.21 mg/mL, CHCl<sub>3</sub>). Analytical HPLC: gradient solvent system from 100% A/0% B to 0% A/100% B (A = 90% H<sub>2</sub>O/10%MeOH + 0.2% H<sub>3</sub>PO<sub>4</sub>) (B = 90% MeOH/10% H<sub>2</sub>O + 0.2% H<sub>3</sub>PO<sub>4</sub>) for 4 min; detection at 220 nm. YMC S5 ODS Ballistic 4.6 mm × 50 mm column; <i>t</i><sub>R</sub> = 4.8 min. Chiral analytical HPLC: <i>t</i><sub>R</sub> = 7.39 min on analytical SFC [Regis (S,S) Whelk-O1 250 mm × 4.6 mm i.d.; 10 μm (S/N 200036); mobile phase CO<sub>2</sub>/IPA, 95/5; flow rate, 2.0 mL/min]. Slower- eluting isomer: <b>11b</b>. [α]<sub>D</sub><sup>25</sup> −52.87° (<i>c</i> 1.021, CHCl<sub>3</sub>). <i>t</i><sub>R</sub> = 7.92 min on chiral analytical SFC.</div></div><div id="sec3_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> Methyl 4-(2,4-Dichlorophenyl)-2,7-dimethyl-5-oxo-6-phenyl-6,7-dihydro-5<i>H</i>-pyrrolo[3,4-<i>b</i>]pyridine-3-carboxylate (<b>9a</b>)</h3><div class="NLM_p last">A mixture of <b>8a</b> (671 mg, 1.6 mmol) and aniline (168 mg, 1.8 mmol) in ethanol (5 mL) was heated to 175 °C for 45 min in a microwave reactor. The mixture was purified by flash chromatography (120 g column, 0–100% EtOAc/hexanes) to give <b>9a</b> (485 mg, 71% yield) as a pale brown solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 2.77 (s, 3H), 3.64 (s, 3H), 4.88 and 5.00 (AB<sub>q</sub>, <i>J</i> = 17.6 Hz, 2H), 7.13–7.20 (m, 2H), 7.33 (dd, <i>J</i> = 8.4, 2.2 Hz, 1H), 7.36–7.44 (m, 2H), 7.53 (d, <i>J</i> = 1.8 Hz, 1H), 7.79 (d, <i>J</i> = 7.9 Hz, 2H). <i>m</i>/<i>z</i> = 473 [M + H]<sup>+</sup>.</div></div><div id="sec3_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> Benzyl 4-(2,4-Dichlorophenyl)-6-(4-methoxyphenyl)-2-methyl-5-oxo-6,7-dihydro-5<i>H</i>-pyrrolo[3,4-<i>b</i>]pyridine-3-carboxylate (<b>9b</b>)</h3><div class="NLM_p last">A mixture of <b>8b</b> (199 mg, 0.4 mmol) and 4-methoxybenzenamine (61 mg, 0.5 mmol) in ethanol (3 mL) was heated in a microwave reactor at 175 °C for 15 min. The solvent was evaporated and the residue was purified by flash chromatography (12 g column, EtOAc/hexanes) to give <b>9b</b> (114.6 mg, 53% yield) as a golden oil. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 2.76 (s, 3H), 3.79 (s, 3H), 4.81 and 4.90 (AB<sub>q</sub>, <i>J</i> = 17.6 Hz, 2H), 5.05 and 5.11 (AB<sub>q</sub>, <i>J</i> = 11.9 Hz, 2H), 6.89 (d, <i>J</i> = 9.2 Hz, 2H), 7.03 (d, <i>J</i> = 8.4 Hz, 1H), 7.08–7.16 (m, 3H), 7.28–7.38 (m, 4H), 7.66 (d, <i>J</i> = 9.2 Hz, 2H). <i>m</i>/<i>z</i> = 533 [M + H]<sup>+</sup>.</div></div><div id="sec3_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> Benzyl 4-(2,4-Dichlorophenyl)-6-(2-(dimethylamino)-2-oxoethyl)-2-methyl-5-oxo-6,7-dihydro-5<i>H</i>-pyrrolo[3,4-<i>b</i>]pyridine-3-carboxylate (<b>9s</b>)</h3><div class="NLM_p last"><b>8b</b> (72.0 g, 0.146 mol) was dissolved in dimethylacetamide (130 mL). This solution was added in three portions as described below. To a mixture of glycine dimethylamide hydrochloride salt (25.9 g, 0.187 mol) in dimethylacetamide (150 mL) at room temperature was added triethylamine (122.5 mL, 0.879 mol). The resulting slurry was heated at 80 °C. The solution of chloride <b>8b</b> in DMA (60 mL) as previously described was added over a period of 10 min. The resultant mixture was stirred for an additional 50 min period. A second portion of the chloride solution (60 mL) was added over a period of 10 min. The mixture was then stirred at this temperature for 1.5 h. The remainder of the chloride solution was added over a period of 10 min, and the resulting mixture was stirred for an additional 2 h. After the mixture was cooled to room temperature, low boiling volatiles were removed under reduced pressure. The mixture was diluted with H<sub>2</sub>O (3 L) and allowed to stand at room temperature overnight. The liquid layer was decanted, and the solid residue was dissolved in EtOAc (3 L) (required heating at 50 °C with stirring). The organic layer was washed with H<sub>2</sub>O (130 mL), 0.5 N HCl (30 mL), and H<sub>2</sub>O (50 mL) and dried (MgSO<sub>4</sub>). The organic layer was concentrated to approximately 250 mL total volume and subjected to filtration to give the desired product (48.17 g) as a beige solid. The mother liquor was concentrated and subjected to recrystallization (EtOAc) to give a second portion of the desired product (5.27 g, 71% overall yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 2.73 (s, 3H), 2.93 (s, 3H), 3.01 (s, 3H), 4.23 and 4.48 (ABq, <i>J</i><sub>AB</sub> = 16.7 Hz, 2H), 4.62 and 4.70 (ABq, <i>J</i><sub>AB</sub> = 17.5 Hz, 2H), 5.04 and 5.09 (ABq, <i>J</i><sub>AB</sub> = 11.8 Hz, 2H), 7.00 (d, <i>J</i> = 8.3 Hz, 1H), 7.05–7.15 (m, 3H), 7.20–7.38 (m, 4H). <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>) δ 172.28, 167.17, 166.68, 165.77, 163.36, 160.21, 142.44, 135.28, 134.37, 133.76, 131.07, 130.24, 129.00, 128.89, 128.58, 128.46, 126.54, 120.95, 67.66, 52.05, 43.27, 36.38, 35.63, 23.66. HPLC (gradient from 100% A/0% B to 0% A/100% B (A = 90% H<sub>2</sub>O/10% MeOH + 0.2% H<sub>3</sub>PO<sub>4</sub>) (B = 90% MeOH/10% H<sub>2</sub>O + 0.2% H<sub>3</sub>PO<sub>4</sub>) for 8 min; detection at 220 nm. Zorbax SB C18 4.6 mm × 75 mm column): <i>t</i><sub>R</sub> = 7.97 min. <i>m</i>/<i>z</i> = 512 [M + H]<sup>+</sup>.</div></div><div id="sec3_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> 3-(Chloromethyl)-4-(2,4-dichlorophenyl)-2,7-dimethyl-6-phenyl-6,7-dihydropyrrolo[3,4-<i>b</i>]pyridin-5-one (<b>10a</b>)</h3><div class="NLM_p last">A mixture of <b>9a</b> (183 mg, 0.43 mmol) and lithium hydroxide (∼200 mg) in THF/H<sub>2</sub>O (4 mL) was allowed to stir at ambient temperature for 18 h. The mixture was then heated in a microwave reactor for 1 h at 120 °C. The reaction was quenched with 1 N HCl, and the aqueous portion was extracted into EtOAc. The combined organic layer was washed with brine, dried (Na<sub>2</sub>SO<sub>4</sub>), and evaporated to give the crude acid product (34 mg, 19% yield) as a pale yellow solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 2.80 (s, 3H), 4.85 and 4.95 (AB<sub>q</sub>, <i>J</i> = 17.6 Hz, 2H), 7.15 (t, <i>J</i> = 7.5 Hz, 1H), 7.20 (d, <i>J</i> = 7.9 Hz, 1H), 7.30 (dd, <i>J</i> = 8.9, 1.8 Hz, 1H), 7.37 (t, <i>J</i> = 7.9 Hz, 2H), 7.49 (d, <i>J</i> = 2.2 Hz, 1H), 7.76 (d, <i>J</i> = 7.9 Hz, 2H). <i>m</i>/<i>z</i> = 413 [M + H]<sup>+</sup>. To a solution of the acid (25 mg, 0.06 mmol) in THF was added ethyl chloroformate (24 μL, 0.25 mmol) followed by addition of triethylamine (50 μL, 0.36 mmol). Immediate precipitation was seen. The mixture was stirred at ambient temperature for 2 h, filtered, and washed with THF (1 mL × 2). NaBH<sub>4</sub> (11 mg, 0.29 mmol) in H<sub>2</sub>O (0.3 mL) was added dropwise to the filtrate. The mixture was allowed to stir at ambient temperature for 18 h and then diluted with EtOAc/H<sub>2</sub>O. The organic layer was washed with brine, dried (Na<sub>2</sub>SO<sub>4</sub>), and evaporated to give the alcohol (11.5 mg) as a colorless oil. To a solution of the alcohol (11.5 mg, 0.03 mmol) and triethylamine (30 μL, 0.22 mmol) in dichloromethane (2 mL) was added mesyl chloride (15 μL, 0.19 mmol). The mixture was allowed to stir at ambient temperature for 4 h. The solvent was evaporated, and the residue was purified by flash chromatography (4 g column, 0–100% EtOAc/hexanes) to give <b>10a</b> (4 mg, 33%) as a colorless oil. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 2.89 (s, 3H), 4.31 and 4.56 (AB<sub>q</sub>, <i>J</i> = 11.9 Hz, 2H), 4.87 and 4.93 (AB<sub>q</sub>, <i>J</i> = 17.6 Hz, 2H), 7.16 (t, <i>J</i> = 7.5 Hz, 1H), 7.29 (d, <i>J</i> = 8.4 Hz, 1H), 7.38 (t, <i>J</i> = 7.9 Hz, 2H), 7.42 (dd, <i>J</i> = 8.1, 2.0 Hz, 1H), 7.57 (d, <i>J</i> = 2.2 Hz, 1H), 7.78 (d, <i>J</i> = 7.9 Hz, 2H). <i>m</i>/<i>z</i> = 418 [M + H]<sup>+</sup>.</div></div><div id="sec3_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> 3-(Chloromethyl)-4-(2,4-dichlorophenyl)-6-(4-methoxyphenyl)-2-methyl-6,7-dihydropyrrolo[3,4-<i>b</i>]pyridin-5-one (<b>10b</b>)</h3><div class="NLM_p last">A mixture of <b>9b</b> (114.6 mg, 0.2 mmol) and 10% Pd/C (44 mg) in ethyl acetate (15 mL) was stirred under a H<sub>2</sub> (g) balloon at ambient temperature for 5 h. The reaction mixture was filtered and the filtrate evaporated to give the acid (114 mg, 0.3 mmol). The acid was dissolved in THF (10 mL), and ethyl chloroformate (50 μL, 0.5 mmol) and triethylamine (150 μL, 1.1 mmol) were added sequentially. The mixture was stirred at ambient temperature for 2 h and then filtered. NaBH<sub>4</sub> (50 mg, 1.3 mmol) was added to the filtrate and the mixture stirred at ambient temperature for 18 h. The reaction was quenched with saturated aqueous NaHCO<sub>3</sub> and extracted into EtOAc. The combined organic layer was washed with brine, dried (Na<sub>2</sub>SO<sub>4</sub>), and evaporated. The residue was purified by flash chromatography (12 g column, EtOAc/hexanes) to give the alcohol (10.5 mg, 10% yield) as a white solid. <i>m</i>/<i>z</i> = 429 [M + H]<sup>+</sup>. To a solution of the alcohol (10 mg, 0.02 mmol) in dichloromethane (4 mL) were added triethylamine (25 μL, 0.18 mmol) and mesyl chloride (20 μL, 0.26 mmol). The mixture was allowed to stir at ambient temperature for 18 h and was evaporated. The residue was purified by flash chromatography (4 g column, EtOAc/hexanes) to give <b>10b</b> (7 mg, 67% yield) as a colorless oil. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 2.89 (s, 3H), 3.80 (s, 3H), 4.31 and 4.56 (AB<sub>q</sub>, <i>J</i> = 11.9 Hz, 2H), 4.82 and 4.89 (AB<sub>q</sub>, <i>J</i> = 17.1 Hz, 2H), 6.87–6.94 (m, 2H), 7.29 (d, <i>J</i> = 7.9 Hz, 1H), 7.41 (dd, <i>J</i> = 7.9, 1.8 Hz, 1H), 7.56 (d, <i>J</i> = 1.8 Hz, 1H), 7.63–7.70 (m, 2H). <i>m</i>/<i>z</i> = 447 [M + H]<sup>+</sup>.</div></div><div id="sec3_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> 2-(3-(Chloromethyl)-4-(2,4-dichlorophenyl)-2-methyl-5-oxo-5<i>H</i>-pyrrolo[3,4-<i>b</i>]pyridin-6(7<i>H</i>)-yl)-<i>N</i>,<i>N</i>-dimethylacetamide (<b>10s</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 2.85 (s, 3H), 2.92 (s, 3H), 3.00 (s, 3H), 4.23 and 4.47 (ABq, <i>J</i><sub>AB</sub> = 16.3 Hz, 2H), 4.29 and 4.54 (ABq, <i>J</i><sub>AB</sub> = 11.9 Hz, 2H), 4.60 and 4.69 (ABq, <i>J</i><sub>AB</sub> = 17.5 Hz, 2H), 7.25 (d, <i>J</i> = 8.3 Hz, 1H), 7.37 (dd, <i>J</i> = 8.3, 2.2 Hz, 1H), 7.52 (d, <i>J</i> = 2.2 Hz, 1H). <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>) δ 67.22, 166.17, 162.90, 162.62, 143.95, 135.58, 133.60, 130.99, 130.75, 129.27, 127.09, 121.57, 51.95, 43.29, 39.83, 36.35, 35.63, 22.99. HPLC (gradient from 100% A/0% B to 0% A/100% B (A = 90% H<sub>2</sub>O/10% MeOH + 0.2% H<sub>3</sub>PO<sub>4</sub>) (B = 90% MeOH/10% H<sub>2</sub>O + 0.2% H<sub>3</sub>PO<sub>4</sub>) for 4 min; detection at 220 nm. YMC S5 ODS 4.6 mm × 50 mm, Ballistic column): <i>t</i><sub>R</sub> = 3.81 min. <i>m</i>/<i>z</i> = 427 [M + H]<sup>+</sup>.</div></div><div id="sec3_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> 3-(Aminomethyl)-4-(2,4-dichlorophenyl)-6-(4-methoxyphenyl)-2-methyl-6,7-dihydropyrrolo[3,4-<i>b</i>]pyridin-5-one, TFA Salt (<b>1b</b>)</h3><div class="NLM_p last">A mixture of <b>10b</b> (7 mg, 0.02 mmol) and 7 M NH<sub>3</sub> in MeOH (4 mL) was heated in a microwave reactor at 100 °C for 15 min. The solvent was removed in vacuo, and the residue was purified by preparative HPLC (Phenomenex, 10 min gradient, 30–100% B) to give <b>1b</b> (6.7 mg, 79% yield) as a TFA salt. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 2.86 (s, 3H), 3.80 (s, 3H), 3.97 and 4.20 (AB<sub>q</sub>, <i>J</i> = 14.5 Hz, 2H), 4.96 and 5.01 (AB<sub>q</sub>, <i>J</i> = 18.0 Hz, 2H), 6.94–7.00 (m, 2H), 7.36 (d, <i>J</i> = 8.4 Hz, 1H), 7.54 (dd, <i>J</i> = 8.4, 2.2 Hz, 1H), 7.59–7.65 (m, 2H), 7.72 (d, <i>J</i> = 1.8 Hz, 1H). HRMS calculated for C<sub>22</sub>H<sub>20</sub>Cl<sub>2</sub>N<sub>3</sub>O<sub>2</sub>: 428.0933. Found: 428.0943. Analytical HPLC method: <i>t</i><sub>R</sub> = 6.1 min.</div></div><div id="sec3_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> 3-(Aminomethyl)-4-(2,4-dichlorophenyl)-2-methyl-6-phenyl-6,7-dihydropyrrolo[3,4-<i>b</i>]pyridin-5-one, TFA Salt (<b>1a</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub> + CD<sub>3</sub>OD as cosolvent) δ 2.83 (s, 3H), 3.88 and 4.10 (AB<sub>q</sub>, <i>J</i> = 14.5 Hz, 2H), 4.85 and 4.90 (AB<sub>q</sub>, <i>J</i> = 18.5 Hz, 2H), 7.14 (t, <i>J</i> = 7.0 Hz, 1H), 7.24–7.27 (m, 1H), 7.34 (t, <i>J</i> = 7.9 Hz, 2H), 7.40 (dd, <i>J</i> = 8.1, 2.0 Hz, 1H), 7.55 (d, <i>J</i> = 1.8 Hz, 1H), 7.70 (d, <i>J</i> = 8.8 Hz, 2H). HRMS calculated for C<sub>21</sub>H<sub>18</sub>Cl<sub>2</sub>N<sub>3</sub>O: 398.0827. Found: 398.0812.</div></div><div id="sec3_16" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> 3-(Aminomethyl)-4-(2,4-dichlorophenyl)-6-(2-methoxyphenyl)-2-methyl-6,7-dihydropyrrolo[3,4-<i>b</i>]pyridin-5-one, TFA Salt (<b>1c</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 2.87 (s, 3H), 3.83 (s, 3H), 3.99 and 4.22 (AB<sub>q</sub>, <i>J</i> = 14.5 Hz, 2H), 4.85–4.95 (m, 2H), 7.01 (broad t, <i>J</i> = 7.5 Hz, 1H), 7.14 (broad d, <i>J</i> = 8.4 Hz, 1H), 7.32 (dd, <i>J</i> = 7.9, 1.8 Hz, 1H), 7.34–7.40 (m, 2H), 7.52 (dd, <i>J</i> = 8.4, 2.2 Hz, 1H), 7.69 (d, <i>J</i> = 2.2 Hz, 1H). HRMS calculated for C<sub>22</sub>H<sub>20</sub>Cl<sub>2</sub>N<sub>3</sub>O<sub>2</sub>: 428.0933. Found: 428.0937.</div></div><div id="sec3_17" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27"> 3-(Aminomethyl)-4-((<i>S</i>)-2,4-dichlorophenyl)-6-(2-methoxyphenyl)-2-methyl-6,7-dihydropyrrolo[3,4-<i>b</i>]pyridin-5-one, TFA Salt (<b>2a</b>) and 3-(Aminomethyl)-4-((<i>R</i>)-2,4-dichlorophenyl)-6-(2-methoxyphenyl)-2-methyl-6,7-dihydropyrrolo[3,4-<i>b</i>]pyridin-5-one, TFA Salt (<b>3a</b>)</h3><div class="NLM_p last"><b>1c</b> was separated on a Chiralcel OJ, 20 μm, 5 cm × 50 cm column using an isocratic gradient of 15% EtOH–MeOH (50%) in heptane to afford individual enantiomers <b>2a</b> and <b>3a</b>. <b>2a</b> (faster-eluting): [α]<sub>D</sub><sup>25</sup> +8.2°. Purity by chiral analytical HPLC [Chiralcel OJ 4.6 mm × 250 mm; 15% EtOH–MeOH (1:1; containing 0.1% DEA) in heptane (containing 0.1% DEA)]: >98%. <b>3a</b> (slower-eluting): [α]<sub>D</sub><sup>25</sup> −8.0°. Purity by chiral analytical HPLC [Chiralcel OJ 4.6 mm × 250 mm; 15% EtOH–MeOH (1:1; containing 0.1% DEA) in heptane (containing 0.1% DEA)]: >98%. The more potent atropisomer, <b>3a</b>, was assigned the <i>Sa</i> stereochemistry based on analogy to a cocrystal structure of a close analogue (compound (+)-<b>3f</b> in ref <a onclick="showRef(event, 'cit6c'); return false;" href="javascript:void(0);" class="ref cit6c">6c</a>). Analytical HPLC: <i>t</i><sub>R</sub> = 4.8 min.</div></div><div id="sec3_18" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28"> 3-(Aminomethyl)-4-(2,4-dichlorophenyl)-6-(2-methoxyethyl)-2-methyl-6,7-dihydropyrrolo[3,4-<i>b</i>]pyridin-5-one, TFA Salt (<b>1e</b>, BMS-744891)</h3><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 2.83 (s, 3H), 3.34 (s, 3H), 3.58–3.63 (m, 2H), 3.65–3.78 (m, 2H), 3.95 and 4.18 (AB<sub>q</sub>, <i>J</i> = 14.5 Hz, 2H), 4.62 (s, 2H), 7.33 (d, <i>J</i> = 8.4 Hz, 1H), 7.52 (dd, <i>J</i> = 8.1, 2.0 Hz, 1H), 7.70 (d, <i>J</i> = 2.2 Hz, 1H). HRMS calculated for C<sub>18</sub>H<sub>20</sub>Cl<sub>2</sub>N<sub>3</sub>O<sub>2</sub>: 380.0933. Found: 380.0941. An X-ray cocrystal structure of <b>1e</b>/DPP4 was obtained.<a onclick="showRef(event, 'cit12c'); return false;" href="javascript:void(0);" class="ref cit12c">(12c)</a> It is presumed that the more active atropisomer (<b>2f</b>) crystallized with the protein under the crystallization conditions.</div></div><div id="sec3_19" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29"> 3-(Aminomethyl)-4-(2,4-dichlorophenyl)-2-methyl-6,7-dihydropyrrolo[3,4-<i>b</i>]pyridin-5-one, TFA Salt (<b>1f</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 2.84 (s, 3H), 3.95 and 4.19 (AB<sub>q</sub>, <i>J</i> = 14.9 Hz, 2H), 4.49 (s, 2H), 7.33 (d, <i>J</i> = 8.4 Hz, 1H), 7.48–7.55 (m, 1H), 7.66–7.72 (m, 1H). HRMS calculated for C<sub>15</sub>H<sub>14</sub>Cl<sub>2</sub>N<sub>3</sub>O: 322.0514. Found: 322.0512.</div></div><div id="sec3_20" class="NLM_sec NLM_sec_level_2"><div id="ac_i30" class="anchor-spacer"></div><h3 class="article-section__title" id="_i30"> Ethyl 3-(Aminomethyl)-4-(2,4-dichlorophenyl)-2-methyl-5-oxo-5<i>H</i>-pyrrolo[3,4-<i>b</i>]pyridine-6(7<i>H</i>)-carboxylate, TFA Salt (<b>1g</b>)</h3><div class="NLM_p last">A mixture of <b>1f</b> (47 mg, 0.096 mmol), 1 M Boc<sub>2</sub>O/THF (0.18 mL, 0.18 mmol), NaHCO<sub>3</sub> (160 mg, 1.9 mmol), and THF (5 mL) was stirred at room temperature overnight. The mixture was taken up in EtOAc and H<sub>2</sub>O and transferred to a separatory funnel. The aqueous layer was extracted with EtOAc (×2), washed with brine, dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and evaporated to yield the crude product which was used as such for the next step without purification. <i>m</i>/<i>z</i> = 422 [M + H]<sup>+</sup>. To a solution of the above crude product in CH<sub>2</sub>Cl<sub>2</sub> (5 mL) was added Et<sub>3</sub>N (0.1 mL, 0.72 mmol) followed by EtOCOCl (0.04 mL, 0.42 mmol), and the mixture was stirred at room temperature overnight. LC indicated ∼10% conversion. DMAP (10 mg) followed by additional EtOCOCl (0.1 mL, 1.05 mmol) was added and mixture allowed to stir at room temperature overnight. Evaporation and flash chromatography (40 g silica, 0–100% EtOAc/hexanes) yielded the carbamate (18.5 mg, 39% two steps) as a colorless oil. <i>m</i>/<i>z</i> = 494 [M + H]<sup>+</sup>. To a solution of the carbamate (18 mg, 0.046 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (1 mL) was added TFA (1 mL) dropwise and the mixture stirred at room temperature for 1 h. Mixture was evaporated and purified by PrepHPLC (Phenomenex LUNA 5 μm C18(2) 21.2 mm × 100 mm; 8 min gradient; 0–100% B; 20 mL/min) to yield <b>1g</b> (16.8 mg, 91%) as a white powder. Analytical HPLC: <i>t</i><sub>R</sub> = 5.2 min.</div></div><div id="sec3_21" class="NLM_sec NLM_sec_level_2"><div id="ac_i31" class="anchor-spacer"></div><h3 class="article-section__title" id="_i31"> 3-(Aminomethyl)-4-((<i>S</i>)-2,4-dichlorophenyl)-6-((<i>S</i>)-1-methoxypropan-2-yl)-2-methyl-6,7-dihydropyrrolo[3,4-<i>b</i>]pyridin-5-one, TFA Salt (<b>2g</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 1.26 (d, <i>J</i> = 7.0 Hz, 3H), 2.83 (s, 3H), 3.32 (s, 3H), 3.49 (dd, <i>J</i> = 10.1, 4.4 Hz, 1H), 3.59 (dd, <i>J</i> = 12.1, 7.9 Hz, 1H), 3.95 and 4.18 (AB<sub>q</sub>, <i>J</i> = 14.5 Hz, 2H), 4.52–4.54 (m, 1H), 4.50 and 4.55 (AB<sub>q</sub>, <i>J</i> = 18.9 Hz, 2H), 7.32 (d, <i>J</i> = 8.4 Hz, 1H), 7.52 (dd, <i>J</i> = 8.4, 1.8 Hz, 1H), 7.70 (d, <i>J</i> = 2.2 Hz, 1H). HRMS calculated for C<sub>19</sub>H<sub>22</sub>Cl<sub>2</sub>N<sub>3</sub>O<sub>2</sub>: 394.1089. Found: 394.1104 [M + H]<sup>+</sup>.</div></div><div id="sec3_22" class="NLM_sec NLM_sec_level_2"><div id="ac_i32" class="anchor-spacer"></div><h3 class="article-section__title" id="_i32"> 3-(Aminomethyl)-4-((<i>R</i>)-2,4-dichlorophenyl)-6-((<i>S</i>)-1-methoxypropan-2-yl)-2-methyl-6,7-dihydropyrrolo[3,4-<i>b</i>]pyridin-5-one, TFA Salt (<b>3b</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 1.27 (d, <i>J</i> = 7.0 Hz, 3H), 2.83 (s, 3H), 3.31 (s, 3H), 3.49 (dd, <i>J</i> = 10.1, 4.4 Hz, 1H), 3.59 (dd, <i>J</i> = 10.1, 7.9 Hz, 1H), 3.94 and 4.18 (AB<sub>q</sub>, <i>J</i> = 14.5 Hz, 2H), 4.46–4.55 (m, 1H), 4.48 and 4.57 (AB<sub>q</sub>, <i>J</i> = 18.5 Hz, 2H), 7.33 (d, <i>J</i> = 8.4 Hz, 1H), 7.52 (dd, <i>J</i> = 8.4, 2.2 Hz, 1H), 7.70 (d, <i>J</i> = 2.2 Hz, 1H). LCMS: 394.10 [M + H]<sup>+</sup>. HRMS calculated for C<sub>19</sub>H<sub>22</sub>Cl<sub>2</sub>N<sub>3</sub>O<sub>2</sub>: 394.1089. Found: 394.1073 [M + H]<sup>+</sup>.</div></div><div id="sec3_23" class="NLM_sec NLM_sec_level_2"><div id="ac_i33" class="anchor-spacer"></div><h3 class="article-section__title" id="_i33"> (<i>R</i>)-2-(3-(Aminomethyl)-4-(2,4-dichlorophenyl)-2-methyl-5-oxo-5<i>H</i>-pyrrolo[3,4-<i>b</i>]pyridin-6(7<i>H</i>)-yl)-<i>N</i>,<i>N</i>-dimethylacetamide, TFA Salt (<b>3e</b>)</h3><div class="NLM_p last">The pure enantiomer was obtained by supercritical fluid chromatography (chiralpak AD-H 250 mm × 30 mm i.d.; 5 μm; flow rate, 120 mL/min; mobile phase, CO<sub>2</sub>/EtOH 75/25 (with 0.1%DEA)). This product was further purified by prep HPLC (Phenomenex Luna 5 μm C18, 21.2 mm × 100 mm; 10 min gradient from 85% A/15% B to 0% A/100% B (A = 90% H<sub>2</sub>O/10% MeOH + 0.1% TFA) (B = 90% MeOH/10% H<sub>2</sub>O + 0.1% TFA); detection at 220 nm) to give <b>3e</b> as white solid. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 2.83 (s, 3H), 2.94 (s, 3H), 3.07 (s, 3H), 3.95 and 4.19 (AB<sub>q</sub><i>J</i> = 18.0 Hz, 2H), 4.38 and 4.53 (AB<sub>q</sub><i>J</i> = 18.0 Hz, 2H), 4.58 (s, 2H), 7.33 (d, <i>J</i> = 8.3 Hz, 1H), 7.52 (dd, <i>J</i> = 8.3, 2.2 Hz, 1H), 7.69 (d, <i>J</i> = 2.2 Hz, 1H). HRMS: calculated for C<sub>19</sub>H<sub>20</sub>Cl<sub>2</sub>N<sub>4</sub>O<sub>2</sub>: 406.0963. Found: 407.1032 [M + H]<sup>+</sup>.</div></div><div id="sec3_24" class="NLM_sec NLM_sec_level_2"><div id="ac_i34" class="anchor-spacer"></div><h3 class="article-section__title" id="_i34"> (<i>S</i>)-3-(Aminomethyl)-4-(2,4-dichlorophenyl)-2-methyl-6-(1-methyl-1<i>H</i>-pyrazol-3-yl)-6,7-dihydro-5<i>H</i>-pyrrolo[3,4-<i>b</i>]pyridin-5-one, TFA Salt (<b>2b</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 2.86 (s, 3H), 3.86 (s, 3H), 3.97 and 4.20 (AB<sub>q</sub>, <i>J</i> = 14.5 Hz, 2H), 4.98 (br s, 2H), 6.65 (d, <i>J</i> = 2.2 Hz, 1H), 7.36 (d, <i>J</i> = 8.4 Hz, 1H), 7.52 (d, <i>J</i> = 2.6 Hz, 1H), 7.55 (dd, <i>J</i> = 8.4, 2.2 Hz, 1H), 7.73 (d, <i>J</i> = 1.8 Hz, 1H). HRMS calculated for C<sub>19</sub>H<sub>18</sub>Cl<sub>2</sub>N<sub>5</sub>O: 402.0888. Found: 402.0891 [M + H]<sup>+</sup>.</div></div><div id="sec3_25" class="NLM_sec NLM_sec_level_2"><div id="ac_i35" class="anchor-spacer"></div><h3 class="article-section__title" id="_i35"> (<i>S</i>)-3-(Aminomethyl)-4-(2,4-dichlorophenyl)-2-methyl-6-((1-methyl-1<i>H</i>-pyrazol-3-yl)methyl)-6,7-dihydro-5<i>H</i>-pyrrolo[3,4-<i>b</i>]pyridin-5-one, TFA Salt (<b>2c</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 2.82 (s, 3H), 3.34 (s, 2H), 3.85 (s, 3H), 3.95 and 4.19 (AB<sub>q</sub>, <i>J</i> = 14.1 Hz, 2H), 4.66 and 4.72 (AB<sub>q</sub>, <i>J</i> = 15.2 Hz, 2H), 6.18 (d, <i>J</i> = 2.2 Hz, 1H), 7.35 (d, <i>J</i> = 8.4 Hz, 1H), 7.48–7.57 (m, 1H), 7.70 (d, <i>J</i> = 2.2 Hz, 1H). HRMS calculated for C<sub>20</sub>H<sub>20</sub>Cl<sub>2</sub>N<sub>5</sub>O<sub>2</sub>: 416.1045. Found: 416.1046 [M + H]<sup>+</sup>.</div></div><div id="sec3_26" class="NLM_sec NLM_sec_level_2"><div id="ac_i36" class="anchor-spacer"></div><h3 class="article-section__title" id="_i36"> (<i>S</i>)-3-(Aminomethyl)-4-(2,4-dichlorophenyl)-2-methyl-6-(oxazol-2-ylmethyl)-6,7-dihydro-5<i>H</i>-pyrrolo[3,4-<i>b</i>]pyridin-5-one, TFA Salt (<b>2d</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (500 MHz, CD<sub>3</sub>OD) δ 2.74 (s, 3 H), 3.86 and 4.10 (AB<sub>q</sub>, <i>J</i> = 14.3 Hz, 2 H), 4.53 and 4.57 (AB<sub>q</sub>, <i>J</i> = 19.0 Hz, 2 H), 4.75 and 4.83 (AB<sub>q</sub>, <i>J</i> = 16.5 Hz, 2 H), 7.03 (s, 1 H), 7.25 (d, <i>J</i> = 8.3 Hz, 1 H), 7.41 (dd, <i>J</i> = 8.3, 2.20 Hz, 1 H), 7.59 (d, <i>J</i> = 1.7 Hz, 1 H), 7.79 (s, 1 H). HRMS calculated for C<sub>19</sub>H<sub>17</sub>Cl<sub>2</sub>N<sub>4</sub>O<sub>2</sub>: 403.0729. Found: 403.0715 [M + H]<sup>+</sup>.</div></div><div id="sec3_27" class="NLM_sec NLM_sec_level_2"><div id="ac_i37" class="anchor-spacer"></div><h3 class="article-section__title" id="_i37"> (<i>S</i>)-3-(Aminomethyl)-4-(2,4-dichlorophenyl)-2-methyl-6-((5-methylisoxazol-3-yl)methyl)-6,7-dihydro-5<i>H</i>-pyrrolo[3,4-<i>b</i>]pyridin-5-one, TFA Salt (<b>2e</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 2.38 (s, 3H), 2.82 (s, 3H), 3.94 and 4.18 (AB<sub>q</sub>, <i>J</i> = 14.5 Hz, 2H), 4.57 (s, 2H), 4.72 and 4.78 (AB<sub>q</sub>, <i>J</i> = 15.8 Hz, 2H), 6.08 (s, 1H), 7.32 (d, <i>J</i> = 8.3 Hz, 1H), 7.53 (dd, <i>J</i> = 8.3, 2.0 Hz, 1H), 7.71 (d, <i>J</i> = 2.0 Hz, 1H). HRMS, Anal. Calcd for C<sub>20</sub>H<sub>19</sub>Cl<sub>2</sub>N<sub>4</sub>O<sub>2</sub>: 417.0885. Found: 417.0869 [M + H]<sup>+</sup>.</div></div><div id="sec3_28" class="NLM_sec NLM_sec_level_2"><div id="ac_i38" class="anchor-spacer"></div><h3 class="article-section__title" id="_i38"> (<i>S</i>)-3-(Aminomethyl)-4-(2,4-dichlorophenyl)-6-(2-methoxyethyl)-2-methyl-6,7-dihydro-5<i>H</i>-pyrrolo[3,4-<i>b</i>]pyridin-5-one, TFA Salt (<b>2f</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 2.83 (s, 3H), 3.34 (s, 3H), 3.60 (t, <i>J</i> = 5.3 Hz, 2H), 3.65–3.80 (m, 2H), 3.95 and 4.18 (AB<sub>q</sub>, <i>J</i> = 14.5 Hz, 2H), 4.62 (s, 2H), 7.33 (d, <i>J</i> = 8.4 Hz, 1H), 7.52 (dd, <i>J</i> = 8.1, 2.0 Hz, 1H), 7.69 (d, <i>J</i> = 2.2 Hz, 1H). HRMS calculated for C<sub>18</sub>H<sub>20</sub>Cl<sub>2</sub>N<sub>3</sub>O<sub>2</sub>: 380.0933. Found: 380.0929 [M + H]<sup>+</sup>. Stereochemistry assigned by X-ray cocrystal structure of <b>1e</b> with DPP4.<a onclick="showRef(event, 'cit12c'); return false;" href="javascript:void(0);" class="ref cit12c">(12c)</a> It is presumed that the more active atropisomer (<b>2f</b>) cocrystallized with the protein under the crystallization conditions.</div></div><div id="sec3_29" class="NLM_sec NLM_sec_level_2"><div id="ac_i39" class="anchor-spacer"></div><h3 class="article-section__title" id="_i39"> (<i>S</i>)-3-(Aminomethyl)-4-(2,4-dichlorophenyl)-2-methyl-6-(((<i>R</i>)-tetrahydrofuran-2-yl)methyl)-6,7-dihydro-5<i>H</i>-pyrrolo[3,4-<i>b</i>]pyridin-5-one, TFA Salt (<b>2h</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 1.53–1.65 (m, 1H), 1.83–1.94 (m, 2H), 1.95–2.06 (m, 1H), 2.83 (s, 3H), 3.52 (dd, <i>J</i> = 14.1, 7.9 Hz, 1H), 3.66–3.76 (m, 2H), 3.82–3.90 (m, 1H), 3.95 and 4.18 (AB<sub>q</sub>, <i>J</i> = 14.5 Hz, 2H), 4.06–4.15 (m, 1H), 4.60 and 4.71 (AB<sub>q</sub>, <i>J</i> = 18.9 Hz, 2H), 7.33 (d, <i>J</i> = 7.91 Hz, 1H), 7.52 (dd, <i>J</i> = 8.1, 2.0 Hz, 1H), 7.69 (d, <i>J</i> = 1.8 Hz, 1H). HRMS calculated for C<sub>20</sub>H<sub>22</sub>Cl<sub>2</sub>N<sub>3</sub>O<sub>2</sub>: 406.1089. Found: 406.1085 [M + H]<sup>+</sup>. [α]<sub>D</sub><sup>25</sup> −15.08° (<i>c</i> 1.9, EtOH).</div></div><div id="sec3_30" class="NLM_sec NLM_sec_level_2"><div id="ac_i40" class="anchor-spacer"></div><h3 class="article-section__title" id="_i40"> (<i>S</i>)-3-(Aminomethyl)-4-(2,4-dichlorophenyl)-2-methyl-6-(((<i>S</i>)-tetrahydrofuran-2-yl)methyl)-6,7-dihydro-5<i>H</i>-pyrrolo[3,4-<i>b</i>]pyridin-5-one, TFA Salt (<b>2i</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 1.53–1.65 (m, 1H), 1.83–1.94 (m, 2H), 1.95–2.06 (m, 1H), 2.83 (s, 3H), 3.49 (dd, <i>J</i> = 14.5, 7.7 Hz, 1H), 3.66–3.76 (m, 2H), 3.82–3.90 (m, 1H), 3.95 and 4.19 (AB<sub>q</sub>, <i>J</i> = 14.5 Hz, 2H), 4.06–4.15 (m, 1H), 4.63 and 4.71 (AB<sub>q</sub>, <i>J</i> = 18.9 Hz, 2H), 7.34 (d, <i>J</i> = 7.91 Hz, 1H), 7.51 (dd, <i>J</i> = 8.4, 1.8 Hz, 1H), 7.68 (d, <i>J</i> = 2.2 Hz, 1H). HRMS calculated for C<sub>20</sub>H<sub>22</sub>Cl<sub>2</sub>N<sub>3</sub>O<sub>2</sub>: 406.1089. Found: 406.1092 [M + H]<sup>+</sup>. [α]<sub>D</sub><sup>25</sup> + 10.27° (<i>c</i> 2.2, EtOH).</div></div><div id="sec3_31" class="NLM_sec NLM_sec_level_2"><div id="ac_i41" class="anchor-spacer"></div><h3 class="article-section__title" id="_i41"> (<i>S</i>)-3-(Aminomethyl)-4-(2,4-dichlorophenyl)-2-methyl-6-((<i>S</i>)-pyrrolidin-2-ylmethyl)-6,7-dihydro-5<i>H</i>-pyrrolo[3,4-<i>b</i>]pyridin-5-one, TFA Salt (<b>2j</b>)</h3><div class="NLM_p last">A mixture of <b>11c</b> (28 mg, 0.055 mmol) and TFA (0.7 mL) in CH<sub>2</sub>Cl<sub>2</sub> (1.0 was allowed to stir at ambient temperature for 1 h and evaporated under reduced pressure. The residue was purified by preparative HPLC (Luna 5 μm C18 (2), 30 mm × 100 mm, 10 min gradient, 0–60% solvent B, 40 mL/min) to give <b>2j</b> (15.9 mg, 45.7% yield) as an off-white solid. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 1.59–1.75 (m, 1 H), 1.83–2.05 (m, 2 H), 2.07–2.18 (m, 1 H), 2.75 (s, 3 H), 3.10–3.30 (m, 2 H), 3.64–3.98 (m, 4 H), 4.12 (part of AB<sub>q</sub>, <i>J</i> = 14.1 Hz, 1 H), 4.50 and 4.61 (AB<sub>q</sub>, <i>J</i> = 18.0 Hz, 2 H), 7.26 (d, <i>J</i> = 8.4 Hz, 1 H), 7.42 (dd, <i>J</i> = 8.1, 2.0 Hz, 1 H), 7.60 (d, <i>J</i> = 2.20 Hz, 1 H). HRMS calculated for C<sub>20</sub>H<sub>23</sub>Cl<sub>2</sub>N<sub>4</sub>O: 405.1249. Found: 405.1256 [M + H]<sup>+</sup>. Analytical HPLC: <i>t</i><sub>R</sub> = 1.4 min.</div></div><div id="sec3_32" class="NLM_sec NLM_sec_level_2"><div id="ac_i42" class="anchor-spacer"></div><h3 class="article-section__title" id="_i42"> (<i>S</i>)-3-(3-(Aminomethyl)-4-(2,4-dichlorophenyl)-2-methyl-5-oxo-5<i>H</i>-pyrrolo[3,4-<i>b</i>]pyridin-6(7<i>H</i>)-yl)propanoic Acid, TFA Salt (<b>2m</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 2.67 (t, <i>J</i> = 6.8 Hz, 2H), 2.83 (s, 3H), 3.73–3.85 (m, 2H), 3.94 and 4.18 (AB<sub>q</sub>, <i>J</i> = 14.5 Hz, 2H), 4.62 (s, 2H), 7.32 (d, <i>J</i> = 8.4 Hz, 1H), 7.52 (dd, <i>J</i> = 8.1, 2.0 Hz, 1H), 7.70 (d, <i>J</i> = 1.8 Hz, 1H). HRMS calculated for C<sub>18</sub>H<sub>18</sub>Cl<sub>2</sub>N<sub>3</sub>O<sub>3</sub>: 394.0725. Found: 394.0735 [M + H]<sup>+</sup>.</div></div><div id="sec3_33" class="NLM_sec NLM_sec_level_2"><div id="ac_i43" class="anchor-spacer"></div><h3 class="article-section__title" id="_i43"> (<i>S</i>)-3-(3-(Aminomethyl)-4-(2,4-dichlorophenyl)-2-methyl-5-oxo-5<i>H</i>-pyrrolo[3,4-<i>b</i>]pyridin-6(7<i>H</i>)-yl)-<i>N</i>,<i>N</i>-diethylpropanamide, TFA Salt (<b>2o</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 1.06 (t, <i>J</i> = 7.0 Hz, 3H), 1.14 (t, <i>J</i> = 7.0 Hz, 3H), 2.54–2.80 (m, 2H), 2.83 (s, 3H), 3.32–3.38 (m, 4H), 3.82 (t, <i>J</i> = 6.8 Hz, 2H), 3.94 and 4.18 (AB<sub>q</sub>, J = 14.5 Hz, 2H), 4.60 and 4.65 (AB<sub>q</sub>, <i>J</i> = 18.9 Hz, 2H), 7.32 (d, <i>J</i> = 8.40 Hz, 1H), 7.51 (dd, <i>J</i> = 8.1, 2.0 Hz, 1H), 7.69 (d, <i>J</i> = 1.8 Hz, 1H). HRMS calculated for C<sub>22</sub>H<sub>27</sub>Cl<sub>2</sub>N<sub>4</sub>O<sub>2</sub>: 449.1511. Found: 449.1506 [M + H]<sup>+</sup>.</div></div><div id="sec3_34" class="NLM_sec NLM_sec_level_2"><div id="ac_i44" class="anchor-spacer"></div><h3 class="article-section__title" id="_i44"> (<i>R</i>)-2-((<i>S</i>)-3-(Aminomethyl)-4-(2,4-dichlorophenyl)-2-methyl-5-oxo-5<i>H</i>-pyrrolo[3,4-<i>b</i>]pyridin-6(7<i>H</i>)-yl)-<i>N</i>,<i>N</i>-diethylpropanamide, TFA Salt (<b>2p</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) possible rotamers; data for major rotamer: δ 1.09 (t, <i>J</i> = 7.3 Hz, 3H), 1.20 (t, <i>J</i> = 7.0 Hz, 3H), 1.52 (d, <i>J</i> = 7.0 Hz, 3H), 2.84 (s, 3H), 3.18–3.28 (m, 4H), 3.93 and 4.20 (AB<sub>q</sub>, <i>J</i> = 14.5 Hz, 2H), 4.67 and 4.80 (AB<sub>q</sub>, <i>J</i> = 18.0 Hz, 2H), 5.24 (q, <i>J</i> = 7.0 Hz, 1H), 7.33 (d, <i>J</i> = 8.4 Hz, 1H), 7.52 (dd, <i>J</i> = 8.4, 2.2 Hz, 1H), 7.69 (d, <i>J</i> = 2.2 Hz, 1H). HRMS calculated for C<sub>22</sub>H<sub>27</sub>Cl<sub>2</sub>N<sub>4</sub>O<sub>2</sub>: 449.1511. Found: 449.1524 [M + H]<sup>+</sup>.</div></div><div id="sec3_35" class="NLM_sec NLM_sec_level_2"><div id="ac_i45" class="anchor-spacer"></div><h3 class="article-section__title" id="_i45"> (<i>S</i>)-3-(Aminomethyl)-6-(((<i>S</i>)-1-(cyclopropylsulfonyl)pyrrolidin-2-yl)methyl)-4-(2,4-dichlorophenyl)-2-methyl-6,7-dihydro-5<i>H</i>-pyrrolo[3,4-<i>b</i>]pyridin-5-one, TFA Salt (<b>2k</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (500 MHz, CD<sub>3</sub>OD) δ 0.81–0.97 (m, 4 H), 1.65–1.74 (m, 1 H), 1.81–1.93 (m, 2 H), 1.91–2.03 (m, 1 H), 2.33–2.50 (m, 1 H), 2.73 (s, 3 H), 3.24–3.31 (m, 1 H), 3.34–3.61 (m, 3 H), 3.85 (part of AB<sub>q</sub>, <i>J</i> = 14.3 Hz, 1 H), 4.06–4.18 (m, 2 H), 4.50–4.66 (m, 2 H), 7.24 (d, <i>J</i> = 8.3 Hz, 1 H), 7.42 (d, <i>J</i> = 8.3 Hz, 1 H), 7.59 (s, 1 H). HRMS calculated for C<sub>23</sub>H<sub>27</sub>Cl<sub>2</sub>N<sub>4</sub>O<sub>3</sub>S: 509.1181. Found: 509.1190 [M + H]<sup>+</sup>.</div></div><div id="sec3_36" class="NLM_sec NLM_sec_level_2"><div id="ac_i46" class="anchor-spacer"></div><h3 class="article-section__title" id="_i46"> (<i>R</i>)-3-(Aminomethyl)-4-(2,4-dichlorophenyl)-6-(2-methoxyethyl)-2-methyl-6,7-dihydro-5<i>H</i>-pyrrolo[3,4-<i>b</i>]pyridin-5-one, TFA Salt (<b>3c</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 2.83 (s, 3H), 3.34 (s, 3H), 3.60 (t, <i>J</i> = 5.1 Hz, 2H), 3.65–3.80 (m, 2H), 3.95 and 4.19 (AB<sub>q</sub>, <i>J</i> = 14.5 Hz, 2H), 4.62 (s, 2H), 7.33 (d, <i>J</i> = 8.4 Hz, 1H), 7.52 (dd, <i>J</i> = 8.4, 2.2 Hz, 1H), 7.69 (d, <i>J</i> = 1.8 Hz, 1H). HRMS calculated for C<sub>18</sub>H<sub>20</sub>Cl<sub>2</sub>N<sub>3</sub>O<sub>2</sub>: 380.0933. Found: 380.0931 [M + H]<sup>+</sup>.</div></div><div id="sec3_37" class="NLM_sec NLM_sec_level_2"><div id="ac_i47" class="anchor-spacer"></div><h3 class="article-section__title" id="_i47"> Benzyl 6-(2-<i>tert</i>-Butoxy-2-oxoethyl)-4-(2,4-dichlorophenyl)-2-methyl-5-oxo-6,7-dihydro-5<i>H</i>-pyrrolo[3,4-<i>b</i>]pyridine-3-carboxylate (<b>9h</b>)</h3><div class="NLM_p last">A mixture of <b>8b</b> (10.59 g, 21.43 mmol), glycine <i>tert</i>-butyl ester hydrochloride (8.26 g, 49.29 mmol), and triethylamine (8.94 mL, 64.29 mmol) in <i>N</i>,<i>N</i>-dimethylacetamide (200 mL) was heated to 100 °C for 2 h and then cooled to ambient temperature. The resulting mixture was partitioned between EtOAc and H<sub>2</sub>O, and the aqueous layer was extracted further with EtOAc (2×). The combined organic extracts were washed with H<sub>2</sub>O and brine, dried (Na<sub>2</sub>SO<sub>4</sub>), and evaporated under reduced pressure. The residue was purified by flash chromatography (330 g column, 0–100% EtOAc/hexanes) to give <b>9h</b> (9.34 g, 77% yield) as a light yellow solid. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 1.44 (s, 9 H), 2.74 (s, 3 H), 4.13 and 4.29 (AB<sub>q</sub>, <i>J</i> = 17.6 Hz, 2 H), 4.56 (s, 2 H), 5.05 and 5.07 (AB<sub>q</sub>, <i>J</i> = 11.8, 2 H), 7.00 (d, <i>J</i> = 8.3 Hz, 1 H), 7.06–7.16 (m, 2 H), 7.21–7.40 (m, 5 H). <i>m</i>/<i>z</i> = 541 [M + H]<sup>+</sup>.</div></div><div id="sec3_38" class="NLM_sec NLM_sec_level_2"><div id="ac_i48" class="anchor-spacer"></div><h3 class="article-section__title" id="_i48"> 6-(2-<i>tert</i>-Butoxy-2-oxoethyl)-4-(2,4-dichlorophenyl)-2-methyl-5-oxo-6,7-dihydro-5<i>H</i>-pyrrolo[3,4-<i>b</i>]pyridine-3-carboxylic Acid (<b>15</b>)</h3><div class="NLM_p last">A mixture of <b>9h</b> (9.33 g, 17.23 mmol) and 10% palladium on carbon (1.36 g) in EtOAc (150 mL) was stirred in the presence of hydrogen (balloon) at ambient temperature for 2 h. The reaction mixture was filtered through a pad of Celite and washed with MeOH and CH<sub>2</sub>Cl<sub>2</sub>. The filtrate was evaporated under reduced pressure to give crude <b>15</b> (8.13 g, 100% yield) as a dark yellow solid. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 1.45 (s, 9 H), 2.75 (s, 3 H), 4.23 and 4.28 (AB<sub>q</sub>, <i>J</i> = 18.0 Hz, 2 H), 4.63 and 4.58 (AB<sub>q</sub>, <i>J</i> = 18.0 Hz, 2 H), 7.27 (d, <i>J</i> = 8.4 Hz, 1 H), 7.39 (dd, <i>J</i> = 8.1, 2.0 Hz, 1 H), 7.55 (d, <i>J</i> = 2.2 Hz, 1 H). <i>m</i>/<i>z</i> = 451 [M + H]<sup>+</sup>.</div></div><div id="sec3_39" class="NLM_sec NLM_sec_level_2"><div id="ac_i49" class="anchor-spacer"></div><h3 class="article-section__title" id="_i49"> <i>tert</i>-Butyl 2-(4-(2,4-Dichlorophenyl)-3-(hydroxymethyl)-2-methyl-5-oxo-5<i>H</i>-pyrrolo[3,4-<i>b</i>]pyridin-6(7<i>H</i>)-yl)acetate (<b>16</b>)</h3><div class="NLM_p last">To a stirred mixture of <b>15</b> (1.18 g, 2.5 mmol) and triphenylphosphine resin (5.07 g, 7.5 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (80 mL) at ambient temperature was added trichloroacetonitrile (0.75 mL, 7.5 mmol) dropwise. The mixture was stirred at ambient temperature for 2.5 h, and additional triphenylphosphine resin (0.33 g, 0.5 mmol) and trichloroacetonitrile (50 μL, 0.5 mmol) were added. After 30 min, the mixture was filtered and the filtrate was concentrated in vacuo to give an acid chloride (1.12 g) as a light yellow solid. To a solution of the above acid chloride (0.93 g, 1.98 mmol) in THF (30 mL) at 0 °C was added lithium tri-<i>tert</i>-butoxyaluminohydride dropwise during a period of 5 min. The mixture was stirred at 0 °C for 20 min, quenched with H<sub>2</sub>O (1.3 mL), and concentrated in vacuo. Purification of the residue by flash chromatography (40 g column, 0–100% EtOAc/hexanes) afforded <b>16</b> (690.4 mg, 80% for 2 steps) as an off-white solid. <sup>1</sup>H NMR (500 MHz, CD<sub>3</sub>OD) δ 1.45 (s, 9 H), 2.84 (s, 3 H), 4.20 and 4.26 (AB<sub>q</sub>, <i>J</i> = 17.6, 2 H), 4.32 and 4.58 (AB<sub>q</sub>, <i>J</i> = 12.1 Hz, 2 H), 4.56 (s, 2 H), 7.32 (d, <i>J</i> = 8.3 Hz, 1 H), 7.44 (d, <i>J</i> = 8.3 Hz, 1 H), 7.59 (s, 1 H). <i>m</i>/<i>z</i> = 437 [M + H]<sup>+</sup>.</div></div><div id="sec3_40" class="NLM_sec NLM_sec_level_2"><div id="ac_i50" class="anchor-spacer"></div><h3 class="article-section__title" id="_i50"> (<i>R</i>)-<i>tert</i>-Butyl 2-(3-(Chloromethyl)-4-(2,4-dichlorophenyl)-2-methyl-5-oxo-5<i>H</i>-pyrrolo[3,4-<i>b</i>]pyridin-6(7<i>H</i>)-yl)acetate (<b>17</b>)</h3><div class="NLM_p last"><b>16</b> (5.7 g) was separated by supercritical fluid chromatography (Chiralpak AD 250 mm × 4.6 mm i.d.; 10 μm; 35 °C; flow rate, 2.0 mL/min; mobile phase, CO<sub>2</sub>/IPA 82/18; injection volume, 5 μL; detector wavelength, 220 nm) to give isomer A (2.43 g, <i>t</i><sub>R</sub> = 5.1 min, 100% ee) and isomer B (2.55 g, <i>t</i><sub>R</sub> = 7.1 min, 100% ee) as an off-white solid. To a mixture of isomer B (763 mg, 1.74 mmol) and Et<sub>3</sub>N (0.97 mL, 6.98 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (15 mL) at 0 °C was added mesyl chloride (0.41 mL, 5.24 mmol) dropwise. The stirred mixture was kept at ambient temperature overnight and evaporated under reduced pressure. The residue was partitioned between EtOAc and H<sub>2</sub>O, and the aqueous layer was extracted further with EtOAc (2×). The combined organic extracts were washed with brine, dried (Na<sub>2</sub>SO<sub>4</sub>), and concentrated in vacuo. The crude product was chromatographed (40 g column, 0–100% EtOAc/hexanes) to give <b>17</b> (785.7 mg, 99%) as a white solid. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 1.45 (s, 9 H), 2.86 (s, 3 H), 4.14 and 4.29 (AB<sub>q</sub>, <i>J</i> = 17.6, 2 H), 4.31 (part of AB<sub>q</sub>, <i>J</i> = 7.1, 1 H), 4.52–4.60 (m, 3 H), 7.27 (d, <i>J</i> = 8.3, 1 H), 7.39 (dd, <i>J</i> = 8.3, 2.2 Hz, 1 H), 7.54 (d, <i>J</i> = 1.7, 1 H). <i>m</i>/<i>z</i> = 455 [M + H]<sup>+</sup>.</div></div><div id="sec3_41" class="NLM_sec NLM_sec_level_2"><div id="ac_i51" class="anchor-spacer"></div><h3 class="article-section__title" id="_i51"> (<i>S</i>)-2-(3-((<i>tert</i>-Butoxycarbonylamino)methyl)-4-(2,4-dichlorophenyl)-2-methyl-5-oxo-5<i>H</i>-pyrrolo[3,4-<i>b</i>]pyridin-6(7<i>H</i>)-yl)acetic Acid (<b>18</b>)</h3><div class="NLM_p last">A solution of <b>17</b> (784 mg, 1.72 mmol) in 7 M NH<sub>3</sub> in MeOH (140 mL) was heated at 50 °C for 50 min, cooled, and concentrated to give crude (<i>S</i>)-<i>tert</i>-butyl 2-(3-(aminomethyl)-4-(2,4-dichlorophenyl)-2-methyl-5-oxo-5<i>H</i>-pyrrolo[3,4-<i>b</i>]pyridin-6(7<i>H</i>)-yl)acetate (1.81 g) as a light orange sticky solid. To the above material in CH<sub>2</sub>Cl<sub>2</sub> (8.0 mL) was added TFA (5.0 mL), and the resulting mixture was allowed to stir at ambient temperature for 3 h and evaporated under reduced pressure. The residue was coevaporated with ethanol several times to give crude (<i>S</i>)-2-(3-(aminomethyl)-4-(2,4-dichlorophenyl)-2-methyl-5-oxo-5<i>H</i>-pyrrolo[3,4-<i>b</i>]pyridin-6(7<i>H</i>)-yl)acetic acid as a yellow solid. The yellow solid was dissolved in THF (35 mL) and treated with saturated aqueous NaHCO<sub>3</sub> (20 mL) followed by di-<i>tert</i>-butyl dicarbonate (1.28 g, 5.85 mmol). The mixture was stirred at ambient temperature for 2.5 h, and then the pH of the mixture was adjusted to 3 with 1 N HCl. The aqueous layer was extracted with EtOAc (2×), and the combined organic extracts were washed with brine, dried (Na<sub>2</sub>SO<sub>4</sub>), and evaporated under reduced pressure to give crude <b>18</b> (1.375 g) as a light yellow solid which was used for the next step without further purification. <i>m</i>/<i>z</i> = 480 [M + H]<sup>+</sup>.</div></div><div id="sec3_42" class="NLM_sec NLM_sec_level_2"><div id="ac_i52" class="anchor-spacer"></div><h3 class="article-section__title" id="_i52"> 2-(3-((Bis-<i>tert</i>-butoxycarbonylamino)methyl)-4-(2,4-dichlorophenyl)-2-methyl-5-oxo-5<i>H</i>-pyrrolo[3,4-<i>b</i>]pyridin-6(7<i>H</i>)-yl)-<i>N</i>,<i>N</i>-dimethylacetamide (<b>19</b>)</h3><div class="NLM_p last">To a stirred solution of <b>18</b> (8.28 g, 19.4 mmol) in THF (125 mL) at 60 °C was added di-<i>tert</i>-butyl iminodicarboxylate, potassium salt (9.95 g, 9.40 mmol). DMF (41.5 mL) was added and the reaction mixture heated at 60 °C for 5 min and stirred at room temperature for another 25 min. The reaction mixture was concentrated under reduced pressure to remove THF. The resulting residue was diluted with EtOAc (570 mL) and extracted with 5% LiCl solution (2 × 380 mL) and brine. The aqueous layers were extracted with EtOAc (1 × 400 mL, 1 × 200 mL). The combined organic layers were dried (MgSO<sub>4</sub>), filtered, and concentrated to give a yellow foam which was purified by silica gel chromatography (EtOAc) to give the desired product (7.19 g, 60%) as a white solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 1.36 (s, 18H), 2.81 (s, 3H), 2.93 (s, 3H), 3.00 (s, 3H), 4.22 and 4.46 (ABq, <i>J</i><sub>AB</sub> = 16.5 Hz, 2H), 4.56 and 4.69 (ABq, <i>J</i><sub>AB</sub> = 17.3 Hz, 2H), 4.66 and 4.91 (ABq, <i>J</i><sub>AB</sub> = 15.2 Hz, 2H), 7.23 (d, <i>J</i> = 8.3 Hz, 1H), 7.30 (dd, <i>J</i> = 8.3, 2.2 Hz, 1H), 7.45 (d, <i>J</i> = 2.2 Hz, 1H). Analytical HPLC: <i>t</i><sub>R</sub> = 8.60 min. <i>m</i>/<i>z</i> = 607 [M + H]<sup>+</sup>.</div></div><div id="sec3_43" class="NLM_sec NLM_sec_level_2"><div id="ac_i53" class="anchor-spacer"></div><h3 class="article-section__title" id="_i53"> (<i>S</i>)-2-(3-((Bis-<i>tert</i>-butoxycarbonylamino)methyl)-4-(2,4-dichlorophenyl)-2-methyl-5-oxo-5<i>H</i>-pyrrolo[3,4-<i>b</i>]pyridin-6(7<i>H</i>)-yl)-<i>N</i>,<i>N</i>-dimethylacetamide (<b>20</b>)</h3><div class="NLM_p last">The desired atropisomer (slower-eluting) was obtained by chiral SFC separation (Chiralpak AD 250 mm × 4.6 mm i.d.; 10 μm; 35 °C; flow rate, 2.0 mL/min; mobile phase, CO<sub>2</sub>/IPA 82/18; injection volume, 5 μL; detector wavelength, 220 nm) in 96% recovery and >99% ee.</div></div><div id="sec3_44" class="NLM_sec NLM_sec_level_2"><div id="ac_i54" class="anchor-spacer"></div><h3 class="article-section__title" id="_i54"> (<i>S</i>)-2-(3-(Aminomethyl)-4-(2,4-dichlorophenyl)-2-methyl-5-oxo-5<i>H</i>-pyrrolo[3,4-<i>b</i>]pyridin-6(7<i>H</i>)-yl)acetamide, TFA Salt (<b>2q</b>)</h3><div class="NLM_p last">To a mixture of <b>18</b> (70 mg, 0.146 mmol), HOBT·H<sub>2</sub>O (29.6 mg, 0.218 mmol), and ammonium chloride (15.6 mg, 0.292 mmol) in DMF (0.5 mL) were added EDCI (42 mg, 0.218 mmol) and diisopropylethylamine (0.101 mL, 0.58 mmol). The mixture was stirred at ambient temperature overnight and then diluted with EtOAc (10 mL) and H<sub>2</sub>O (2.5 mL). The organic layer was separated and evaporated in vacuo to yield the crude amide product. To a solution of the amide product in CH<sub>2</sub>Cl<sub>2</sub> (1 mL) was added TFA (0.5 mL), and the resulting mixture was stirred for 3 h. Solvent was removed in vacuo and the residue purified by preparative HPLC (Phenomenex Axia, 8 min gradient, 0–100% B) to give <b>2q</b> (8.6 mg, 12%) as a white powder. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 2.76 (s, 3H), 3.88 and 4.12 (AB<sub>q</sub>, <i>J</i> = 15.0 Hz, 2H), 4.13 and 4.24 (AB<sub>q</sub>, <i>J</i> = 17.2 Hz, 2H), 4.54 (s, 2H), 7.26 (d, <i>J</i> = 8.3 Hz, 1H), 7.45 (dd, <i>J</i> = 8.3, 2.2 Hz, 1H), 7.62 (d, <i>J</i> = 2.2 Hz, 1H). HRMS, Anal. Calcd for C<sub>17</sub>H<sub>17</sub>Cl<sub>2</sub>N<sub>4</sub>O<sub>2</sub>: 379.0729. Found: 379.0739 [M + H]<sup>+</sup>. Analytical HPLC: <i>t</i><sub>R</sub> = 3.0 min.</div></div><div id="sec3_45" class="NLM_sec NLM_sec_level_2"><div id="ac_i55" class="anchor-spacer"></div><h3 class="article-section__title" id="_i55"> (<i>S</i>)-2-(3-(Aminomethyl)-4-(2,4-dichlorophenyl)-2-methyl-5-oxo-5<i>H</i>-pyrrolo[3,4-<i>b</i>]pyridin-6(7<i>H</i>)-yl)-<i>N</i>,<i>N</i>-dimethylacetamide (<b>2s</b>)</h3><div class="NLM_p"><i>Procedure A</i>. To a solution of <b>18</b> (100.9 mg, 0.21 mmol) in THF (5.0 mL) was added benzotriazol-1-yloxytripyrrolidinophosphonium hexafluorophosphate (163.9 mg, 0.315 mmol), <i>N</i>,<i>N</i>-diisopropylethylamine (0.15 mL, 0.84 mmol), and 2 M NHMe<sub>2</sub>/THF (0.157 mL, 0.315 mmol). The reaction mixture was stirred at ambient temperature for 2.5 h and evaporated. The residue was partitioned between EtOAc and H<sub>2</sub>O, and the aqueous layer was extracted further with EtOAc (2×). The combined organic extracts were washed with H<sub>2</sub>O and brine, dried with (Na<sub>2</sub>SO<sub>4</sub>), and evaporated under reduced pressure to give the crude amide (186.1 mg) as a light orange solid. The above crude product was dissolved in CH<sub>2</sub>Cl<sub>2</sub> (1.5 mL) and treated with TFA (0.8 mL). The reaction mixture was allowed to stir at ambient temperature for 2.5 h and concentrated in vacuo. The residue was purified by preparative HPLC (YMC S5 ODS 30 mm × 100 mm, 12 min gradient, 0–80% solvent B, 40 mL/min) to give <b>2s</b>, TFA salt (78.9 mg, 98.2% ee, 70% yield over two steps) as an off-white powder. <sup>1</sup>H NMR (500 MHz, CD<sub>3</sub>OD) δ 2.83 (s, 3 H), 2.94 (s, 3 H), 3.07 (s, 3 H), 3.95 and 4.19 (AB<sub>q</sub>, <i>J</i> = 14.3 Hz, 2 H), 4.39 and 4.51 (AB<sub>q</sub>, <i>J</i> = 17.0 Hz, 2 H), 7.33 (d, <i>J</i> = 8.3 Hz, 1 H), 7.51 (d, <i>J</i> = 8.3 Hz, 1 H), 7.69 (s, 1 H). HRMS calculated for C<sub>19</sub>H<sub>21</sub>Cl<sub>2</sub>N<sub>4</sub>O<sub>2</sub>: 407.1042. Found: 407.1046 [M + H]<sup>+</sup>.</div><div class="NLM_p last"><i>Procedure B</i>. A mixture of <b>20</b> (4.4 g, 7.3 mmol) and 4 N HCl in dioxane (30 mL) was stirred at room temperature for 8.5 h. The reaction mixture was diluted with ether (150 mL) and filtered. The solid cake was washed with ether (150 mL) and dissolved in MeOH (60 mL). The volatiles were removed under reduced pressure to give <b>2s</b>, dihydrochloride salt, as a beige solid (3.3 g, 86%). The dihydrochloride salt of <b>2s</b> thus obtained (5.63 g, 11.6 mmol) was dissolved in CH<sub>2</sub>Cl<sub>2</sub> (100 mL), and 1 N NaOH (75 mL) was added slowly. The resulting mixture was transferred to a separatory funnel, and the aqueous layer was extracted with CH<sub>2</sub>Cl<sub>2</sub> (2 × 100 mL). The combined organic layer was washed with brine, dried (Na<sub>2</sub>SO<sub>4</sub>), filtered, and concentrated under reduced pressure to afford the free base as a foamy solid. Recrystallization from EtOAc yielded <b>2s</b>, crystalline free base (4.23 g, 90%), as a colorless solid. Mp 193–194 °C. <sup>1</sup>H NMR (400 MHz, methanol<i>-d</i><sub>4</sub>) δ 2.82 (s, 3 H), 2.93 (s, 3 H), 3.06 (s, 3 H), 3.57 and 3.75 (ABq, <i>J</i><sub>AB</sub> = 13.9 Hz, 2 H), 4.39 and 4.48 (ABq, <i>J</i><sub>AB</sub> = 16.8 Hz, 2 H), 4.54 (s, 2 H), 7.33 (d, <i>J</i> = 8.2 Hz, 1 H), 7.45 (dd, <i>J</i> = 8.4, 2.0 Hz, 1 H), 7.61 (d, <i>J</i> = 2.0 Hz, 1 H). <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>) δ 167.34, 166.58, 162.39, 161.22, 143.16, 135.09, 133.70, 133.41, 132.08, 130.80, 129.29, 127.04, 121.22, 51.88, 43.27, 39.83, 36.35, 35.60, 23.04. HRMS calculated for C<sub>19</sub>H<sub>21</sub>N<sub>4</sub>O<sub>2</sub>Cl<sub>2</sub>: 407.1042. Found: 407.1041. Elemental analysis calculated: C 55.80, H 4.99, N 13.65, Cl 17.27. Found: C 56.09, H 4.71, N 13.73, Cl 17.40. [α]<sub>D</sub><sup>25</sup> +18.8 (<i>c</i> 1.024, MeOH). Analytical HPLC: <i>t</i><sub>R</sub> = 2.6 min.</div></div><div id="sec3_46" class="NLM_sec NLM_sec_level_2"><div id="ac_i56" class="anchor-spacer"></div><h3 class="article-section__title" id="_i56"> (<i>S</i>)-2-(3-(Aminomethyl)-4-(2,4-dichlorophenyl)-2-methyl-5-oxo-5<i>H</i>-pyrrolo[3,4-<i>b</i>]pyridin-6(7<i>H</i>)-yl)-<i>N</i>,<i>N</i>-diethylacetamide, TFA Salt (<b>2n</b>)</h3><div class="NLM_p last">59% yield over two steps. <sup>1</sup>H NMR (500 MHz, CD<sub>3</sub>OD) δ 1.12 (t, <i>J</i> = 7.2 Hz, 3 H), 1.24 (t, <i>J</i> = 7.2 Hz, 3 H), 2.84 (s, 3 H), 3.34–3.48 (m, 4 H), 3.96 and 4.20 (AB<sub>q</sub>, <i>J</i> = 14.3 Hz, 2 H), 4.40 and 4.52 (AB<sub>q</sub>, <i>J</i> = 16.7 Hz, 2 H), 4.61 (s, 2 H), 7.34 (d, <i>J</i> = 8.3 Hz, 1 H), 7.51 (d, <i>J</i> = 8.3 Hz, 1 H), 7.69 (s, 1 H). HRMS calculated for C<sub>21</sub>H<sub>25</sub>Cl<sub>2</sub>N<sub>4</sub>O<sub>2</sub>: 435.1355. Found: 435.1366 [M + H]<sup>+</sup>.</div></div><div id="sec3_47" class="NLM_sec NLM_sec_level_2"><div id="ac_i57" class="anchor-spacer"></div><h3 class="article-section__title" id="_i57"> (<i>S</i>)-2-(3-(Aminomethyl)-4-(2,4-dichlorophenyl)-2-methyl-5-oxo-5<i>H</i>-pyrrolo[3,4-<i>b</i>]pyridin-6(7<i>H</i>)-yl)-<i>N</i>-methylacetamide, TFA Salt (<b>2r</b>)</h3><div class="NLM_p last">74% yield over two steps. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 2.63 (s, 3 H), 2.74 (s, 3 H), 3.86 and 4.11 (AB<sub>q</sub>, <i>J</i> = 14.5 Hz, 2 H), 4.08 and 4.20 (AB<sub>q</sub>, <i>J</i> = 16.8 Hz, 2 H), 4.50 (s, 2 H), 7.25 (d, <i>J</i> = 8.3 Hz, 1 H), 7.42 (dd, <i>J</i> = 8.3, 1.6 Hz, 1 H), 7.59 (d, <i>J</i> = 1.6 Hz, 1 H). HRMS calculated for C<sub>18</sub>H<sub>19</sub>Cl<sub>2</sub>N<sub>4</sub>O<sub>2</sub>: 393.0885. Found: 393.0894 [M + H]<sup>+</sup>.</div></div><div id="sec3_48" class="NLM_sec NLM_sec_level_2"><div id="ac_i58" class="anchor-spacer"></div><h3 class="article-section__title" id="_i58"> (<i>S</i>)-2-(3-(Aminomethyl)-4-(2,4-dichlorophenyl)-2-methyl-5-oxo-5<i>H</i>-pyrrolo[3,4-<i>b</i>]pyridin-6(7<i>H</i>)-yl)-<i>N</i>-methyl-<i>N</i>-propylacetamide, TFA Salt (<b>2t</b>)</h3><div class="NLM_p last">57% yield over two steps.<sup>1</sup>H NMR (500 MHz, CD<sub>3</sub>OD) δ 0.88 and 0.96 (t, <i>J</i> = 7.3 Hz, 3 H, rotamers), 1.56 and 1.68 (q, <i>J</i> = 7.2 Hz, 2 H, rotamers), 2.84 (s, 3 H), 2.92 and 3.06 (s, 3 H, rotamers), 3.26–3.41 (m, 2 H), 3.96 and 4.20 (AB<sub>q</sub>, <i>J</i> = 14.3 Hz, 2 H), 4.33–4.61 (m, 4 H), 7.34 (d, <i>J</i> = 7.7 Hz, 1 H), 7.51 (d, <i>J</i> = 8.3 Hz, 1 H), 7.68 (s, 1H). HRMS calculated for C<sub>21</sub>H<sub>25</sub>Cl<sub>2</sub>N<sub>4</sub>O<sub>2</sub>: 435.1355. Found: 435.1368 [M + H]<sup>+</sup>.</div></div><div id="sec3_49" class="NLM_sec NLM_sec_level_2"><div id="ac_i59" class="anchor-spacer"></div><h3 class="article-section__title" id="_i59"> (<i>S</i>)-3-(Aminomethyl)-4-(2,4-dichlorophenyl)-2-methyl-6-(2-oxo-2-(pyrrolidin-1-yl)ethyl)-6,7-dihydro-5<i>H</i>-pyrrolo[3,4-<i>b</i>]pyridin-5-one, TFA Salt (<b>2u</b>)</h3><div class="NLM_p last">45% yield over two steps. <sup>1</sup>H NMR (500 MHz, CD<sub>3</sub>OD) δ 1.83–1.95 (m, 2 H), 1.96–2.09 (m, 2 H), 2.84 (s, 3 H), 3.43 (t, <i>J</i> = 6.9 Hz, 2 H), 3.52 (t, <i>J</i> = 6.9 Hz, 2 H), 3.96 and 4.20 (AB<sub>q</sub>, <i>J</i> = 14.3 Hz, 2 H), 4.33 and 4.44 (AB<sub>q</sub>, <i>J</i> = 17.1 Hz, 2 H), 4.62 (s, 2 H), 7.34 (d, <i>J</i> = 8.3 Hz, 1 H), 7.51 (d, <i>J</i> = 8.3 Hz, 1 H), 7.69 (s, 1 H). HRMS calculated for C<sub>21</sub>H<sub>23</sub>Cl<sub>2</sub>N<sub>4</sub>O<sub>2</sub>: 433.1198. Found: 433.1194 [M + H]<sup>+</sup>.</div></div><div id="sec3_50" class="NLM_sec NLM_sec_level_2"><div id="ac_i60" class="anchor-spacer"></div><h3 class="article-section__title" id="_i60"> (<i>S</i>)-3-(Aminomethyl)-4-(2,4-dichlorophenyl)-2-methyl-6-(2-oxo-2-(piperidin-1-yl)ethyl)-6,7-dihydro-5<i>H</i>-pyrrolo[3,4-<i>b</i>]pyridin-5-one, TFA Salt (<b>2v</b>)</h3><div class="NLM_p last">60% yield over two steps. <sup>1</sup>H NMR (500 MHz, CD<sub>3</sub>OD) δ 1.55 (m, 2 H), 1.65 (m, <i>J</i> = 24.2, 3.9 Hz, 4 H), 2.84 (s, 3 H), 3.47 (t, <i>J</i> = 5.3, 2H), 3.52 (t, <i>J</i> = 5.0, 2H), 3.96 and 4.20 (AB<sub>q</sub>, <i>J</i> = 14.6 Hz, 2 H), 4.41 and 4.50 (AB<sub>q</sub>, <i>J</i> = 16.8 Hz, 2 H), 4.59 (s, 2 H), 7.34 (dd, <i>J</i> = 8.3, 2.2 Hz, 1 H), 7.51 (dd, <i>J</i> = 8.3, 1.7 Hz, 1 H), 7.68 (s, 1 H). HRMS calculated for C<sub>22</sub>H<sub>25</sub>Cl<sub>2</sub>N<sub>4</sub>O<sub>2</sub>: 447.1355. Found: 447.1362 [M + H]<sup>+</sup>.</div></div><div id="sec3_51" class="NLM_sec NLM_sec_level_2"><div id="ac_i61" class="anchor-spacer"></div><h3 class="article-section__title" id="_i61"> In Vitro DPP4 Inhibition Assays</h3><div class="NLM_p last">Inhibition of human DPP4 activity was measured under steady-state conditions by following the absorbance increase at 405 nm upon the cleavage of the pseudosubstrate, Gly-Pro-<i>p</i>NA. Assays were performed in 96-well plates using a Thermomax plate reader. Typical reactions contained 100 μL of ATE buffer (100 mM Aces, 52 mM Tris, 52 mM ethanolamine, pH 7.4), 0.45 nM enzyme, either 120 or 1000 μM substrate (<i>S</i> < <i>K</i><sub>m</sub> and <i>S</i> > <i>K</i><sub>m</sub>, <i>K</i><sub>m</sub> = 180 μM) and 10 or 11 concentrations of the inhibitor. To ensure steady-state conditions for slow-binding inhibitors, enzyme was preincubated with the compound for 40 min prior to substrate addition. All serial inhibitor dilutions were in DMSO, and final solvent concentration did not exceed 1%. Inhibitor potency was evaluated by calculating IC<sub>50</sub> values at each substrate concentration and then converting them to <i>K</i><sub>i</sub> values by assuming competitive inhibition according to the equation <i>K</i><sub>i</sub> = IC<sub>50</sub>/[1 + (<i>S</i>/<i>K</i><sub>m</sub>)]. All inhibitors were competitive as judged by close agreement of <i>K</i><sub>i</sub> values obtained from assays at high and low substrate concentrations. In cases where IC<sub>50</sub> at the low substrate concentration was close to the enzyme concentration used in the assay, the data were fit to the Morrison equation to account for the depletion of the free inhibitor.</div></div><div id="sec3_52" class="NLM_sec NLM_sec_level_2"><div id="ac_i62" class="anchor-spacer"></div><h3 class="article-section__title" id="_i62"> Oral Glucose Tolerance Test in ob/ob Mice</h3><div class="NLM_p last">Male 13- to 14 week-old ob/ob mice (Jackson Labs) were maintained under constant temperature and humidity conditions and a 12 h/12 h light–dark cycle and had free access to a 10% fat rodent diet (D1245B Research Diets) and tap water. After an overnight fasting period, animals were dosed orally with vehicle (water) or DPP4 inhibitor (0.1–10 μmol/kg) at −60 min. Two blood samples were collected at −60 and 0 min by tail bleed for glucose and insulin determinations. Glucose (2 g/kg) was then administered orally (at 0 min). Additional blood samples were collected at 15, 30, 60, 90, and 120 min for glucose and insulin determinations. Blood samples were collected into EDTA containing tubes (Sarstedt). Plasma glucose was determined with an Accu-Chek Advantage (Roche) glucometer. Plasma insulin was assayed using a mouse insulin ELISA kit (ALPCO Diagnostics). Data represent the mean of 12–24 mice/group. Data analysis was performed using one way ANOVA followed by Dunnett’s test. All procedures were performed according to BMS-IACUC guidelines.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id=""></div><div class="testing" data-doi="10.1021/jm4008906" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_20584" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_20584" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Pratik Devasthale</span> - <span class="hlFld-Affiliation affiliation">†Metabolic Diseases Chemistry, ‡Metabolic Diseases
Biology, §Pharmaceutical
Candidate Optimization, ∥Protein Science and Structure, ⊥Computer-Assisted Drug Design, Bristol-Myers Squibb Research
and Development, Princeton, New Jersey 08543-5400, United States</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#daaaa8bbaeb3b1f4bebfacbba9aeb2bbb6bf9ab8b7a9f4b9b5b7"><span class="__cf_email__" data-cfemail="45353724312c2e6b2120332436312d242920052728366b262a28">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ying Wang</span> - <span class="hlFld-Affiliation affiliation">†Metabolic Diseases Chemistry, ‡Metabolic Diseases
Biology, §Pharmaceutical
Candidate Optimization, ∥Protein Science and Structure, ⊥Computer-Assisted Drug Design, Bristol-Myers Squibb Research
and Development, Princeton, New Jersey 08543-5400, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Wei Wang</span> - <span class="hlFld-Affiliation affiliation">†Metabolic Diseases Chemistry, ‡Metabolic Diseases
Biology, §Pharmaceutical
Candidate Optimization, ∥Protein Science and Structure, ⊥Computer-Assisted Drug Design, Bristol-Myers Squibb Research
and Development, Princeton, New Jersey 08543-5400, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">John Fevig</span> - <span class="hlFld-Affiliation affiliation">†Metabolic Diseases Chemistry, ‡Metabolic Diseases
Biology, §Pharmaceutical
Candidate Optimization, ∥Protein Science and Structure, ⊥Computer-Assisted Drug Design, Bristol-Myers Squibb Research
and Development, Princeton, New Jersey 08543-5400, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">JianXin Feng</span> - <span class="hlFld-Affiliation affiliation">†Metabolic Diseases Chemistry, ‡Metabolic Diseases
Biology, §Pharmaceutical
Candidate Optimization, ∥Protein Science and Structure, ⊥Computer-Assisted Drug Design, Bristol-Myers Squibb Research
and Development, Princeton, New Jersey 08543-5400, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Aiying Wang</span> - <span class="hlFld-Affiliation affiliation">†Metabolic Diseases Chemistry, ‡Metabolic Diseases
Biology, §Pharmaceutical
Candidate Optimization, ∥Protein Science and Structure, ⊥Computer-Assisted Drug Design, Bristol-Myers Squibb Research
and Development, Princeton, New Jersey 08543-5400, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Tom Harrity</span> - <span class="hlFld-Affiliation affiliation">†Metabolic Diseases Chemistry, ‡Metabolic Diseases
Biology, §Pharmaceutical
Candidate Optimization, ∥Protein Science and Structure, ⊥Computer-Assisted Drug Design, Bristol-Myers Squibb Research
and Development, Princeton, New Jersey 08543-5400, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Don Egan</span> - <span class="hlFld-Affiliation affiliation">†Metabolic Diseases Chemistry, ‡Metabolic Diseases
Biology, §Pharmaceutical
Candidate Optimization, ∥Protein Science and Structure, ⊥Computer-Assisted Drug Design, Bristol-Myers Squibb Research
and Development, Princeton, New Jersey 08543-5400, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Nathan Morgan</span> - <span class="hlFld-Affiliation affiliation">†Metabolic Diseases Chemistry, ‡Metabolic Diseases
Biology, §Pharmaceutical
Candidate Optimization, ∥Protein Science and Structure, ⊥Computer-Assisted Drug Design, Bristol-Myers Squibb Research
and Development, Princeton, New Jersey 08543-5400, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Michael Cap</span> - <span class="hlFld-Affiliation affiliation">†Metabolic Diseases Chemistry, ‡Metabolic Diseases
Biology, §Pharmaceutical
Candidate Optimization, ∥Protein Science and Structure, ⊥Computer-Assisted Drug Design, Bristol-Myers Squibb Research
and Development, Princeton, New Jersey 08543-5400, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Aberra Fura</span> - <span class="hlFld-Affiliation affiliation">†Metabolic Diseases Chemistry, ‡Metabolic Diseases
Biology, §Pharmaceutical
Candidate Optimization, ∥Protein Science and Structure, ⊥Computer-Assisted Drug Design, Bristol-Myers Squibb Research
and Development, Princeton, New Jersey 08543-5400, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Herbert E. Klei</span> - <span class="hlFld-Affiliation affiliation">†Metabolic Diseases Chemistry, ‡Metabolic Diseases
Biology, §Pharmaceutical
Candidate Optimization, ∥Protein Science and Structure, ⊥Computer-Assisted Drug Design, Bristol-Myers Squibb Research
and Development, Princeton, New Jersey 08543-5400, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kevin Kish</span> - <span class="hlFld-Affiliation affiliation">†Metabolic Diseases Chemistry, ‡Metabolic Diseases
Biology, §Pharmaceutical
Candidate Optimization, ∥Protein Science and Structure, ⊥Computer-Assisted Drug Design, Bristol-Myers Squibb Research
and Development, Princeton, New Jersey 08543-5400, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Carolyn Weigelt</span> - <span class="hlFld-Affiliation affiliation">†Metabolic Diseases Chemistry, ‡Metabolic Diseases
Biology, §Pharmaceutical
Candidate Optimization, ∥Protein Science and Structure, ⊥Computer-Assisted Drug Design, Bristol-Myers Squibb Research
and Development, Princeton, New Jersey 08543-5400, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Lucy Sun</span> - <span class="hlFld-Affiliation affiliation">†Metabolic Diseases Chemistry, ‡Metabolic Diseases
Biology, §Pharmaceutical
Candidate Optimization, ∥Protein Science and Structure, ⊥Computer-Assisted Drug Design, Bristol-Myers Squibb Research
and Development, Princeton, New Jersey 08543-5400, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Paul Levesque</span> - <span class="hlFld-Affiliation affiliation">†Metabolic Diseases Chemistry, ‡Metabolic Diseases
Biology, §Pharmaceutical
Candidate Optimization, ∥Protein Science and Structure, ⊥Computer-Assisted Drug Design, Bristol-Myers Squibb Research
and Development, Princeton, New Jersey 08543-5400, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Frederic Moulin</span> - <span class="hlFld-Affiliation affiliation">†Metabolic Diseases Chemistry, ‡Metabolic Diseases
Biology, §Pharmaceutical
Candidate Optimization, ∥Protein Science and Structure, ⊥Computer-Assisted Drug Design, Bristol-Myers Squibb Research
and Development, Princeton, New Jersey 08543-5400, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yi-Xin Li</span> - <span class="hlFld-Affiliation affiliation">†Metabolic Diseases Chemistry, ‡Metabolic Diseases
Biology, §Pharmaceutical
Candidate Optimization, ∥Protein Science and Structure, ⊥Computer-Assisted Drug Design, Bristol-Myers Squibb Research
and Development, Princeton, New Jersey 08543-5400, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Robert Zahler</span> - <span class="hlFld-Affiliation affiliation">†Metabolic Diseases Chemistry, ‡Metabolic Diseases
Biology, §Pharmaceutical
Candidate Optimization, ∥Protein Science and Structure, ⊥Computer-Assisted Drug Design, Bristol-Myers Squibb Research
and Development, Princeton, New Jersey 08543-5400, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Mark S. Kirby</span> - <span class="hlFld-Affiliation affiliation">†Metabolic Diseases Chemistry, ‡Metabolic Diseases
Biology, §Pharmaceutical
Candidate Optimization, ∥Protein Science and Structure, ⊥Computer-Assisted Drug Design, Bristol-Myers Squibb Research
and Development, Princeton, New Jersey 08543-5400, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Lawrence G. Hamann</span> - <span class="hlFld-Affiliation affiliation">†Metabolic Diseases Chemistry, ‡Metabolic Diseases
Biology, §Pharmaceutical
Candidate Optimization, ∥Protein Science and Structure, ⊥Computer-Assisted Drug Design, Bristol-Myers Squibb Research
and Development, Princeton, New Jersey 08543-5400, United States</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br><sup>×</sup>Deceased.<br /></br></div></li></ul></div><div class="ack" id="ACK-d2372e5432-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i66">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_10558" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_10558" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We thank our colleagues from Discovery Analytical Sciences for their assistance in the characterization of the compounds reported herein, Discovery Synthesis for help with intermediate synthesis at BMS and Syngene, Javed Khan for help with PDB X-ray database depositions, and Fang Moore for help with preparation of the manuscript.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i67" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i67"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i68" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i68"> Abbreviations Used:</h2><tr><td class="NLM_term">hERG EP</td><td class="NLM_def"><p class="first last">human ether-a-go-go related gene</p></td></tr><tr><td class="NLM_term">CYP3A4</td><td class="NLM_def"><p class="first last">cytochrome P450 3A4</p></td></tr><tr><td class="NLM_term">iv</td><td class="NLM_def"><p class="first last">intravenous</p></td></tr><tr><td class="NLM_term">po</td><td class="NLM_def"><p class="first last">per os (oral)</p></td></tr><tr><td class="NLM_term">oGTT</td><td class="NLM_def"><p class="first last">oral glucose tolerance test</p></td></tr><tr><td class="NLM_term">AUC</td><td class="NLM_def"><p class="first last">area under the curve</p></td></tr><tr><td class="NLM_term">PDB</td><td class="NLM_def"><p class="first last">Protein Data Bank</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i69">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_55686" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_55686" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 13 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="note"><p class="first last">Recent DPP4 inhibitors reviews:</p></div><div class="NLM_citation" id="cit1a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Ahren, B.</span><span> </span><span class="NLM_article-title">Emerging Dipeptidyl Peptidase-4 Inhibitors for the Treatment of Diabetes</span> <span class="citation_source-journal">Exp. Opin. Emerging Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">593</span><span class="NLM_x">–</span> <span class="NLM_lpage">607</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=16&amp;doi=10.1021%2Fjm4008906&amp;key=10.1517%2F14728210802584126" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=8&amp;doi=10.1021%2Fjm4008906&amp;key=19046129" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=32&amp;doi=10.1021%2Fjm4008906&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsVCnurjE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2008&pages=593-607&issue=4&author=B.+Ahren&title=Emerging+Dipeptidyl+Peptidase-4+Inhibitors+for+the+Treatment+of+Diabetes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1aR"><div class="casContent"><span class="casTitleNuber">1a</span><div class="casTitle"><span class="NLM_cas:atitle">Emerging dipeptidyl peptidase-4 inhibitors for the treatment of diabetes</span></div><div class="casAuthors">Ahren, Bo</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Emerging Drugs</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">593-607</span>CODEN:
                <span class="NLM_cas:coden">EOEDA3</span>;
        ISSN:<span class="NLM_cas:issn">1472-8214</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Inhibition of dipeptidyl peptidase-4 (DPP-4) prevents the inactivation of glucagon-like peptide-1 (GLP-1).  This increases circulating levels of active GLP-1, stimulates insulin secretion and inhibits glucagon secretion, resulting in lowering of glucose levels and improvement of glycemic control in patients with type 2 diabetes.  Several DPP-4 inhibitors are emerging for therapeutic use.  Most experience exists for sitagliptin, vildagliptin, saxagliptin and alogliptin.  They all improve metabolic control in type 2 diabetes in monotherapy and in combination therapy with metformin, sulfonylurea and thiazolidinediones.  Vildagliptin and alogliptin have also been shown to improve glycemic control when added to insulin therapy, and sitagliptin improves glycemic control in triple therapy with metformin plus thiazolidinedione.  DPP-4 inhibition also shows a favorable safety profile, high tolerability, only a minimal risk of hypoglycemia, and body-wt. neutrality.  The main clin. indication for DPP-4 inhibitors will be in the early stage of type 2 diabetes, in combination with metformin or other treatments in subjects with inadequate glycemic control on these treatments alone.  The durability and long-term safety of DPP-4 inhibition, as well as clin. positioning in relation to GLP-1 mimetics, remain now to be established.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoc18qdMIDGU7Vg90H21EOLACvtfcHk0lizMIC9Noarew"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsVCnurjE&md5=47f973c7343e215dd6d06e770936f5ba</span></div><a href="/servlet/linkout?suffix=cit1a&amp;dbid=16384&amp;doi=10.1517%2F14728210802584126&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F14728210802584126%26sid%3Dliteratum%253Aachs%26aulast%3DAhren%26aufirst%3DB.%26atitle%3DEmerging%2520Dipeptidyl%2520Peptidase-4%2520Inhibitors%2520for%2520the%2520Treatment%2520of%2520Diabetes%26jtitle%3DExp.%2520Opin.%2520Emerging%2520Drugs%26date%3D2008%26volume%3D13%26issue%3D4%26spage%3D593%26epage%3D607" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit1b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Zettl, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schubert-Zsilavecz, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steinhilber, D.</span><span> </span><span class="NLM_article-title">Medicinal Chemistry of Incretin Mimetics and DPP-4 Inhibitors</span> <span class="citation_source-journal">ChemMedChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">179</span><span class="NLM_x">–</span> <span class="NLM_lpage">185</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2010&pages=179-185&author=H.+Zettlauthor=M.+Schubert-Zsilaveczauthor=D.+Steinhilber&title=Medicinal+Chemistry+of+Incretin+Mimetics+and+DPP-4+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZettl%26aufirst%3DH.%26aulast%3DSchubert-Zsilavecz%26aufirst%3DM.%26aulast%3DSteinhilber%26aufirst%3DD.%26atitle%3DMedicinal%2520Chemistry%2520of%2520Incretin%2520Mimetics%2520and%2520DPP-4%2520Inhibitors%26jtitle%3DChemMedChem%26date%3D2010%26volume%3D5%26spage%3D179%26epage%3D185" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Dhillon, S.</span><span> </span><span class="NLM_article-title">Sitagliptin: A Review of Its Use in the Management of Type 2 Diabetes Mellitus</span> <span class="citation_source-journal">Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">70</span><span class="NLM_x"> (</span><span class="NLM_issue">42</span><span class="NLM_x">) </span> <span class="NLM_fpage">489</span><span class="NLM_x">–</span> <span class="NLM_lpage">512</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2010&pages=489-512&issue=42&author=S.+Dhillon&title=Sitagliptin%3A+A+Review+of+Its+Use+in+the+Management+of+Type+2+Diabetes+Mellitus"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDhillon%26aufirst%3DS.%26atitle%3DSitagliptin%253A%2520A%2520Review%2520of%2520Its%2520Use%2520in%2520the%2520Management%2520of%2520Type%25202%2520Diabetes%2520Mellitus%26jtitle%3DDrugs%26date%3D2010%26volume%3D70%26issue%3D42%26spage%3D489%26epage%3D512" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit2b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Kim, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beconi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eiermann, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fisher, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hickey, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kowalchick, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leiting, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lyon, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marsilio, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCann, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petrov, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scapin, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roy, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wyvratt, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, B. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thornberry, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weber, A. E.</span><span> </span><span class="NLM_article-title">(2<i>R</i>)-4-Oxo-4-[3-(trifluoromethyl)-5,6-dihydro[1,2,4]triazolo[4,3-<i>a</i>]pyrazin-7(8<i>H</i>)-yl]-1-(2,4,5-trifluorophenyl)butan-2-amine: A Potent, Orally Active Dipeptidyl Peptidase IV Inhibitor for the Treatment of Type 2 Diabetes</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">141</span><span class="NLM_x">–</span> <span class="NLM_lpage">151</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0493156" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=141-151&issue=1&author=D.+Kimauthor=L.+Wangauthor=M.+Beconiauthor=G.+J.+Eiermannauthor=M.+H.+Fisherauthor=H.+Heauthor=G.+J.+Hickeyauthor=J.+E.+Kowalchickauthor=B.+Leitingauthor=K.+Lyonauthor=F.+Marsilioauthor=M.+E.+McCannauthor=R.+A.+Patelauthor=A.+Petrovauthor=G.+Scapinauthor=S.+B.+Patelauthor=R.+S.+Royauthor=J.+K.+Wuauthor=M.+J.+Wyvrattauthor=B.+B.+Zhangauthor=L.+Zhuauthor=N.+A.+Thornberryauthor=A.+E.+Weber&title=%282R%29-4-Oxo-4-%5B3-%28trifluoromethyl%29-5%2C6-dihydro%5B1%2C2%2C4%5Dtriazolo%5B4%2C3-a%5Dpyrazin-7%288H%29-yl%5D-1-%282%2C4%2C5-trifluorophenyl%29butan-2-amine%3A+A+Potent%2C+Orally+Active+Dipeptidyl+Peptidase+IV+Inhibitor+for+the+Treatment+of+Type+2+Diabetes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2b&amp;dbid=16384&amp;doi=10.1021%2Fjm0493156&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0493156%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DD.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DBeconi%26aufirst%3DM.%26aulast%3DEiermann%26aufirst%3DG.%2BJ.%26aulast%3DFisher%26aufirst%3DM.%2BH.%26aulast%3DHe%26aufirst%3DH.%26aulast%3DHickey%26aufirst%3DG.%2BJ.%26aulast%3DKowalchick%26aufirst%3DJ.%2BE.%26aulast%3DLeiting%26aufirst%3DB.%26aulast%3DLyon%26aufirst%3DK.%26aulast%3DMarsilio%26aufirst%3DF.%26aulast%3DMcCann%26aufirst%3DM.%2BE.%26aulast%3DPatel%26aufirst%3DR.%2BA.%26aulast%3DPetrov%26aufirst%3DA.%26aulast%3DScapin%26aufirst%3DG.%26aulast%3DPatel%26aufirst%3DS.%2BB.%26aulast%3DRoy%26aufirst%3DR.%2BS.%26aulast%3DWu%26aufirst%3DJ.%2BK.%26aulast%3DWyvratt%26aufirst%3DM.%2BJ.%26aulast%3DZhang%26aufirst%3DB.%2BB.%26aulast%3DZhu%26aufirst%3DL.%26aulast%3DThornberry%26aufirst%3DN.%2BA.%26aulast%3DWeber%26aufirst%3DA.%2BE.%26atitle%3D%25282R%2529-4-Oxo-4-%255B3-%2528trifluoromethyl%2529-5%252C6-dihydro%255B1%252C2%252C4%255Dtriazolo%255B4%252C3-a%255Dpyrazin-7%25288H%2529-yl%255D-1-%25282%252C4%252C5-trifluorophenyl%2529butan-2-amine%253A%2520A%2520Potent%252C%2520Orally%2520Active%2520Dipeptidyl%2520Peptidase%2520IV%2520Inhibitor%2520for%2520the%2520Treatment%2520of%2520Type%25202%2520Diabetes%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26issue%3D1%26spage%3D141%26epage%3D151" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Augeri, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robl, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Betebenner, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Magnin, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khanna, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robertson, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simpkins, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taunk, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Han, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abboa-Offei, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cap, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xin, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tao, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tozzo, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Welzel, G. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Egan, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marcinkeviciene, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, S. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biller, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kirby, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parker, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamann, L. G.</span><span> </span><span class="NLM_article-title">Discovery and Preclinical Profile of Saxagliptin (BMS-477118): A Highly Potent, Long-Acting, Orally Active Dipeptidyl Peptidase IV Inhibitor for the Treatment of Type 2 Diabetes</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x"> (</span><span class="NLM_issue">15</span><span class="NLM_x">) </span> <span class="NLM_fpage">5025</span><span class="NLM_x">–</span> <span class="NLM_lpage">5037</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm050261p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref3/cit3a&amp;dbid=32&amp;doi=10.1021%2Fjm4008906&amp;key=1%3ACAS%3A528%3ADC%252BD2MXlsVeltb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=5025-5037&issue=15&author=D.+J.+Augeriauthor=J.+A.+Roblauthor=D.+A.+Betebennerauthor=D.+R.+Magninauthor=A.+Khannaauthor=J.+G.+Robertsonauthor=A.+Wangauthor=L.+M.+Simpkinsauthor=P.+Taunkauthor=Q.+Huangauthor=S.+P.+Hanauthor=B.+Abboa-Offeiauthor=M.+Capauthor=L.+Xinauthor=L.+Taoauthor=E.+Tozzoauthor=G.+E.+Welzelauthor=D.+M.+Eganauthor=J.+Marcinkevicieneauthor=S.+Y.+Changauthor=S.+A.+Billerauthor=M.+S.+Kirbyauthor=R.+A.+Parkerauthor=L.+G.+Hamann&title=Discovery+and+Preclinical+Profile+of+Saxagliptin+%28BMS-477118%29%3A+A+Highly+Potent%2C+Long-Acting%2C+Orally+Active+Dipeptidyl+Peptidase+IV+Inhibitor+for+the+Treatment+of+Type+2+Diabetes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3aR"><div class="casContent"><span class="casTitleNuber">3a</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery and Preclinical Profile of Saxagliptin (BMS-477118): A Highly Potent, Long-Acting, Orally Active Dipeptidyl Peptidase IV Inhibitor for the Treatment of Type 2 Diabetes</span></div><div class="casAuthors">Augeri, David J.; Robl, Jeffrey A.; Betebenner, David A.; Magnin, David R.; Khanna, Ashish; Robertson, James G.; Wang, Aiying; Simpkins, Ligaya M.; Taunk, Prakash; Huang, Qi; Han, Song-Ping; Abboa-Offei, Benoni; Cap, Michael; Xin, Li; Tao, Li; Tozzo, Effie; Welzel, Gustav E.; Egan, Donald M.; Marcinkeviciene, Jovita; Chang, Shu Y.; Biller, Scott A.; Kirby, Mark S.; Parker, Rex A.; Hamann, Lawrence G.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">5025-5037</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Efforts to further elucidate structure-activity relationships (SAR) within the authors previously disclosed series of β-quaternary amino acid linked L-cis-4,5-methanoprolinenitrile dipeptidyl peptidase IV (DPP-IV) inhibitors led to the investigation of vinyl substitution at the β-position of α-cycloalkyl-substituted glycines.  Despite poor systemic exposure, vinyl-substituted compds. showed extended duration of action in acute rat ex vivo plasma DPP-IV inhibition models.  Oxygenated putative metabolites were prepd. and were shown to exhibit the potency and extended duration of action of their precursors in efficacy models measuring glucose clearance in Zuckerfa/fa rats.  Extension of this approach to adamantylglycine-derived inhibitors led to the discovery of highly potent inhibitors, including hydroxyadamantyl compd. BMS-477118 (saxagliptin), a highly efficacious, stable, and long-acting DPP-IV inhibitor, which is currently undergoing clin. trials for treatment of type 2 diabetes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpGrIJX7K8p67Vg90H21EOLACvtfcHk0lizyh2fnFkPrw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXlsVeltb0%253D&md5=878355880133bb0ddd6bd14ecbf1d070</span></div><a href="/servlet/linkout?suffix=cit3a&amp;dbid=16384&amp;doi=10.1021%2Fjm050261p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm050261p%26sid%3Dliteratum%253Aachs%26aulast%3DAugeri%26aufirst%3DD.%2BJ.%26aulast%3DRobl%26aufirst%3DJ.%2BA.%26aulast%3DBetebenner%26aufirst%3DD.%2BA.%26aulast%3DMagnin%26aufirst%3DD.%2BR.%26aulast%3DKhanna%26aufirst%3DA.%26aulast%3DRobertson%26aufirst%3DJ.%2BG.%26aulast%3DWang%26aufirst%3DA.%26aulast%3DSimpkins%26aufirst%3DL.%2BM.%26aulast%3DTaunk%26aufirst%3DP.%26aulast%3DHuang%26aufirst%3DQ.%26aulast%3DHan%26aufirst%3DS.%2BP.%26aulast%3DAbboa-Offei%26aufirst%3DB.%26aulast%3DCap%26aufirst%3DM.%26aulast%3DXin%26aufirst%3DL.%26aulast%3DTao%26aufirst%3DL.%26aulast%3DTozzo%26aufirst%3DE.%26aulast%3DWelzel%26aufirst%3DG.%2BE.%26aulast%3DEgan%26aufirst%3DD.%2BM.%26aulast%3DMarcinkeviciene%26aufirst%3DJ.%26aulast%3DChang%26aufirst%3DS.%2BY.%26aulast%3DBiller%26aufirst%3DS.%2BA.%26aulast%3DKirby%26aufirst%3DM.%2BS.%26aulast%3DParker%26aufirst%3DR.%2BA.%26aulast%3DHamann%26aufirst%3DL.%2BG.%26atitle%3DDiscovery%2520and%2520Preclinical%2520Profile%2520of%2520Saxagliptin%2520%2528BMS-477118%2529%253A%2520A%2520Highly%2520Potent%252C%2520Long-Acting%252C%2520Orally%2520Active%2520Dipeptidyl%2520Peptidase%2520IV%2520Inhibitor%2520for%2520the%2520Treatment%2520of%2520Type%25202%2520Diabetes%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26issue%3D15%26spage%3D5025%26epage%3D5037" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit3b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Dhillon, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weber, J.</span><span> </span><span class="NLM_article-title">Saxagliptin</span> <span class="citation_source-journal">Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">69</span><span class="NLM_x"> (</span><span class="NLM_issue">15</span><span class="NLM_x">) </span> <span class="NLM_fpage">2103</span><span class="NLM_x">–</span> <span class="NLM_lpage">2114</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2009&pages=2103-2114&issue=15&author=S.+Dhillonauthor=J.+Weber&title=Saxagliptin"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDhillon%26aufirst%3DS.%26aulast%3DWeber%26aufirst%3DJ.%26atitle%3DSaxagliptin%26jtitle%3DDrugs%26date%3D2009%26volume%3D69%26issue%3D15%26spage%3D2103%26epage%3D2114" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Villhauer, E. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brinkman, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naderi, G. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burkey, B. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dunning, B. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prasad, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mangold, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Russell, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hughes, T. E.</span><span> </span><span class="NLM_article-title">1-[[(3-Hydroxy-1-adamantyl)amino]acetyl]-2-cyano-(<i>S</i>)-pyrrolidine: A Potent, Selective, and Orally Bioavailable Dipeptidyl Peptidase IV Inhibitor with Antihyperglycemic Properties</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x"> (</span><span class="NLM_issue">13</span><span class="NLM_x">) </span> <span class="NLM_fpage">2774</span><span class="NLM_x">–</span> <span class="NLM_lpage">2789</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm030091l" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2003&pages=2774-2789&issue=13&author=E.+B.+Villhauerauthor=J.+A.+Brinkmanauthor=G.+B.+Naderiauthor=B.+F.+Burkeyauthor=B.+E.+Dunningauthor=K.+Prasadauthor=B.+L.+Mangoldauthor=M.+E.+Russellauthor=T.+E.+Hughes&title=1-%5B%5B%283-Hydroxy-1-adamantyl%29amino%5Dacetyl%5D-2-cyano-%28S%29-pyrrolidine%3A+A+Potent%2C+Selective%2C+and+Orally+Bioavailable+Dipeptidyl+Peptidase+IV+Inhibitor+with+Antihyperglycemic+Properties"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4a&amp;dbid=16384&amp;doi=10.1021%2Fjm030091l&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm030091l%26sid%3Dliteratum%253Aachs%26aulast%3DVillhauer%26aufirst%3DE.%2BB.%26aulast%3DBrinkman%26aufirst%3DJ.%2BA.%26aulast%3DNaderi%26aufirst%3DG.%2BB.%26aulast%3DBurkey%26aufirst%3DB.%2BF.%26aulast%3DDunning%26aufirst%3DB.%2BE.%26aulast%3DPrasad%26aufirst%3DK.%26aulast%3DMangold%26aufirst%3DB.%2BL.%26aulast%3DRussell%26aufirst%3DM.%2BE.%26aulast%3DHughes%26aufirst%3DT.%2BE.%26atitle%3D1-%255B%255B%25283-Hydroxy-1-adamantyl%2529amino%255Dacetyl%255D-2-cyano-%2528S%2529-pyrrolidine%253A%2520A%2520Potent%252C%2520Selective%252C%2520and%2520Orally%2520Bioavailable%2520Dipeptidyl%2520Peptidase%2520IV%2520Inhibitor%2520with%2520Antihyperglycemic%2520Properties%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2003%26volume%3D46%26issue%3D13%26spage%3D2774%26epage%3D2789" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit4b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Banerjee, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Younis, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soran, H.</span><span> </span><span class="NLM_article-title">Vildagliptin in Clinical Practice: A Review of Literature</span> <span class="citation_source-journal">Expert Opin. Pharmacother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x"> (</span><span class="NLM_issue">16</span><span class="NLM_x">) </span> <span class="NLM_fpage">2745</span><span class="NLM_x">–</span> <span class="NLM_lpage">2757</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=16&amp;doi=10.1021%2Fjm4008906&amp;key=10.1517%2F14656560903302265" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=8&amp;doi=10.1021%2Fjm4008906&amp;key=19874253" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=32&amp;doi=10.1021%2Fjm4008906&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtleksbzN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2009&pages=2745-2757&issue=16&author=M.+Banerjeeauthor=N.+Younisauthor=H.+Soran&title=Vildagliptin+in+Clinical+Practice%3A+A+Review+of+Literature"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4bR"><div class="casContent"><span class="casTitleNuber">4b</span><div class="casTitle"><span class="NLM_cas:atitle">Vildagliptin in clinical practice: a review of literature</span></div><div class="casAuthors">Banerjee, Moulinath; Younis, Naveed; Soran, Handrean</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Pharmacotherapy</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">2745-2757</span>CODEN:
                <span class="NLM_cas:coden">EOPHF7</span>;
        ISSN:<span class="NLM_cas:issn">1465-6566</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Vildagliptin is the second member of the DPP-IV inhibitor class of drugs licensed for the treatment of type 2 diabetes mellitus (T2DM).  The novel action of these drugs has promoted a new outlook in the pathobiol. of T2DM.  This review undertakes to examine the clin. studies published to date, with the aim of evaluating the position of vildagliptin among the drugs that are now available to treat this common dysmetabolic state.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGppN-1Bi-FdXLVg90H21EOLACvtfcHk0lizyh2fnFkPrw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtleksbzN&md5=97786a0b3041e1c49278c7118f1a4948</span></div><a href="/servlet/linkout?suffix=cit4b&amp;dbid=16384&amp;doi=10.1517%2F14656560903302265&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F14656560903302265%26sid%3Dliteratum%253Aachs%26aulast%3DBanerjee%26aufirst%3DM.%26aulast%3DYounis%26aufirst%3DN.%26aulast%3DSoran%26aufirst%3DH.%26atitle%3DVildagliptin%2520in%2520Clinical%2520Practice%253A%2520A%2520Review%2520of%2520Literature%26jtitle%3DExpert%2520Opin.%2520Pharmacother.%26date%3D2009%26volume%3D10%26issue%3D16%26spage%3D2745%26epage%3D2757" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Del Prato, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barnett, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huisman, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neubacher, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woerle, H.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dugi, K. A.</span><span> </span><span class="NLM_article-title">Effect of Linagliptin Monotherapy on Glycaemic Control and Markers of β-Cell Function in Patients with Inadequately Controlled Type 2 Diabetes: A Randomized Controlled Trial</span> <span class="citation_source-journal">Diabetes Obes. Metab.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">258</span><span class="NLM_x">–</span> <span class="NLM_lpage">267</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Fjm4008906&amp;key=10.1111%2Fj.1463-1326.2010.01350.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Fjm4008906&amp;key=21205122" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Fjm4008906&amp;key=1%3ACAS%3A528%3ADC%252BC3MXjtFSgt74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2011&pages=258-267&author=S.+Del+Pratoauthor=A.+H.+Barnettauthor=H.+Huismanauthor=D.+Neubacherauthor=H.-J.+Woerleauthor=K.+A.+Dugi&title=Effect+of+Linagliptin+Monotherapy+on+Glycaemic+Control+and+Markers+of+%CE%B2-Cell+Function+in+Patients+with+Inadequately+Controlled+Type+2+Diabetes%3A+A+Randomized+Controlled+Trial"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Effect of linagliptin monotherapy on glycemic control and markers of β-cell function in patients with inadequately controlled type 2 diabetes: a randomized controlled trial</span></div><div class="casAuthors">del Prato, S.; Barnett, A. H.; Huisman, H.; Neubacher, D.; Woerle, H.-J.; Dugi, K. A.</div><div class="citationInfo"><span class="NLM_cas:title">Diabetes, Obesity and Metabolism</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">258-267</span>CODEN:
                <span class="NLM_cas:coden">DOMEF6</span>;
        ISSN:<span class="NLM_cas:issn">1462-8902</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">To assess the safety and efficacy of the potent and selective dipeptidyl peptidase-4 inhibitor linagliptin 5 mg when given for 24 wk to patients with type 2 diabetes who were either treatment-naive or who had received one oral antidiabetes drug (OAD).  This multicenter, randomized, parallel group, phase III study compared linagliptin treatment (5 mg once daily, n = 336) with placebo (n = 167) for 24 wk in type 2 diabetes patients.  Before randomization, patients pretreated with one OAD underwent a washout period of 6 wk, which included a placebo run-in period during the last 2 wk.  Patients previously untreated with an OAD underwent a 2-wk placebo run-in period.  The primary endpoint was the change in HbA1c from baseline after 24 wk of treatment.  Linagliptin treatment resulted in a placebo-cor. change in HbA1c from baseline of -0.69% (p < 0.0001) at 24 wk.  In patients with baseline HbA1c ≥ 9.0%, the adjusted redn. in HbA1c was 1.01% (p < 0.0001).  Patients treated with linagliptin were more likely to achieve a redn. in HbA1c of ≥0.5% at 24 wk than those in the placebo arm (47.1 and 19.0%, resp.; odds ratio, OR = 4.2, p < 0.0001).  Fasting plasma glucose improved by -1.3 mmol/l (p < 0.0001) with linagliptin vs. placebo, and linagliptin produced an adjusted mean redn. from baseline after 24 wk in 2-h postprandial glucose of -3.2 mmol/l (p < 0.0001).  Statistically significant and relevant treatment differences were obsd. for proinsulin/insulin ratio (p = 0.025), Homeostasis Model Assessment-percent 8 (p = 0.049) and disposition index (p = 0.0005).  There was no excess of hypoglycemic episodes with linagliptin vs. placebo and no patient required third-party intervention.  Mild or moderate renal impairment did not influence the through plasma levels of linagliptin.  monotherapy with linagliptin produced a significant, clin. meaningful and sustained improvement in glycemic control, accompanied by enhanced parameters of β-cell function.  The safety profile of linagliptin was comparable with that of placebo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp4wT5EBdmBrLVg90H21EOLACvtfcHk0lidXiH4XloyyA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXjtFSgt74%253D&md5=eee381cf7037a84d2744fec5bbfcfd43</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1111%2Fj.1463-1326.2010.01350.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1463-1326.2010.01350.x%26sid%3Dliteratum%253Aachs%26aulast%3DDel%2BPrato%26aufirst%3DS.%26aulast%3DBarnett%26aufirst%3DA.%2BH.%26aulast%3DHuisman%26aufirst%3DH.%26aulast%3DNeubacher%26aufirst%3DD.%26aulast%3DWoerle%26aufirst%3DH.-J.%26aulast%3DDugi%26aufirst%3DK.%2BA.%26atitle%3DEffect%2520of%2520Linagliptin%2520Monotherapy%2520on%2520Glycaemic%2520Control%2520and%2520Markers%2520of%2520%25CE%25B2-Cell%2520Function%2520in%2520Patients%2520with%2520Inadequately%2520Controlled%2520Type%25202%2520Diabetes%253A%2520A%2520Randomized%2520Controlled%2520Trial%26jtitle%3DDiabetes%2520Obes.%2520Metab.%26date%3D2011%26volume%3D13%26spage%3D258%26epage%3D267" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Brigance, R. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meng, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fura, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harrity, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zahler, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kirby, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamann, L. G.</span><span> </span><span class="NLM_article-title">Synthesis and SAR of Azolopyrimidines as Potent and Selective Dipeptidyl Peptidase-4 (DPP4) Inhibitors for Type 2 Diabetes</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x"> (</span><span class="NLM_issue">15</span><span class="NLM_x">) </span> <span class="NLM_fpage">4395</span><span class="NLM_x">–</span> <span class="NLM_lpage">4398</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=4395-4398&issue=15&author=R.+P.+Briganceauthor=W.+Mengauthor=A.+Furaauthor=T.+Harrityauthor=A.+Wangauthor=R.+Zahlerauthor=M.+S.+Kirbyauthor=L.+G.+Hamann&title=Synthesis+and+SAR+of+Azolopyrimidines+as+Potent+and+Selective+Dipeptidyl+Peptidase-4+%28DPP4%29+Inhibitors+for+Type+2+Diabetes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBrigance%26aufirst%3DR.%2BP.%26aulast%3DMeng%26aufirst%3DW.%26aulast%3DFura%26aufirst%3DA.%26aulast%3DHarrity%26aufirst%3DT.%26aulast%3DWang%26aufirst%3DA.%26aulast%3DZahler%26aufirst%3DR.%26aulast%3DKirby%26aufirst%3DM.%2BS.%26aulast%3DHamann%26aufirst%3DL.%2BG.%26atitle%3DSynthesis%2520and%2520SAR%2520of%2520Azolopyrimidines%2520as%2520Potent%2520and%2520Selective%2520Dipeptidyl%2520Peptidase-4%2520%2528DPP4%2529%2520Inhibitors%2520for%2520Type%25202%2520Diabetes%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26issue%3D15%26spage%3D4395%26epage%3D4398" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit6b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Meng, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brigance, R. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chao, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fura, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harrity, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marcinkeviciene, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Connor, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tamura, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xie, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klei, H. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weigelt, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tuerdi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zahler, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kirby, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamann, L. G.</span><span> </span><span class="NLM_article-title">Discovery of 6-(Aminomethyl)-5-(2,4-dichlorophenyl)-7-methylimidazo[1,2-<i>a</i>]pyrimidine-2-carboxamides as Potent, Selective Dipeptidyl Peptidase-4 (DPP4) Inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x"> (</span><span class="NLM_issue">15</span><span class="NLM_x">) </span> <span class="NLM_fpage">5620</span><span class="NLM_x">–</span> <span class="NLM_lpage">5628</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm100634a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=5620-5628&issue=15&author=W.+Mengauthor=R.+P.+Briganceauthor=H.+J.+Chaoauthor=A.+Furaauthor=T.+Harrityauthor=J.+Marcinkevicieneauthor=S.+P.+O%E2%80%99Connorauthor=J.+K.+Tamuraauthor=D.+Xieauthor=Y.+Zhangauthor=H.+E.+Kleiauthor=C.+A.+Weigeltauthor=H.+Tuerdiauthor=A.+Wangauthor=R.+Zahlerauthor=M.+S.+Kirbyauthor=L.+G.+Hamann&title=Discovery+of+6-%28Aminomethyl%29-5-%282%2C4-dichlorophenyl%29-7-methylimidazo%5B1%2C2-a%5Dpyrimidine-2-carboxamides+as+Potent%2C+Selective+Dipeptidyl+Peptidase-4+%28DPP4%29+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6b&amp;dbid=16384&amp;doi=10.1021%2Fjm100634a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm100634a%26sid%3Dliteratum%253Aachs%26aulast%3DMeng%26aufirst%3DW.%26aulast%3DBrigance%26aufirst%3DR.%2BP.%26aulast%3DChao%26aufirst%3DH.%2BJ.%26aulast%3DFura%26aufirst%3DA.%26aulast%3DHarrity%26aufirst%3DT.%26aulast%3DMarcinkeviciene%26aufirst%3DJ.%26aulast%3DO%25E2%2580%2599Connor%26aufirst%3DS.%2BP.%26aulast%3DTamura%26aufirst%3DJ.%2BK.%26aulast%3DXie%26aufirst%3DD.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DKlei%26aufirst%3DH.%2BE.%26aulast%3DWeigelt%26aufirst%3DC.%2BA.%26aulast%3DTuerdi%26aufirst%3DH.%26aulast%3DWang%26aufirst%3DA.%26aulast%3DZahler%26aufirst%3DR.%26aulast%3DKirby%26aufirst%3DM.%2BS.%26aulast%3DHamann%26aufirst%3DL.%2BG.%26atitle%3DDiscovery%2520of%25206-%2528Aminomethyl%2529-5-%25282%252C4-dichlorophenyl%2529-7-methylimidazo%255B1%252C2-a%255Dpyrimidine-2-carboxamides%2520as%2520Potent%252C%2520Selective%2520Dipeptidyl%2520Peptidase-4%2520%2528DPP4%2529%2520Inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26issue%3D15%26spage%3D5620%26epage%3D5628" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit6c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Wang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Devasthale, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harrity, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Egan, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morgan, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cap, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fura, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klei, H. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kish, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weigelt, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levesque, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Y.-X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zahler, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kirby, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamann, L. G.</span><span> </span><span class="NLM_article-title">7-Oxopyrrolopyridine-Derived DPP4 Inhibitors—Mitigation of CYP and hERG Liabilities via Introduction of Polar Functionalities in the Active Site</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x"> (</span><span class="NLM_issue">22</span><span class="NLM_x">) </span> <span class="NLM_fpage">6646</span><span class="NLM_x">–</span> <span class="NLM_lpage">6651</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=6646-6651&issue=22&author=W.+Wangauthor=P.+Devasthaleauthor=A.+Wangauthor=T.+Harrityauthor=D.+Eganauthor=N.+Morganauthor=M.+Capauthor=A.+Furaauthor=H.+E.+Kleiauthor=K.+Kishauthor=C.+A.+Weigeltauthor=L.+Sunauthor=P.+Levesqueauthor=Y.-X.+Liauthor=R.+Zahlerauthor=M.+S.+Kirbyauthor=L.+G.+Hamann&title=7-Oxopyrrolopyridine-Derived+DPP4+Inhibitors%E2%80%94Mitigation+of+CYP+and+hERG+Liabilities+via+Introduction+of+Polar+Functionalities+in+the+Active+Site"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DW.%26aulast%3DDevasthale%26aufirst%3DP.%26aulast%3DWang%26aufirst%3DA.%26aulast%3DHarrity%26aufirst%3DT.%26aulast%3DEgan%26aufirst%3DD.%26aulast%3DMorgan%26aufirst%3DN.%26aulast%3DCap%26aufirst%3DM.%26aulast%3DFura%26aufirst%3DA.%26aulast%3DKlei%26aufirst%3DH.%2BE.%26aulast%3DKish%26aufirst%3DK.%26aulast%3DWeigelt%26aufirst%3DC.%2BA.%26aulast%3DSun%26aufirst%3DL.%26aulast%3DLevesque%26aufirst%3DP.%26aulast%3DLi%26aufirst%3DY.-X.%26aulast%3DZahler%26aufirst%3DR.%26aulast%3DKirby%26aufirst%3DM.%2BS.%26aulast%3DHamann%26aufirst%3DL.%2BG.%26atitle%3D7-Oxopyrrolopyridine-Derived%2520DPP4%2520Inhibitors%25E2%2580%2594Mitigation%2520of%2520CYP%2520and%2520hERG%2520Liabilities%2520via%2520Introduction%2520of%2520Polar%2520Functionalities%2520in%2520the%2520Active%2520Site%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D21%26issue%3D22%26spage%3D6646%26epage%3D6651" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit6d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">O’Connor, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simpkins, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brigance, R. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meng, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kirby, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weigelt, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamann, L. G.</span><span> </span><span class="NLM_article-title">Synthesis, SAR, and Atropisomerism of Imidazolopyrimidine DPP4 Inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">6273</span><span class="NLM_x">–</span> <span class="NLM_lpage">6276</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=6273-6276&author=S.+P.+O%E2%80%99Connorauthor=Y.+Wangauthor=L.+M.+Simpkinsauthor=R.+P.+Briganceauthor=W.+Mengauthor=A.+Wangauthor=M.+S.+Kirbyauthor=C.+A.+Weigeltauthor=L.+G.+Hamann&title=Synthesis%2C+SAR%2C+and+Atropisomerism+of+Imidazolopyrimidine+DPP4+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6d&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DO%25E2%2580%2599Connor%26aufirst%3DS.%2BP.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DSimpkins%26aufirst%3DL.%2BM.%26aulast%3DBrigance%26aufirst%3DR.%2BP.%26aulast%3DMeng%26aufirst%3DW.%26aulast%3DWang%26aufirst%3DA.%26aulast%3DKirby%26aufirst%3DM.%2BS.%26aulast%3DWeigelt%26aufirst%3DC.%2BA.%26aulast%3DHamann%26aufirst%3DL.%2BG.%26atitle%3DSynthesis%252C%2520SAR%252C%2520and%2520Atropisomerism%2520of%2520Imidazolopyrimidine%2520DPP4%2520Inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D6273%26epage%3D6276" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit6e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">Kirby, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, D. M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Connor, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gorrell, M. D.</span><span> </span><span class="NLM_article-title">Inhibitor Selectivity in the Clinical Application of Dipeptidyl Peptidase-4 Inhibition</span> <span class="citation_source-journal">Clin. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">118</span><span class="NLM_x">, </span> <span class="NLM_fpage">31</span><span class="NLM_x">–</span> <span class="NLM_lpage">41</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6e&amp;dbid=16&amp;doi=10.1021%2Fjm4008906&amp;key=10.1042%2FCS20090047" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6e&amp;dbid=32&amp;doi=10.1021%2Fjm4008906&amp;key=1%3ACAS%3A528%3ADC%252BD1MXht1WntbrL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=118&publication_year=2010&pages=31-41&author=M.+Kirbyauthor=D.+M.+T.+Yuauthor=S.+P.+O%E2%80%99Connorauthor=M.+D.+Gorrell&title=Inhibitor+Selectivity+in+the+Clinical+Application+of+Dipeptidyl+Peptidase-4+Inhibition"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6eR"><div class="casContent"><span class="casTitleNuber">6e</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibitor selectivity in the clinical application of dipeptidyl peptidase-4 inhibition</span></div><div class="casAuthors">Kirby, Mark; Yu, Denise M. T.; O'Connor, Steven; Gorrell, Mark D.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Science</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">118</span>
        (<span class="NLM_cas:issue">1/2</span>),
    <span class="NLM_cas:pages">31-41</span>CODEN:
                <span class="NLM_cas:coden">CSCIAE</span>;
        ISSN:<span class="NLM_cas:issn">0143-5221</span>.
    
            (<span class="NLM_cas:orgname">Portland Press Ltd.</span>)
        </div><div class="casAbstract">A review.  DPP-4 (dipeptidyl peptidase-4) degrades the incretin hormones GLP-1 (glucagon-like peptide-1) and GIP (gastric inhibitory polypeptide), decreasing their stimulatory effects on β-cell insulin secretion.  In patients with Type 2 diabetes, meal-related GLP-1 secretion is reduced.  DPP-4 inhibitors (alogliptin, saxagliptin, sitagliptin and vildagliptin) correct the GLP-1 deficiency by blocking this degrdn., prolonging the incretin effect and enhancing glucose homoeostasis.  DPP-4 is a member of a family of ubiquitous atypical serine proteases with many physiol. functions beyond incretin degrdn., including effects on the endocrine and immune systems.  The role of DPP-4 on the immune system relates to its extra-enzymic activities.  The intracytosolic enzymes DPP-8 and DPP-9 are recently discovered DPP-4 family members.  Although specific functions of DPP-8 and DPP-9 are unclear, a potential for adverse effects assocd. with DPP-8 and DPP-9 inhibition by non-selective DPP inhibitors has been posed based on a single adverse preclin. study.  However, the preponderance of data suggests that such DPP-8 and DPP-9 enzyme inhibition is probably without clin. consequence.  This review examines the structure and function of the DPP-4 family, assocd. DPP-4 inhibitor selectivity and the implications of DPP-4 inhibition in the treatment of Type 2 diabetes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqYcV4MFkHr_bVg90H21EOLACvtfcHk0liBK78qZ5T0NQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXht1WntbrL&md5=ba5650dc1c928a621aea4e30b123b27d</span></div><a href="/servlet/linkout?suffix=cit6e&amp;dbid=16384&amp;doi=10.1042%2FCS20090047&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252FCS20090047%26sid%3Dliteratum%253Aachs%26aulast%3DKirby%26aufirst%3DM.%26aulast%3DYu%26aufirst%3DD.%2BM.%2BT.%26aulast%3DO%25E2%2580%2599Connor%26aufirst%3DS.%2BP.%26aulast%3DGorrell%26aufirst%3DM.%2BD.%26atitle%3DInhibitor%2520Selectivity%2520in%2520the%2520Clinical%2520Application%2520of%2520Dipeptidyl%2520Peptidase-4%2520Inhibition%26jtitle%3DClin.%2520Sci.%26date%3D2010%26volume%3D118%26spage%3D31%26epage%3D41" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Lankas, G. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leiting, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roy, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eiermann, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beconi, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biftu, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, C.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edmondson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feeney, W. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ippolito, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lyons, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ok, H. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petrov, A. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pryor, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qian, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reigle, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woods, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zaller, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weber, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thornberry, N. A.</span><span> </span><span class="NLM_article-title">Dipeptidyl Peptidase IV Inhibition for the Treatment of Type 2 Diabetes. Potential Importance of Selectivity over Dipeptidyl Peptidases 8 and 9</span> <span class="citation_source-journal">Diabetes</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">2988</span><span class="NLM_x">–</span> <span class="NLM_lpage">2994</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2005&pages=2988-2994&author=G.+R.+Lankasauthor=B.+Leitingauthor=R.+S.+Royauthor=G.+J.+Eiermannauthor=M.+G.+Beconiauthor=T.+Biftuauthor=C.-C.+Chanauthor=S.+Edmondsonauthor=W.+P.+Feeneyauthor=H.+Heauthor=D.+E.+Ippolitoauthor=D.+Kimauthor=K.+A.+Lyonsauthor=H.+A.+Okauthor=R.+A.+Patelauthor=A.+N.+Petrovauthor=K.+A.+Pryorauthor=X.+Qianauthor=L.+Reigleauthor=A.+Woodsauthor=J.+K.+Wuauthor=D.+Zallerauthor=X.+Zhangauthor=L.+Zuauthor=A.+E.+Weberauthor=N.+A.+Thornberry&title=Dipeptidyl+Peptidase+IV+Inhibition+for+the+Treatment+of+Type+2+Diabetes.+Potential+Importance+of+Selectivity+over+Dipeptidyl+Peptidases+8+and+9"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLankas%26aufirst%3DG.%2BR.%26aulast%3DLeiting%26aufirst%3DB.%26aulast%3DRoy%26aufirst%3DR.%2BS.%26aulast%3DEiermann%26aufirst%3DG.%2BJ.%26aulast%3DBeconi%26aufirst%3DM.%2BG.%26aulast%3DBiftu%26aufirst%3DT.%26aulast%3DChan%26aufirst%3DC.-C.%26aulast%3DEdmondson%26aufirst%3DS.%26aulast%3DFeeney%26aufirst%3DW.%2BP.%26aulast%3DHe%26aufirst%3DH.%26aulast%3DIppolito%26aufirst%3DD.%2BE.%26aulast%3DKim%26aufirst%3DD.%26aulast%3DLyons%26aufirst%3DK.%2BA.%26aulast%3DOk%26aufirst%3DH.%2BA.%26aulast%3DPatel%26aufirst%3DR.%2BA.%26aulast%3DPetrov%26aufirst%3DA.%2BN.%26aulast%3DPryor%26aufirst%3DK.%2BA.%26aulast%3DQian%26aufirst%3DX.%26aulast%3DReigle%26aufirst%3DL.%26aulast%3DWoods%26aufirst%3DA.%26aulast%3DWu%26aufirst%3DJ.%2BK.%26aulast%3DZaller%26aufirst%3DD.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DZu%26aufirst%3DL.%26aulast%3DWeber%26aufirst%3DA.%2BE.%26aulast%3DThornberry%26aufirst%3DN.%2BA.%26atitle%3DDipeptidyl%2520Peptidase%2520IV%2520Inhibition%2520for%2520the%2520Treatment%2520of%2520Type%25202%2520Diabetes.%2520Potential%2520Importance%2520of%2520Selectivity%2520over%2520Dipeptidyl%2520Peptidases%25208%2520and%25209%26jtitle%3DDiabetes%26date%3D2005%26volume%3D54%26spage%3D2988%26epage%3D2994" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit7b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Kushner, P.; Gorrell, M.</span><span> </span><span class="NLM_article-title">DPP-4 Inhibitors in Type 2 Diabetes: Importance of Selective Enzyme Inhibition and Implications for Clinical Use</span> <span class="citation_source-journal">J. Fam. Pract.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span>), <a href="http://www.jfponline.com/Pages.asp?AID=8408" class="extLink">http://www.jfponline.com/Pages.asp?AID=8408</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2010&issue=2&author=P.+Kushner&author=M.+Gorrell&title=DPP-4+Inhibitors+in+Type+2+Diabetes%3A+Importance+of+Selective+Enzyme+Inhibition+and+Implications+for+Clinical+Use"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKushner%26aufirst%3DP.%26atitle%3DDPP-4%2520Inhibitors%2520in%2520Type%25202%2520Diabetes%253A%2520Importance%2520of%2520Selective%2520Enzyme%2520Inhibition%2520and%2520Implications%2520for%2520Clinical%2520Use%26jtitle%3DJ.%2520Fam.%2520Pract.%26date%3D2010%26volume%3D59%26issue%3D2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit7c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Burkey, B. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoffmann, P. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hassiepen, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trappe, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Juedes, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foley, J. E.</span><span> </span><span class="NLM_article-title">Adverse Effects of Dipeptidyl Peptidases 8 and 9 Inhibition in Rodents Revisited</span> <span class="citation_source-journal">Diabetes Obes. Metab.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">1057</span><span class="NLM_x">–</span> <span class="NLM_lpage">1061</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7c&amp;dbid=16&amp;doi=10.1021%2Fjm4008906&amp;key=10.1111%2Fj.1463-1326.2008.00860.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7c&amp;dbid=8&amp;doi=10.1021%2Fjm4008906&amp;key=18422675" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7c&amp;dbid=32&amp;doi=10.1021%2Fjm4008906&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsVeqsLfJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2008&pages=1057-1061&author=B.+F.+Burkeyauthor=P.+K.+Hoffmannauthor=U.+Hassiepenauthor=J.+Trappeauthor=M.+Juedesauthor=J.+E.+Foley&title=Adverse+Effects+of+Dipeptidyl+Peptidases+8+and+9+Inhibition+in+Rodents+Revisited"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7cR"><div class="casContent"><span class="casTitleNuber">7c</span><div class="casTitle"><span class="NLM_cas:atitle">Adverse effects of dipeptidyl peptidases 8 and 9 inhibition in rodents revisited</span></div><div class="casAuthors">Burkey, B. F.; Hoffmann, P. K.; Hassiepen, U.; Trappe, J.; Juedes, M.; Foley, J. E.</div><div class="citationInfo"><span class="NLM_cas:title">Diabetes, Obesity and Metabolism</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1057-1061</span>CODEN:
                <span class="NLM_cas:coden">DOMEF6</span>;
        ISSN:<span class="NLM_cas:issn">1462-8902</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Aim: To evaluate the assocn. between inhibition of dipeptidyl peptidase (DPP)-8 and/or DPP-9 organ toxicities and mortality in rodents.  Research Design and Methods: The relative selectivity of the DPP-4 inhibitor, vildagliptin, was detd. by comparing its KI (concn. of compd. yielding 50% inhibition of the enzyme) values for inhibition of recombinant human DPP-4, DPP-8 and DPP-9 assessed in vitro.  In expts. performed in vivo, vildagliptin was administered by gavage for 13 wk, at doses up to 1500 mg/kg/day in CD-1 mice and at doses up to 900 mg/kg/day in Wistar rats.  Plasma concns. of vildagliptin were assessed at week 12, and toxicities previously ascribed to inhibition of DPP-8 and/or DPP-9 were assessed at week 13.  Results: The KI values for vildagliptin-induced inhibition of DPP-4, DPP-8 and DPP-9 were 3, 810 and 95 nM resp.  The mean plasma concn. 24 h after dose after 12-wk daily dosing with 1500 mg/kg/day in mice was 2279 nM.  The mean plasma drug level 24 h after dose after 12-wk daily dosing with 900 mg/kg/day in rats was 5729 nM.  These high doses maintained plasma drug levels well above the KI values for DPP-8 and DPP-9 throughout a 24-h period.  At these high doses, the toxicities of a selective DPP-8/DPP-9 inhibitor that were reported previously (100% mortality in mice, alopecia, thrombocytopenia, reticulocytopenia, enlarged lymph nodes, splenomegaly and 20% mortality in rats) were not obsd.  Conclusions: Inhibition of DPP-8 and DPP-9 per se does not lead to organ toxicities and mortality in rodents.  Thus, a mechanism other than DPP-8/DPP-9 inhibition likely underlies the toxicity previously reported to be assocd. with a selective DPP-8/DPP-9 inhibitor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoY8zdsP6qpIbVg90H21EOLACvtfcHk0lhp5F4qf_j87Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsVeqsLfJ&md5=0da6c4f34499ce1f558e28b877142519</span></div><a href="/servlet/linkout?suffix=cit7c&amp;dbid=16384&amp;doi=10.1111%2Fj.1463-1326.2008.00860.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1463-1326.2008.00860.x%26sid%3Dliteratum%253Aachs%26aulast%3DBurkey%26aufirst%3DB.%2BF.%26aulast%3DHoffmann%26aufirst%3DP.%2BK.%26aulast%3DHassiepen%26aufirst%3DU.%26aulast%3DTrappe%26aufirst%3DJ.%26aulast%3DJuedes%26aufirst%3DM.%26aulast%3DFoley%26aufirst%3DJ.%2BE.%26atitle%3DAdverse%2520Effects%2520of%2520Dipeptidyl%2520Peptidases%25208%2520and%25209%2520Inhibition%2520in%2520Rodents%2520Revisited%26jtitle%3DDiabetes%2520Obes.%2520Metab.%26date%3D2008%26volume%3D10%26spage%3D1057%26epage%3D1061" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit7d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Wu, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, H. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yeh, T. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, C. M</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shy, H. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chu, Y. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chien, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsai, T. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, Y. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, Y. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tseng, H. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiaang, W. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chao, Y. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, X.</span><span> </span><span class="NLM_article-title">Biochemistry, Pharmacokinetics, and Toxicology of a Potent and Selective DPP8/9 Inhibitor</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">78</span><span class="NLM_x">, </span> <span class="NLM_fpage">203</span><span class="NLM_x">–</span> <span class="NLM_lpage">210</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=78&publication_year=2009&pages=203-210&author=J.+J.+Wuauthor=H.+K.+Tangauthor=T.+K.+Yehauthor=C.+M+Chenauthor=H.+S.+Shyauthor=Y.+R.+Chuauthor=C.+H.+Chienauthor=T.+Y.+Tsaiauthor=Y.+C.+Huangauthor=Y.+L.+Huangauthor=C.+H.+Huangauthor=H.+Y.+Tsengauthor=W.+T.+Jiaangauthor=Y.+S.+Chaoauthor=X.+Chen&title=Biochemistry%2C+Pharmacokinetics%2C+and+Toxicology+of+a+Potent+and+Selective+DPP8%2F9+Inhibitor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7d&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DJ.%2BJ.%26aulast%3DTang%26aufirst%3DH.%2BK.%26aulast%3DYeh%26aufirst%3DT.%2BK.%26aulast%3DChen%26aufirst%3DC.%2BM%26aulast%3DShy%26aufirst%3DH.%2BS.%26aulast%3DChu%26aufirst%3DY.%2BR.%26aulast%3DChien%26aufirst%3DC.%2BH.%26aulast%3DTsai%26aufirst%3DT.%2BY.%26aulast%3DHuang%26aufirst%3DY.%2BC.%26aulast%3DHuang%26aufirst%3DY.%2BL.%26aulast%3DHuang%26aufirst%3DC.%2BH.%26aulast%3DTseng%26aufirst%3DH.%2BY.%26aulast%3DJiaang%26aufirst%3DW.%2BT.%26aulast%3DChao%26aufirst%3DY.%2BS.%26aulast%3DChen%26aufirst%3DX.%26atitle%3DBiochemistry%252C%2520Pharmacokinetics%252C%2520and%2520Toxicology%2520of%2520a%2520Potent%2520and%2520Selective%2520DPP8%252F9%2520Inhibitor%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2009%26volume%3D78%26spage%3D203%26epage%3D210" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Peters, J.-U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weber, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kritter, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weiss, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wallier, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zimmerli, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boehringer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steger, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loeffler, B.-M.</span><span> </span><span class="NLM_article-title">Aminomethylpyridines as DPP-IV Inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">3579</span><span class="NLM_x">–</span> <span class="NLM_lpage">3580</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2004&pages=3579-3580&author=J.-U.+Petersauthor=S.+Weberauthor=S.+Kritterauthor=P.+Weissauthor=A.+Wallierauthor=D.+Zimmerliauthor=M.+Boehringerauthor=M.+Stegerauthor=B.-M.+Loeffler&title=Aminomethylpyridines+as+DPP-IV+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPeters%26aufirst%3DJ.-U.%26aulast%3DWeber%26aufirst%3DS.%26aulast%3DKritter%26aufirst%3DS.%26aulast%3DWeiss%26aufirst%3DP.%26aulast%3DWallier%26aufirst%3DA.%26aulast%3DZimmerli%26aufirst%3DD.%26aulast%3DBoehringer%26aufirst%3DM.%26aulast%3DSteger%26aufirst%3DM.%26aulast%3DLoeffler%26aufirst%3DB.-M.%26atitle%3DAminomethylpyridines%2520as%2520DPP-IV%2520Inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2004%26volume%3D14%26spage%3D3579%26epage%3D3580" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit8b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Peters, J.-U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weber, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kritter, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weiss, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wallier, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boehringer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hennig, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuhn, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loeffler, B.-M.</span><span> </span><span class="NLM_article-title">Aminomethylpyrimidines as Novel DPP-IV Inhibitors: A 10(5)-Fold Activity Increase by Optimization of Aromatic Substituents</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">1491</span><span class="NLM_x">–</span> <span class="NLM_lpage">1493</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8b&amp;dbid=16&amp;doi=10.1021%2Fjm4008906&amp;key=10.1016%2Fj.bmcl.2004.01.019" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8b&amp;dbid=8&amp;doi=10.1021%2Fjm4008906&amp;key=15006388" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8b&amp;dbid=32&amp;doi=10.1021%2Fjm4008906&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhvV2itL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2004&pages=1491-1493&author=J.-U.+Petersauthor=S.+Weberauthor=S.+Kritterauthor=P.+Weissauthor=A.+Wallierauthor=M.+Boehringerauthor=M.+Hennigauthor=B.+Kuhnauthor=B.-M.+Loeffler&title=Aminomethylpyrimidines+as+Novel+DPP-IV+Inhibitors%3A+A+10%285%29-Fold+Activity+Increase+by+Optimization+of+Aromatic+Substituents"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8bR"><div class="casContent"><span class="casTitleNuber">8b</span><div class="casTitle"><span class="NLM_cas:atitle">Aminomethylpyrimidines as novel DPP-IV inhibitors: A 100 000-fold activity increase by optimization of aromatic substituents</span></div><div class="casAuthors">Peters, Jens-Uwe; Weber, Silja; Kritter, Stephane; Weiss, Peter; Wallier, Angelina; Boehringer, Markus; Hennig, Michael; Kuhn, Bernd; Loeffler, Bernd-Michael</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1491-1493</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">The influence of arom. substitution on a newly discovered class of inhibitors of dipeptidyl peptidase IV was investigated.  A 100,000-fold increase in potency was achieved by the optimization of arom. substituents in a parallel chem. program.  The obsd. SAR could be explained by an x-ray structure of the protein-ligand complex.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpF-3TwgQdprLVg90H21EOLACvtfcHk0lhp5F4qf_j87Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhvV2itL0%253D&md5=37d4692f2c8b41de5cc1994bcfa21c58</span></div><a href="/servlet/linkout?suffix=cit8b&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2004.01.019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2004.01.019%26sid%3Dliteratum%253Aachs%26aulast%3DPeters%26aufirst%3DJ.-U.%26aulast%3DWeber%26aufirst%3DS.%26aulast%3DKritter%26aufirst%3DS.%26aulast%3DWeiss%26aufirst%3DP.%26aulast%3DWallier%26aufirst%3DA.%26aulast%3DBoehringer%26aufirst%3DM.%26aulast%3DHennig%26aufirst%3DM.%26aulast%3DKuhn%26aufirst%3DB.%26aulast%3DLoeffler%26aufirst%3DB.-M.%26atitle%3DAminomethylpyrimidines%2520as%2520Novel%2520DPP-IV%2520Inhibitors%253A%2520A%252010%25285%2529-Fold%2520Activity%2520Increase%2520by%2520Optimization%2520of%2520Aromatic%2520Substituents%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2004%26volume%3D14%26spage%3D1491%26epage%3D1493" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Sato, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shimoji, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fujita, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mizuno, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kumakura, S.</span><span> </span><span class="NLM_article-title">Synthetic Studies on Cardiovascular Agents. IV. Synthesis of Fused Dihydropyridine Derivatives (Author’s Transl)</span> <span class="citation_source-journal">Yakugaku Zasshi</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1978</span><span class="NLM_x">, </span> <span class="NLM_volume">98</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">448</span><span class="NLM_x">–</span> <span class="NLM_lpage">465</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=98&publication_year=1978&pages=448-465&issue=4&author=Y.+Satoauthor=Y.+Shimojiauthor=H.+Fujitaauthor=H.+Mizunoauthor=S.+Kumakura&title=Synthetic+Studies+on+Cardiovascular+Agents.+IV.+Synthesis+of+Fused+Dihydropyridine+Derivatives+%28Author%E2%80%99s+Transl%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSato%26aufirst%3DY.%26aulast%3DShimoji%26aufirst%3DY.%26aulast%3DFujita%26aufirst%3DH.%26aulast%3DMizuno%26aufirst%3DH.%26aulast%3DKumakura%26aufirst%3DS.%26atitle%3DSynthetic%2520Studies%2520on%2520Cardiovascular%2520Agents.%2520IV.%2520Synthesis%2520of%2520Fused%2520Dihydropyridine%2520Derivatives%2520%2528Author%25E2%2580%2599s%2520Transl%2529%26jtitle%3DYakugaku%2520Zasshi%26date%3D1978%26volume%3D98%26issue%3D4%26spage%3D448%26epage%3D465" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit9b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Southwick, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barnas, E. F.</span><span> </span><span class="NLM_article-title">4-Benzylidine-2,3-dioxopyrrolidines and 4-Benzyl-2,3-dioxopyrrolidines. Synthesis and Experiments on Reduction and Alkylation</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1962</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">98</span><span class="NLM_x">–</span> <span class="NLM_lpage">106</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo01048a026" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=1962&pages=98-106&issue=1&author=P.+L.+Southwickauthor=E.+F.+Barnas&title=4-Benzylidine-2%2C3-dioxopyrrolidines+and+4-Benzyl-2%2C3-dioxopyrrolidines.+Synthesis+and+Experiments+on+Reduction+and+Alkylation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9b&amp;dbid=16384&amp;doi=10.1021%2Fjo01048a026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo01048a026%26sid%3Dliteratum%253Aachs%26aulast%3DSouthwick%26aufirst%3DP.%2BL.%26aulast%3DBarnas%26aufirst%3DE.%2BF.%26atitle%3D4-Benzylidine-2%252C3-dioxopyrrolidines%2520and%25204-Benzyl-2%252C3-dioxopyrrolidines.%2520Synthesis%2520and%2520Experiments%2520on%2520Reduction%2520and%2520Alkylation%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1962%26volume%3D27%26issue%3D1%26spage%3D98%26epage%3D106" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit9c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Madhav, R.</span><span> </span><span class="NLM_article-title">A New Synthesis of Compounds in the 5<i>H</i>-Pyrrolo-[3,4-<i>b</i>]pyridine Series</span> <span class="citation_source-journal">Synthesis</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1973</span><span class="NLM_x">, </span> <span class="NLM_fpage">609</span><span class="NLM_x">–</span> <span class="NLM_lpage">610</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9c&amp;dbid=16&amp;doi=10.1021%2Fjm4008906&amp;key=10.1055%2Fs-1973-22266" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9c&amp;dbid=32&amp;doi=10.1021%2Fjm4008906&amp;key=1%3ACAS%3A528%3ADyaE2cXjsVSl" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1973&pages=609-610&author=R.+Madhav&title=A+New+Synthesis+of+Compounds+in+the+5H-Pyrrolo-%5B3%2C4-b%5Dpyridine+Series"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9cR"><div class="casContent"><span class="casTitleNuber">9c</span><div class="casTitle"><span class="NLM_cas:atitle">New synthesis of compounds in the 5H-pyrrolo[3,4-b]pyridine series</span></div><div class="casAuthors">Madhav, R.</div><div class="citationInfo"><span class="NLM_cas:title">Synthesis</span>
        (<span class="NLM_cas:date">1973</span>),
    <span class="NLM_cas:volume"></span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">609-10</span>CODEN:
                <span class="NLM_cas:coden">SYNTBF</span>;
        ISSN:<span class="NLM_cas:issn">0039-7881</span>.
    </div><div class="casAbstract">The pyrrolopyridine I (R = cyclohexyl, R1 = Ph, p-MeOC6H4, m-O2NC6H4; R = Me3C, PhCH2, R1 = Ph) were prepd. by cycloaddn. of pyrrolidinediones II with MeC(NH2):CHCO2Et and treatment of the product with Br-NaOAc.  The pyrrolopyridines III (R = cyclohexyl, PhCH2) were prepd. from II and phenacylpyridinium bromide.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoIkqm_VWteYLVg90H21EOLACvtfcHk0ljf11CEKuvWSQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE2cXjsVSl&md5=18dab46a8214e59e6ffcfd10f5913b52</span></div><a href="/servlet/linkout?suffix=cit9c&amp;dbid=16384&amp;doi=10.1055%2Fs-1973-22266&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1055%252Fs-1973-22266%26sid%3Dliteratum%253Aachs%26aulast%3DMadhav%26aufirst%3DR.%26atitle%3DA%2520New%2520Synthesis%2520of%2520Compounds%2520in%2520the%25205H-Pyrrolo-%255B3%252C4-b%255Dpyridine%2520Series%26jtitle%3DSynthesis%26date%3D1973%26spage%3D609%26epage%3D610" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Jang, D. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, J.</span><span> </span><span class="NLM_article-title">A Mild and Efficient Procedure for the Preparation of Acid Chlorides from Carboxylic Acids</span> <span class="citation_source-journal">Tetrahedron Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">40</span><span class="NLM_x">, </span> <span class="NLM_fpage">5323</span><span class="NLM_x">–</span> <span class="NLM_lpage">5326</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=1999&pages=5323-5326&author=D.+O.+Jangauthor=D.+J.+Parkauthor=J.+Kim&title=A+Mild+and+Efficient+Procedure+for+the+Preparation+of+Acid+Chlorides+from+Carboxylic+Acids"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJang%26aufirst%3DD.%2BO.%26aulast%3DPark%26aufirst%3DD.%2BJ.%26aulast%3DKim%26aufirst%3DJ.%26atitle%3DA%2520Mild%2520and%2520Efficient%2520Procedure%2520for%2520the%2520Preparation%2520of%2520Acid%2520Chlorides%2520from%2520Carboxylic%2520Acids%26jtitle%3DTetrahedron%2520Lett.%26date%3D1999%26volume%3D40%26spage%3D5323%26epage%3D5326" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Brown, H. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Subba Rao, B. C.</span><span> </span><span class="NLM_article-title">A New Aldehyde Synthesis. The Reduction of Acid Chlorides by Lithium Tri-butoxyaluminohydride</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1958</span><span class="NLM_x">, </span> <span class="NLM_volume">80</span><span class="NLM_x">, </span> <span class="NLM_fpage">5377</span><span class="NLM_x">–</span> <span class="NLM_lpage">5380</span></span><div class="citationLinks">[<a href="/doi/10.1021/ja01553a014" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=80&publication_year=1958&pages=5377-5380&author=H.+C.+Brownauthor=B.+C.+Subba+Rao&title=A+New+Aldehyde+Synthesis.+The+Reduction+of+Acid+Chlorides+by+Lithium+Tri-butoxyaluminohydride"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1021%2Fja01553a014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja01553a014%26sid%3Dliteratum%253Aachs%26aulast%3DBrown%26aufirst%3DH.%2BC.%26aulast%3DSubba%2BRao%26aufirst%3DB.%2BC.%26atitle%3DA%2520New%2520Aldehyde%2520Synthesis.%2520The%2520Reduction%2520of%2520Acid%2520Chlorides%2520by%2520Lithium%2520Tri-butoxyaluminohydride%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1958%26volume%3D80%26spage%3D5377%26epage%3D5380" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12a"><span><span class="NLM_label">(a) </span>X-ray analysis of (<i>Sa</i>)-<b>2s</b>: PDB deposition number <span class="NLM_ext-link">4JH0</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=X-ray+analysis+of+%28Sa%29-2s%3A+PDB+deposition+number+4JH0."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit12b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Metzler, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yanchunas, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weigelt, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kish, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klei, H. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xie, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corbett, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tamura, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamann, L. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kirby, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marcinkeviciene, J.</span> <span class="citation_source-journal">Protein Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">240</span><span class="NLM_x">–</span> <span class="NLM_lpage">250</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12b&amp;dbid=16&amp;doi=10.1021%2Fjm4008906&amp;key=10.1110%2Fps.073253208" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12b&amp;dbid=8&amp;doi=10.1021%2Fjm4008906&amp;key=18227430" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12b&amp;dbid=32&amp;doi=10.1021%2Fjm4008906&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhvVOntLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Metzler%2C+W.+J.%3B+Yanchunas%2C+J.%3B+Weigelt%2C+C.%3B+Kish%2C+K.%3B+Klei%2C+H.+E.%3B+Xie%2C+D.%3B+Zhang%2C+Y.%3B+Corbett%2C+M.%3B+Tamura%2C+J.+K.%3B+He%2C+B.%3B+Hamann%2C+L.+G.%3B+Kirby%2C+M.+S.%3B+Marcinkeviciene%2C+J.Protein+Sci.+2008%2C+17%2C+240%E2%80%93250"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12bR"><div class="casContent"><span class="casTitleNuber">12b</span><div class="casTitle"><span class="NLM_cas:atitle">Involvement of DPP-IV catalytic residues in enzyme-saxagliptin complex formation</span></div><div class="casAuthors">Metzler, William J.; Yanchunas, Joseph; Weigelt, Carolyn; Kish, Kevin; Klei, Herbert E.; Xie, Dianlin; Zhang, Yaqun; Corbett, Martin; Tamura, James K.; He, Bin; Hamann, Lawrence G.; Kirby, Mark S.; Marcinkeviciene, Jovita</div><div class="citationInfo"><span class="NLM_cas:title">Protein Science</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">240-250</span>CODEN:
                <span class="NLM_cas:coden">PRCIEI</span>;
        ISSN:<span class="NLM_cas:issn">0961-8368</span>.
    
            (<span class="NLM_cas:orgname">Cold Spring Harbor Laboratory Press</span>)
        </div><div class="casAbstract">The inhibition of DPP-IV by saxagliptin has been proposed to occur through formation of a covalent but reversible complex.  To evaluate further the mechanism of inhibition, we detd. the x-ray crystal structure of the DPP-IV:saxagliptin complex.  This structure reveals covalent attachment between S630 and the inhibitor nitrile carbon (C-O distance <1.3 Å).  To investigate whether this serine addn. is assisted by the catalytic His-Asp dyad, we generated two mutants of DPP-IV, S630A and H740Q, and assayed them for ability to bind inhibitor.  DPP-IVH740Q bound saxagliptin with an ∼1000-fold redn. in affinity relative to DPP-IVWT, while DPP-IVS630A showed no evidence for binding inhibitor.  An analog of saxagliptin lacking the nitrile group showed unchanged binding properties to the both mutant proteins, highlighting the essential role S630 and H740 play in covalent bond formation between S630 and saxagliptin.  Further supporting mechanism-based inhibition by saxagliptin, NMR spectra of enzyme-saxagliptin complexes revealed the presence of three downfield resonances with low fractionation factors characteristic of short and strong hydrogen bonds (SSHB).  Comparison of the NMR spectra of various wild-type and mutant DPP-IV:ligand complexes enabled assignment of a resonance at ∼14 ppm to H740.  Two addnl. DPP-IV mutants, Y547F and Y547Q, generated to probe potential stabilization of the enzyme-inhibitor complex by this residue, did not show any differences in inhibitor binding either by ITC or NMR.  Together with the previously published enzymic data, the structural and binding data presented here strongly support a histidine-assisted covalent bond formation between S630 hydroxyl oxygen and the nitrile group of saxagliptin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp9JzGRDJ1J7rVg90H21EOLACvtfcHk0lghH7hDtd1BPg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhvVOntLo%253D&md5=d76619e8d6843e595a5bc971191a4828</span></div><a href="/servlet/linkout?suffix=cit12b&amp;dbid=16384&amp;doi=10.1110%2Fps.073253208&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1110%252Fps.073253208%26sid%3Dliteratum%253Aachs%26aulast%3DMetzler%26aufirst%3DW.%2BJ.%26aulast%3DYanchunas%26aufirst%3DJ.%26aulast%3DWeigelt%26aufirst%3DC.%26aulast%3DKish%26aufirst%3DK.%26aulast%3DKlei%26aufirst%3DH.%2BE.%26aulast%3DXie%26aufirst%3DD.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DCorbett%26aufirst%3DM.%26aulast%3DTamura%26aufirst%3DJ.%2BK.%26aulast%3DHe%26aufirst%3DB.%26aulast%3DHamann%26aufirst%3DL.%2BG.%26aulast%3DKirby%26aufirst%3DM.%2BS.%26aulast%3DMarcinkeviciene%26aufirst%3DJ.%26jtitle%3DProtein%2520Sci.%26date%3D2008%26volume%3D17%26spage%3D240%26epage%3D250" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit12c"><span><span class="NLM_label">(c) </span>X-ray analysis of <b>1e</b> (BMS-744891)/DPP4 [presumed to be (<i>Sa</i>)-<b>2f</b>/DPP4]: PDB deposition number <span class="NLM_ext-link">4LKO</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=X-ray+analysis+of+1e+%28BMS-744891%29%2FDPP4+%5Bpresumed+to+be+%28Sa%29-2f%2FDPP4%5D%3A+PDB+deposition+number+4LKO."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><div class="note"><p class="first last">BMS-538305 was used as an internal standard for relevant DPP4-related studies:</p></div><span class="NLM_contrib-group">Simpkins, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bolton, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pi, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sutton, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kwon, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Magnin, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Augeri, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gungor, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rotella, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Slusarchyk, W. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marcinkeviciene, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robertson, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robl, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Atwal, K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zahler, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parker, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kirby, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamann, L. G.</span><span> </span><span class="NLM_article-title">Potent Non-Nitrile Dipeptidic Dipeptidyl Peptidase IV Inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">6476</span><span class="NLM_x">–</span> <span class="NLM_lpage">6480</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=6476-6480&author=L.+M.+Simpkinsauthor=S.+Boltonauthor=Z.+Piauthor=J.+C.+Suttonauthor=C.+Kwonauthor=G.+Zhaoauthor=D.+R.+Magninauthor=D.+J.+Augeriauthor=T.+Gungorauthor=D.+P.+Rotellaauthor=Z.+Sunauthor=Y.+Liuauthor=W.+S.+Slusarchykauthor=J.+Marcinkevicieneauthor=J.+G.+Robertsonauthor=A.+Wangauthor=J.+A.+Roblauthor=K.+S.+Atwalauthor=R.+L.+Zahlerauthor=R.+A.+Parkerauthor=M.+S.+Kirbyauthor=L.+G.+Hamann&title=Potent+Non-Nitrile+Dipeptidic+Dipeptidyl+Peptidase+IV+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSimpkins%26aufirst%3DL.%2BM.%26aulast%3DBolton%26aufirst%3DS.%26aulast%3DPi%26aufirst%3DZ.%26aulast%3DSutton%26aufirst%3DJ.%2BC.%26aulast%3DKwon%26aufirst%3DC.%26aulast%3DZhao%26aufirst%3DG.%26aulast%3DMagnin%26aufirst%3DD.%2BR.%26aulast%3DAugeri%26aufirst%3DD.%2BJ.%26aulast%3DGungor%26aufirst%3DT.%26aulast%3DRotella%26aufirst%3DD.%2BP.%26aulast%3DSun%26aufirst%3DZ.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DSlusarchyk%26aufirst%3DW.%2BS.%26aulast%3DMarcinkeviciene%26aufirst%3DJ.%26aulast%3DRobertson%26aufirst%3DJ.%2BG.%26aulast%3DWang%26aufirst%3DA.%26aulast%3DRobl%26aufirst%3DJ.%2BA.%26aulast%3DAtwal%26aufirst%3DK.%2BS.%26aulast%3DZahler%26aufirst%3DR.%2BL.%26aulast%3DParker%26aufirst%3DR.%2BA.%26aulast%3DKirby%26aufirst%3DM.%2BS.%26aulast%3DHamann%26aufirst%3DL.%2BG.%26atitle%3DPotent%2520Non-Nitrile%2520Dipeptidic%2520Dipeptidyl%2520Peptidase%2520IV%2520Inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2007%26volume%3D17%26spage%3D6476%26epage%3D6480" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1a','cit1b'],'ref2':['cit2a','cit2b'],'ref3':['cit3a','cit3b'],'ref4':['cit4a','cit4b'],'ref5':['cit5'],'ref6':['cit6a','cit6b','cit6c','cit6d','cit6e'],'ref7':['cit7a','cit7b','cit7c','cit7d'],'ref8':['cit8a','cit8b'],'ref9':['cit9a','cit9b','cit9c'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12a','cit12b','cit12c'],'ref13':['cit13']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 18 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alex M.  Ayoub</span>, <span class="hlFld-ContribAuthor ">Laura M. L.  Hawk</span>, <span class="hlFld-ContribAuthor ">Ryan J.  Herzig</span>, <span class="hlFld-ContribAuthor ">Jiewei  Jiang</span>, <span class="hlFld-ContribAuthor ">Andrea J.  Wisniewski</span>, <span class="hlFld-ContribAuthor ">Clifford T.  Gee</span>, <span class="hlFld-ContribAuthor ">Peiliang  Zhao</span>, <span class="hlFld-ContribAuthor ">Jin-Yi  Zhu</span>, <span class="hlFld-ContribAuthor ">Norbert  Berndt</span>, <span class="hlFld-ContribAuthor ">Nana K.  Offei-Addo</span>, <span class="hlFld-ContribAuthor ">Thomas G.  Scott</span>, <span class="hlFld-ContribAuthor ">Jun  Qi</span>, <span class="hlFld-ContribAuthor ">James E.  Bradner</span>, <span class="hlFld-ContribAuthor ">Timothy R.  Ward</span>, <span class="hlFld-ContribAuthor ">Ernst  Schönbrunn</span>, <span class="hlFld-ContribAuthor ">Gunda I.  Georg</span>, and <span class="hlFld-ContribAuthor ">William C. K.  Pomerantz</span>  . </span><span class="cited-content_cbyCitation_article-title">BET Bromodomain Inhibitors with One-Step Synthesis Discovered from Virtual Screen. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>60 </em>
                                    (12)
                                     , 4805-4817. <a href="https://doi.org/10.1021/acs.jmedchem.6b01336" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b01336</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b01336&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.6b01336%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DBET%252BBromodomain%252BInhibitors%252Bwith%252BOne-Step%252BSynthesis%252BDiscovered%252Bfrom%252BVirtual%252BScreen%26aulast%3DAyoub%26aufirst%3DAlex%2BM.%26date%3D2017%26date%3D2017%26date%3D2016%26date%3D05092016%26date%3D07062017%26date%3D22062017%26date%3D23052017%26volume%3D60%26issue%3D12%26spage%3D4805%26epage%3D4817" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Arik  Dahan</span>, <span class="hlFld-ContribAuthor ">Omri  Wolk</span>, <span class="hlFld-ContribAuthor ">Peihua  Yang</span>, <span class="hlFld-ContribAuthor ">Sachin  Mittal</span>, <span class="hlFld-ContribAuthor ">Zhiqian  Wu</span>, <span class="hlFld-ContribAuthor ">Christopher P.  Landowski</span>, and <span class="hlFld-ContribAuthor ">Gordon L.  Amidon</span>  . </span><span class="cited-content_cbyCitation_article-title">Dipeptidyl Peptidase IV as a Potential Target for Selective Prodrug Activation and Chemotherapeutic Action in Cancers. </span><span class="cited-content_cbyCitation_journal-name">Molecular Pharmaceutics</span><span> <strong>2014,</strong> <em>11 </em>
                                    (12)
                                     , 4385-4394. <a href="https://doi.org/10.1021/mp500483v" title="DOI URL">https://doi.org/10.1021/mp500483v</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/mp500483v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fmp500483v%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Pharmaceutics%26atitle%3DDipeptidyl%252BPeptidase%252BIV%252Bas%252Ba%252BPotential%252BTarget%252Bfor%252BSelective%252BProdrug%252BActivation%252Band%252BChemotherapeutic%252BAction%252Bin%252BCancers%26aulast%3DDahan%26aufirst%3DArik%26date%3D2014%26date%3D2014%26date%3D2014%26date%3D2014%26date%3D2014%26date%3D16072014%26date%3D03112014%26date%3D05102014%26date%3D13112014%26date%3D01122014%26date%3D03112014%26volume%3D11%26issue%3D12%26spage%3D4385%26epage%3D4394" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shrikant G.  Pharande</span>, <span class="hlFld-ContribAuthor ">Manuel A.  Rentería-Gómez</span>, <span class="hlFld-ContribAuthor ">Rocío  Gámez-Montaño</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of Polyheterocyclic Dimers Containing Restricted and Constrained Peptidomimetics via IMCR-Based Domino/Double CuAAC Click Strategy. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2020,</strong> <em>25 </em>
                                    (22)
                                     , 5246. <a href="https://doi.org/10.3390/molecules25225246" title="DOI URL">https://doi.org/10.3390/molecules25225246</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules25225246&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules25225246%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DSynthesis%252Bof%252BPolyheterocyclic%252BDimers%252BContaining%252BRestricted%252Band%252BConstrained%252BPeptidomimetics%252Bvia%252BIMCR-Based%252BDomino%25252FDouble%252BCuAAC%252BClick%252BStrategy%26aulast%3DPharande%26aufirst%3DShrikant%2BG.%26date%3D2020%26date%3D2020%26volume%3D25%26issue%3D22%26spage%3D5246" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dao‐Juan  Cheng</span>, <span class="hlFld-ContribAuthor ">You‐Dong  Shao</span>. </span><span class="cited-content_cbyCitation_article-title">Advances in the Catalytic Asymmetric Synthesis of Atropisomeric Hexatomic N‐Heterobiaryls. </span><span class="cited-content_cbyCitation_journal-name">Advanced Synthesis & Catalysis</span><span> <strong>2020,</strong> <em>362 </em>
                                    (15)
                                     , 3081-3099. <a href="https://doi.org/10.1002/adsc.202000354" title="DOI URL">https://doi.org/10.1002/adsc.202000354</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/adsc.202000354&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fadsc.202000354%26sid%3Dliteratum%253Aachs%26jtitle%3DAdvanced%2520Synthesis%2520%2526%2520Catalysis%26atitle%3DAdvances%252Bin%252Bthe%252BCatalytic%252BAsymmetric%252BSynthesis%252Bof%252BAtropisomeric%252BHexatomic%252BN%2525E2%252580%252590Heterobiaryls%26aulast%3DCheng%26aufirst%3DDao%25E2%2580%2590Juan%26date%3D2020%26date%3D2020%26volume%3D362%26issue%3D15%26spage%3D3081%26epage%3D3099" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Amna M.  Abdella</span>, <span class="hlFld-ContribAuthor ">Amr M.  Abdelmoniem</span>, <span class="hlFld-ContribAuthor ">Ismail A.  Abdelhamid</span>, <span class="hlFld-ContribAuthor ">Ahmed H. M.  Elwahy</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of heterocyclic compounds via Michael and Hantzsch reactions. </span><span class="cited-content_cbyCitation_journal-name">Journal of Heterocyclic Chemistry</span><span> <strong>2020,</strong> <em>57 </em>
                                    (4)
                                     , 1476-1523. <a href="https://doi.org/10.1002/jhet.3883" title="DOI URL">https://doi.org/10.1002/jhet.3883</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/jhet.3883&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fjhet.3883%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Heterocyclic%2520Chemistry%26atitle%3DSynthesis%252Bof%252Bheterocyclic%252Bcompounds%252Bvia%252BMichael%252Band%252BHantzsch%252Breactions%26aulast%3DAbdella%26aufirst%3DAmna%2BM.%26date%3D2020%26volume%3D57%26issue%3D4%26spage%3D1476%26epage%3D1523" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Simone Queiroz  Pantaleão</span>, <span class="hlFld-ContribAuthor ">Eric Allison  Philot</span>, <span class="hlFld-ContribAuthor ">Michell  de Oliveira Almeida</span>, <span class="hlFld-ContribAuthor ">Angelica Nakagawa  Lima</span>, <span class="hlFld-ContribAuthor ">Mirela Inês  de Sairre</span>, <span class="hlFld-ContribAuthor ">Ana Ligia  Scott</span>, <span class="hlFld-ContribAuthor ">Kathia Maria  Honorio</span>. </span><span class="cited-content_cbyCitation_article-title">Integrated Protocol to Design Potential Inhibitors of Dipeptidyl Peptidase- 4 (DPP-4). </span><span class="cited-content_cbyCitation_journal-name">Current Topics in Medicinal Chemistry</span><span> <strong>2020,</strong> <em>20 </em>
                                    (3)
                                     , 209-226. <a href="https://doi.org/10.2174/1568026620666191226101543" title="DOI URL">https://doi.org/10.2174/1568026620666191226101543</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2174/1568026620666191226101543&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2174%2F1568026620666191226101543%26sid%3Dliteratum%253Aachs%26jtitle%3DCurrent%2520Topics%2520in%2520Medicinal%2520Chemistry%26atitle%3DIntegrated%252BProtocol%252Bto%252BDesign%252BPotential%252BInhibitors%252Bof%252BDipeptidyl%252BPeptidase-%252B4%252B%252528DPP-4%252529%26aulast%3DPantale%25C3%25A3o%26aufirst%3DSimone%2BQueiroz%26date%3D2020%26volume%3D20%26issue%3D3%26spage%3D209%26epage%3D226" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Manuel A.  Rentería-Gómez</span>, <span class="hlFld-ContribAuthor ">Alejandro  Islas-Jácome</span>, <span class="hlFld-ContribAuthor ">Shrikant G.  Pharande</span>, <span class="hlFld-ContribAuthor ">David A.  Vosburg</span>, <span class="hlFld-ContribAuthor ">Rocío  Gámez-Montaño</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of Tris-Heterocycles via a Cascade IMCR/Aza Diels-Alder + CuAAC Strategy. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Chemistry</span><span> <strong>2019,</strong> <em>7 </em><a href="https://doi.org/10.3389/fchem.2019.00546" title="DOI URL">https://doi.org/10.3389/fchem.2019.00546</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fchem.2019.00546&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffchem.2019.00546%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Chemistry%26atitle%3DSynthesis%252Bof%252BTris-Heterocycles%252Bvia%252Ba%252BCascade%252BIMCR%25252FAza%252BDiels-Alder%252B%25252B%252BCuAAC%252BStrategy%26aulast%3DRenter%25C3%25ADa-G%25C3%25B3mez%26aufirst%3DManuel%2BA.%26date%3D2019%26date%3D2019%26volume%3D7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Valeriya G  Melekhina</span>, <span class="hlFld-ContribAuthor ">Andrey N  Komogortsev</span>, <span class="hlFld-ContribAuthor ">Boris V  Lichitsky</span>, <span class="hlFld-ContribAuthor ">Vitaly S  Mityanov</span>, <span class="hlFld-ContribAuthor ">Artem N  Fakhrutdinov</span>, <span class="hlFld-ContribAuthor ">Arkady A  Dudinov</span>, <span class="hlFld-ContribAuthor ">Vasily A  Migulin</span>, <span class="hlFld-ContribAuthor ">Yulia V  Nelyubina</span>, <span class="hlFld-ContribAuthor ">Elizaveta K  Melnikova</span>, <span class="hlFld-ContribAuthor ">Michail M  Krayushkin</span>. </span><span class="cited-content_cbyCitation_article-title">One-pot synthesis of substituted pyrrolo[3,4-
              b
              ]pyridine-4,5-diones based on the reaction of
              N
              -(1-(4-hydroxy-6-methyl-2-oxo-2
              H
              -pyran-3-yl)-2-oxo-2-arylethyl)acetamide with amines. </span><span class="cited-content_cbyCitation_journal-name">Beilstein Journal of Organic Chemistry</span><span> <strong>2019,</strong> <em>15 </em>, 2840-2846. <a href="https://doi.org/10.3762/bjoc.15.277" title="DOI URL">https://doi.org/10.3762/bjoc.15.277</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3762/bjoc.15.277&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3762%2Fbjoc.15.277%26sid%3Dliteratum%253Aachs%26jtitle%3DBeilstein%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DOne-pot%252Bsynthesis%252Bof%252Bsubstituted%252Bpyrrolo%25255B3%25252C4-%252Bb%252B%25255Dpyridine-4%25252C5-diones%252Bbased%252Bon%252Bthe%252Breaction%252Bof%252BN%252B-%2525281-%2525284-hydroxy-6-methyl-2-oxo-2%252BH%252B-pyran-3-yl%252529-2-oxo-2-arylethyl%252529acetamide%252Bwith%252Bamines%26aulast%3DMelekhina%26aufirst%3DValeriya%2BG%26date%3D2019%26date%3D2019%26volume%3D15%26spage%3D2840%26epage%3D2846" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ning  Li</span>, <span class="hlFld-ContribAuthor ">Li-Jun  Wang</span>, <span class="hlFld-ContribAuthor ">Bo  Jiang</span>, <span class="hlFld-ContribAuthor ">Xiang-qian  Li</span>, <span class="hlFld-ContribAuthor ">Chuan-long  Guo</span>, <span class="hlFld-ContribAuthor ">Shu-ju  Guo</span>, <span class="hlFld-ContribAuthor ">Da-Yong  Shi</span>. </span><span class="cited-content_cbyCitation_article-title">Recent progress of the development of dipeptidyl peptidase-4 inhibitors for the treatment of type 2 diabetes mellitus. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>151 </em>, 145-157. <a href="https://doi.org/10.1016/j.ejmech.2018.03.041" title="DOI URL">https://doi.org/10.1016/j.ejmech.2018.03.041</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2018.03.041&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2018.03.041%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DRecent%252Bprogress%252Bof%252Bthe%252Bdevelopment%252Bof%252Bdipeptidyl%252Bpeptidase-4%252Binhibitors%252Bfor%252Bthe%252Btreatment%252Bof%252Btype%252B2%252Bdiabetes%252Bmellitus%26aulast%3DLi%26aufirst%3DNing%26date%3D2018%26volume%3D151%26spage%3D145%26epage%3D157" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Peter W.  Glunz</span>. </span><span class="cited-content_cbyCitation_article-title">Recent encounters with atropisomerism in drug discovery. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2018,</strong> <em>28 </em>
                                    (2)
                                     , 53-60. <a href="https://doi.org/10.1016/j.bmcl.2017.11.050" title="DOI URL">https://doi.org/10.1016/j.bmcl.2017.11.050</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2017.11.050&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2017.11.050%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DRecent%252Bencounters%252Bwith%252Batropisomerism%252Bin%252Bdrug%252Bdiscovery%26aulast%3DGlunz%26aufirst%3DPeter%2BW.%26date%3D2018%26volume%3D28%26issue%3D2%26spage%3D53%26epage%3D60" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sho  Hirai</span>, <span class="hlFld-ContribAuthor ">Yurie  Horikawa</span>, <span class="hlFld-ContribAuthor ">Haruyasu  Asahara</span>, <span class="hlFld-ContribAuthor ">Nagatoshi  Nishiwaki</span>. </span><span class="cited-content_cbyCitation_article-title">Tailor-made synthesis of fully alkylated/arylated nicotinates by FeCl
              3
              -mediated condensation of enamino esters with enones. </span><span class="cited-content_cbyCitation_journal-name">Chemical Communications</span><span> <strong>2017,</strong> <em>53 </em>
                                    (15)
                                     , 2390-2393. <a href="https://doi.org/10.1039/C7CC00051K" title="DOI URL">https://doi.org/10.1039/C7CC00051K</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C7CC00051K&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC7CC00051K%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Communications%26atitle%3DTailor-made%252Bsynthesis%252Bof%252Bfully%252Balkylated%25252Farylated%252Bnicotinates%252Bby%252BFeCl%252B3%252B-mediated%252Bcondensation%252Bof%252Benamino%252Besters%252Bwith%252Benones%26aulast%3DHirai%26aufirst%3DSho%26date%3D2017%26date%3D2017%26volume%3D53%26issue%3D15%26spage%3D2390%26epage%3D2393" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yanhong  Jiang</span>, <span class="hlFld-ContribAuthor ">Chaoguo  Yan</span>. </span><span class="cited-content_cbyCitation_article-title">Selective Synthesis of 1,2-Diarylpyrrolo[3,4-
              b
              ]pyridine-5,7-diones via Cyclization Reaction of
              β
              -Enamino Imides with Cinnamaldehydes. </span><span class="cited-content_cbyCitation_journal-name">Chinese Journal of Chemistry</span><span> <strong>2016,</strong> <em>34 </em>
                                    (12)
                                     , 1255-1262. <a href="https://doi.org/10.1002/cjoc.201600504" title="DOI URL">https://doi.org/10.1002/cjoc.201600504</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cjoc.201600504&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcjoc.201600504%26sid%3Dliteratum%253Aachs%26jtitle%3DChinese%2520Journal%2520of%2520Chemistry%26atitle%3DSelective%252BSynthesis%252Bof%252B1%25252C2-Diarylpyrrolo%25255B3%25252C4-%252Bb%252B%25255Dpyridine-5%25252C7-diones%252Bvia%252BCyclization%252BReaction%252Bof%252B%2525CE%2525B2%252B-Enamino%252BImides%252Bwith%252BCinnamaldehydes%26aulast%3DJiang%26aufirst%3DYanhong%26date%3D2016%26date%3D2016%26volume%3D34%26issue%3D12%26spage%3D1255%26epage%3D1262" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hiroyuki  Nojima</span>, <span class="hlFld-ContribAuthor ">Kazuhiko  Kanou</span>, <span class="hlFld-ContribAuthor ">Genki  Terashi</span>, <span class="hlFld-ContribAuthor ">Mayuko  Takeda-Shitaka</span>, <span class="hlFld-ContribAuthor ">Gaku  Inoue</span>, <span class="hlFld-ContribAuthor ">Koichiro  Atsuda</span>, <span class="hlFld-ContribAuthor ">Chihiro  Itoh</span>, <span class="hlFld-ContribAuthor ">Chie  Iguchi</span>, <span class="hlFld-ContribAuthor ">Hajime  Matsubara</span>. </span><span class="cited-content_cbyCitation_article-title">Comprehensive analysis of the Co-structures of dipeptidyl peptidase IV and its inhibitor. </span><span class="cited-content_cbyCitation_journal-name">BMC Structural Biology</span><span> <strong>2016,</strong> <em>16 </em>
                                    (1)
                                     <a href="https://doi.org/10.1186/s12900-016-0062-8" title="DOI URL">https://doi.org/10.1186/s12900-016-0062-8</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1186/s12900-016-0062-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1186%2Fs12900-016-0062-8%26sid%3Dliteratum%253Aachs%26jtitle%3DBMC%2520Structural%2520Biology%26atitle%3DComprehensive%252Banalysis%252Bof%252Bthe%252BCo-structures%252Bof%252Bdipeptidyl%252Bpeptidase%252BIV%252Band%252Bits%252Binhibitor%26aulast%3DNojima%26aufirst%3DHiroyuki%26date%3D2016%26date%3D2016%26volume%3D16%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">F. Z.  El-Ablak</span>, <span class="hlFld-ContribAuthor ">N. S.  Abu-Elenein</span>, <span class="hlFld-ContribAuthor ">M. A.  Sofan</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of New Pyrrolo Heterocycles (I): Novel Synthesis of Pyrano[2,3-
              c
              ]pyrrole, Isoindoline, Pyrrolo[3,4-
              b
              ]pyridine, and Pyrrolo[3,4-
              d
              ]pyrimidine Derivatives. </span><span class="cited-content_cbyCitation_journal-name">Journal of Heterocyclic Chemistry</span><span> <strong>2016,</strong> <em>53 </em>
                                    (6)
                                     , 1999-2006. <a href="https://doi.org/10.1002/jhet.2520" title="DOI URL">https://doi.org/10.1002/jhet.2520</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/jhet.2520&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fjhet.2520%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Heterocyclic%2520Chemistry%26atitle%3DSynthesis%252Bof%252BNew%252BPyrrolo%252BHeterocycles%252B%252528I%252529%25253A%252BNovel%252BSynthesis%252Bof%252BPyrano%25255B2%25252C3-%252Bc%252B%25255Dpyrrole%25252C%252BIsoindoline%25252C%252BPyrrolo%25255B3%25252C4-%252Bb%252B%25255Dpyridine%25252C%252Band%252BPyrrolo%25255B3%25252C4-%252Bd%252B%25255Dpyrimidine%252BDerivatives%26aulast%3DEl-Ablak%26aufirst%3DF.%2BZ.%26date%3D2016%26date%3D2015%26volume%3D53%26issue%3D6%26spage%3D1999%26epage%3D2006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Joseph R.  Lizza</span>, <span class="hlFld-ContribAuthor ">Savan V.  Patel</span>, <span class="hlFld-ContribAuthor ">Catherine F.  Yang</span>, <span class="hlFld-ContribAuthor ">Gustavo  Moura-Letts</span>. </span><span class="cited-content_cbyCitation_article-title">Direct Synthesis of Cyanopyrrolidinyl β-Amino Alcohols for the Development of Diabetes Therapeutics. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Organic Chemistry</span><span> <strong>2016,</strong> <em>2016 </em>
                                    (30)
                                     , 5160-5168. <a href="https://doi.org/10.1002/ejoc.201600969" title="DOI URL">https://doi.org/10.1002/ejoc.201600969</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ejoc.201600969&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fejoc.201600969%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DDirect%252BSynthesis%252Bof%252BCyanopyrrolidinyl%252B%2525CE%2525B2-Amino%252BAlcohols%252Bfor%252Bthe%252BDevelopment%252Bof%252BDiabetes%252BTherapeutics%26aulast%3DLizza%26aufirst%3DJoseph%2BR.%26date%3D2016%26date%3D2016%26volume%3D2016%26issue%3D30%26spage%3D5160%26epage%3D5168" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alejandro  Islas-Jácome</span>, <span class="hlFld-ContribAuthor ">Angel  Rentería-Gómez</span>, <span class="hlFld-ContribAuthor ">Manuel A.  Rentería-Gómez</span>, <span class="hlFld-ContribAuthor ">Eduardo  González-Zamora</span>, <span class="hlFld-ContribAuthor ">J. Oscar C.  Jiménez-Halla</span>, <span class="hlFld-ContribAuthor ">Rocío  Gámez-Montaño</span>. </span><span class="cited-content_cbyCitation_article-title">Selective reaction route in the construction of the pyrrolo[3,4-b]pyridin-5-one core from a variety of 5-aminooxazoles and maleic anhydride. A DFT study. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron Letters</span><span> <strong>2016,</strong> <em>57 </em>
                                    (31)
                                     , 3496-3500. <a href="https://doi.org/10.1016/j.tetlet.2016.06.099" title="DOI URL">https://doi.org/10.1016/j.tetlet.2016.06.099</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tetlet.2016.06.099&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tetlet.2016.06.099%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%2520Letters%26atitle%3DSelective%252Breaction%252Broute%252Bin%252Bthe%252Bconstruction%252Bof%252Bthe%252Bpyrrolo%25255B3%25252C4-b%25255Dpyridin-5-one%252Bcore%252Bfrom%252Ba%252Bvariety%252Bof%252B5-aminooxazoles%252Band%252Bmaleic%252Banhydride.%252BA%252BDFT%252Bstudy%26aulast%3DIslas-J%25C3%25A1come%26aufirst%3DAlejandro%26date%3D2016%26volume%3D57%26issue%3D31%26spage%3D3496%26epage%3D3500" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Qing  Li</span>, <span class="hlFld-ContribAuthor ">Muxing  Zhou</span>, <span class="hlFld-ContribAuthor ">Li  Han</span>, <span class="hlFld-ContribAuthor ">Qing  Cao</span>, <span class="hlFld-ContribAuthor ">Xinning  Wang</span>, <span class="hlFld-ContribAuthor ">LeiLei  Zhao</span>, <span class="hlFld-ContribAuthor ">Jinpei  Zhou</span>, <span class="hlFld-ContribAuthor ">Huibin  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Design, Synthesis and Biological Evaluation of Imidazo[1,2-a]pyridine Derivatives as Novel DPP-4 Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Chemical Biology & Drug Design</span><span> <strong>2015,</strong> <em>86 </em>
                                    (4)
                                     , 849-856. <a href="https://doi.org/10.1111/cbdd.12560" title="DOI URL">https://doi.org/10.1111/cbdd.12560</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/cbdd.12560&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fcbdd.12560%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Biology%2520%2526%2520Drug%2520Design%26atitle%3DDesign%25252C%252BSynthesis%252Band%252BBiological%252BEvaluation%252Bof%252BImidazo%25255B1%25252C2-a%25255Dpyridine%252BDerivatives%252Bas%252BNovel%252BDPP-4%252BInhibitors%26aulast%3DLi%26aufirst%3DQing%26date%3D2015%26date%3D2015%26volume%3D86%26issue%3D4%26spage%3D849%26epage%3D856" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Vanessa G.  Santos</span>, <span class="hlFld-ContribAuthor ">Marla N.  Godoi</span>, <span class="hlFld-ContribAuthor ">Thaís  Regiani</span>, <span class="hlFld-ContribAuthor ">Fernando H. S.  Gama</span>, <span class="hlFld-ContribAuthor ">Mirela B.  Coelho</span>, <span class="hlFld-ContribAuthor ">Rodrigo O. M. A.  de Souza</span>, <span class="hlFld-ContribAuthor ">Marcos N.  Eberlin</span>, <span class="hlFld-ContribAuthor ">Simon J.  Garden</span>. </span><span class="cited-content_cbyCitation_article-title">The Multicomponent Hantzsch Reaction: Comprehensive Mass Spectrometry Monitoring Using Charge-Tagged Reagents. </span><span class="cited-content_cbyCitation_journal-name">Chemistry - A European Journal</span><span> <strong>2014,</strong> <em>20 </em>
                                    (40)
                                     , 12808-12816. <a href="https://doi.org/10.1002/chem.201303065" title="DOI URL">https://doi.org/10.1002/chem.201303065</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/chem.201303065&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fchem.201303065%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistry%2520-%2520A%2520European%2520Journal%26atitle%3DThe%252BMulticomponent%252BHantzsch%252BReaction%25253A%252BComprehensive%252BMass%252BSpectrometry%252BMonitoring%252BUsing%252BCharge-Tagged%252BReagents%26aulast%3DSantos%26aufirst%3DVanessa%2BG.%26date%3D2014%26date%3D2014%26volume%3D20%26issue%3D40%26spage%3D12808%26epage%3D12816" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-18/jm4008906/production/images/medium/jm-2013-008906_0015.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-18/jm4008906/production/images/large/jm-2013-008906_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4008906&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-18/jm4008906/production/images/medium/jm-2013-008906_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-18/jm4008906/production/images/large/jm-2013-008906_0002.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Design of novel bicyclic cores.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-18/jm4008906/production/images/large/jm-2013-008906_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4008906&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-18/jm4008906/production/images/medium/jm-2013-008906_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-18/jm4008906/production/images/large/jm-2013-008906_0006.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 1. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-18/jm4008906/production/images/large/jm-2013-008906_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4008906&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) 2,4-dichlorobenzaldehyde, BnNH<sub>2</sub>, AcOH, IPA, 100%; (b) IPA, 79% <b>7a</b>, 65% <b>7b</b>; (c) AcOH, HNO<sub>3</sub>/H<sub>2</sub>O, 57% <b>8a</b>, 68% <b>8b</b>; (d) R<sub>2</sub>NH<sub>2</sub>, EtOH, microwave 150 °C, 71% <b>9a</b>, 53% <b>9b</b>, 71% <b>9s</b>; (e) LiOH, THF, H<sub>2</sub>O, 19% for <b>9a</b> or 10% Pd/C, H<sub>2</sub>, EtOAc, 100% for <b>9b</b>–<b>s</b>; (f) ClCO<sub>2</sub>Et, Et<sub>3</sub>N, THF, then NaBH<sub>4</sub>, THF, H<sub>2</sub>O; (g) MsCl, Et<sub>3</sub>N, CH<sub>2</sub>Cl<sub>2</sub>, 33% two steps <b>10a</b>, 7% two steps <b>10b</b>, 66% two steps <b>10s</b>; (h) 7 M NH<sub>3</sub> in MeOH, microwave 100 °C, 79% <b>1b</b>; (i) Boc<sub>2</sub>O, NaHCO<sub>3</sub>, THF; (j) ClCO<sub>2</sub>Et, Et<sub>3</sub>N, DMAP, CH<sub>2</sub>Cl<sub>2</sub>, 39% two steps; (k) TFA, CH<sub>2</sub>Cl<sub>2</sub>, 91% <b>1g</b>; (l) chiral separation (Chiralcel OJ 5 cm × 50 cm column; 20 μm; mobile phase, isocratic gradient of 15% EtOH–MeOH (50%) in heptane); (m) supercritical fluid chromatography (Chiralpak AD-H 250 mm × 30 mm i.d.; 5 μm; flow rate, 120 mL/min; mobile phase, CO<sub>2</sub>/EtOH 75/25 with 0.1% DEA).</p></p></figure><figure data-id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-18/jm4008906/production/images/medium/jm-2013-008906_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-18/jm4008906/production/images/large/jm-2013-008906_0007.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 2. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-18/jm4008906/production/images/large/jm-2013-008906_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4008906&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) supercritical fluid chromatography (Chiralpak AD 250 mm × 4.6 mm i.d.; 10 μm; 35 °C; flow rate, 2.0 mL/min; mobile phase, CO<sub>2</sub>/IPA 82/18; injection volume, 5 μL; detector wavelength, 220 nm); (b) R<sub>2</sub>NH<sub>2</sub>, EtOH, microwave 150 °C; (c) 10% Pd/C, H<sub>2</sub>, EtOAc, 100%; (d) ClCO<sub>2</sub>Et, Et<sub>3</sub>N, THF, then NaBH<sub>4</sub>, THF, H<sub>2</sub>O; (e) MsCl, Et<sub>3</sub>N, CH<sub>2</sub>Cl<sub>2</sub>; (f) 7 M NH<sub>3</sub> in MeOH, microwave 100 °C; (g) TFA, CH<sub>2</sub>Cl<sub>2</sub>, 46%; (h) Boc<sub>2</sub>O, NaHCO<sub>3</sub>, THF, H<sub>2</sub>O; (i) Et<sub>2</sub>NH, PyBOP, DIEA, THF, 100% two steps.</p></p></figure><figure data-id="sch3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-18/jm4008906/production/images/medium/jm-2013-008906_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-18/jm4008906/production/images/large/jm-2013-008906_0008.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 3. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-18/jm4008906/production/images/large/jm-2013-008906_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4008906&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) H<sub>2</sub>, 10% Pd/C, 100%; (b) CCl<sub>3</sub>CN, Ph<sub>3</sub>P resin, CH<sub>2</sub>Cl<sub>2</sub>; (c) LiAl(OBu)<sub>3</sub>H, THF, 0 °C, 80% two steps; (d) supercritical fluid chromatography (Chiralpak AD 250 mm × 4.6 mm i.d.; 10 μm; 35 °C; flow rate, 2.0 mL/min; mobile phase, CO<sub>2</sub>/IPA 82/18; injection volume, 5 μL; detector wavelength, 220 nm); (e) MsCl, Et<sub>3</sub>N, CH<sub>2</sub>Cl<sub>2</sub>, 0 °C, >90%; (f) 7 M NH<sub>3</sub> in MeOH, 50 °C; (g) TFA, CH<sub>2</sub>Cl<sub>2</sub>; (h) Boc<sub>2</sub>O, NaHCO<sub>3</sub>, THF, H<sub>2</sub>O, 73% three steps; (i) HOBt·H<sub>2</sub>O, EDCI, NH<sub>4</sub>Cl, DIEA, DMF, <b>2q</b>; amine, PyBOP, DIEA, THF, <b>2n</b>, <b>2r, 2s, 2t, 2u, 2v</b>; (j) TFA, CH<sub>2</sub>Cl<sub>2</sub>, 12–74% two steps.</p></p></figure><figure data-id="sch4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-18/jm4008906/production/images/medium/jm-2013-008906_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-18/jm4008906/production/images/large/jm-2013-008906_0009.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 4. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-18/jm4008906/production/images/large/jm-2013-008906_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4008906&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) KNBoc<sub>2</sub>, THF/DMF (15:5), 60 °C, 60%; (b) supercritical fluid chromatography (Chiralpak AD 250 mm × 4.6 mm i.d.; 10 μm; 35 °C; flow rate, 2.0 mL/min; mobile phase, CO<sub>2</sub>/IPA 82/18; injection volume, 5 μL; detector wavelength, 220 nm); (c) 4 N HCl, dioxane; (d) 1 N NaOH, CH<sub>2</sub>Cl<sub>2</sub>, 86% two steps.</p></p></figure><figure data-id="fig2" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-18/jm4008906/production/images/medium/jm-2013-008906_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-18/jm4008906/production/images/large/jm-2013-008906_0003.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. X-ray cocrystal structure of <b>2s</b> bound to the DPP4 active site at 2.35 Å resolution.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-18/jm4008906/production/images/large/jm-2013-008906_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4008906&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-18/jm4008906/production/images/medium/jm-2013-008906_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-18/jm4008906/production/images/large/jm-2013-008906_0004.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Insulin response and effects on plasma insulin AUC during an oGTT in an ob/ob mouse model, following treatment with <b>2s</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-18/jm4008906/production/images/large/jm-2013-008906_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4008906&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-18/jm4008906/production/images/medium/jm-2013-008906_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-18/jm4008906/production/images/large/jm-2013-008906_0005.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Glucose response and effects on glucose AUC during an oGTT in an ob/ob mouse model, following treatment with <b>2s</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-18/jm4008906/production/images/large/jm-2013-008906_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4008906&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i69">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_22385" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_22385" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 13 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="note"><p class="first last">Recent DPP4 inhibitors reviews:</p></div><div class="NLM_citation" id="rightTab-cit1a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Ahren, B.</span><span> </span><span class="NLM_article-title">Emerging Dipeptidyl Peptidase-4 Inhibitors for the Treatment of Diabetes</span> <span class="citation_source-journal">Exp. Opin. Emerging Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">593</span><span class="NLM_x">–</span> <span class="NLM_lpage">607</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=16&amp;doi=10.1021%2Fjm4008906&amp;key=10.1517%2F14728210802584126" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=8&amp;doi=10.1021%2Fjm4008906&amp;key=19046129" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=32&amp;doi=10.1021%2Fjm4008906&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsVCnurjE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2008&pages=593-607&issue=4&author=B.+Ahren&title=Emerging+Dipeptidyl+Peptidase-4+Inhibitors+for+the+Treatment+of+Diabetes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1aR"><div class="casContent"><span class="casTitleNuber">1a</span><div class="casTitle"><span class="NLM_cas:atitle">Emerging dipeptidyl peptidase-4 inhibitors for the treatment of diabetes</span></div><div class="casAuthors">Ahren, Bo</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Emerging Drugs</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">593-607</span>CODEN:
                <span class="NLM_cas:coden">EOEDA3</span>;
        ISSN:<span class="NLM_cas:issn">1472-8214</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Inhibition of dipeptidyl peptidase-4 (DPP-4) prevents the inactivation of glucagon-like peptide-1 (GLP-1).  This increases circulating levels of active GLP-1, stimulates insulin secretion and inhibits glucagon secretion, resulting in lowering of glucose levels and improvement of glycemic control in patients with type 2 diabetes.  Several DPP-4 inhibitors are emerging for therapeutic use.  Most experience exists for sitagliptin, vildagliptin, saxagliptin and alogliptin.  They all improve metabolic control in type 2 diabetes in monotherapy and in combination therapy with metformin, sulfonylurea and thiazolidinediones.  Vildagliptin and alogliptin have also been shown to improve glycemic control when added to insulin therapy, and sitagliptin improves glycemic control in triple therapy with metformin plus thiazolidinedione.  DPP-4 inhibition also shows a favorable safety profile, high tolerability, only a minimal risk of hypoglycemia, and body-wt. neutrality.  The main clin. indication for DPP-4 inhibitors will be in the early stage of type 2 diabetes, in combination with metformin or other treatments in subjects with inadequate glycemic control on these treatments alone.  The durability and long-term safety of DPP-4 inhibition, as well as clin. positioning in relation to GLP-1 mimetics, remain now to be established.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoc18qdMIDGU7Vg90H21EOLACvtfcHk0lhv-CH71qgs5A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsVCnurjE&md5=47f973c7343e215dd6d06e770936f5ba</span></div><a href="/servlet/linkout?suffix=cit1a&amp;dbid=16384&amp;doi=10.1517%2F14728210802584126&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F14728210802584126%26sid%3Dliteratum%253Aachs%26aulast%3DAhren%26aufirst%3DB.%26atitle%3DEmerging%2520Dipeptidyl%2520Peptidase-4%2520Inhibitors%2520for%2520the%2520Treatment%2520of%2520Diabetes%26jtitle%3DExp.%2520Opin.%2520Emerging%2520Drugs%26date%3D2008%26volume%3D13%26issue%3D4%26spage%3D593%26epage%3D607" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit1b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Zettl, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schubert-Zsilavecz, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steinhilber, D.</span><span> </span><span class="NLM_article-title">Medicinal Chemistry of Incretin Mimetics and DPP-4 Inhibitors</span> <span class="citation_source-journal">ChemMedChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">179</span><span class="NLM_x">–</span> <span class="NLM_lpage">185</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2010&pages=179-185&author=H.+Zettlauthor=M.+Schubert-Zsilaveczauthor=D.+Steinhilber&title=Medicinal+Chemistry+of+Incretin+Mimetics+and+DPP-4+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZettl%26aufirst%3DH.%26aulast%3DSchubert-Zsilavecz%26aufirst%3DM.%26aulast%3DSteinhilber%26aufirst%3DD.%26atitle%3DMedicinal%2520Chemistry%2520of%2520Incretin%2520Mimetics%2520and%2520DPP-4%2520Inhibitors%26jtitle%3DChemMedChem%26date%3D2010%26volume%3D5%26spage%3D179%26epage%3D185" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Dhillon, S.</span><span> </span><span class="NLM_article-title">Sitagliptin: A Review of Its Use in the Management of Type 2 Diabetes Mellitus</span> <span class="citation_source-journal">Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">70</span><span class="NLM_x"> (</span><span class="NLM_issue">42</span><span class="NLM_x">) </span> <span class="NLM_fpage">489</span><span class="NLM_x">–</span> <span class="NLM_lpage">512</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2010&pages=489-512&issue=42&author=S.+Dhillon&title=Sitagliptin%3A+A+Review+of+Its+Use+in+the+Management+of+Type+2+Diabetes+Mellitus"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDhillon%26aufirst%3DS.%26atitle%3DSitagliptin%253A%2520A%2520Review%2520of%2520Its%2520Use%2520in%2520the%2520Management%2520of%2520Type%25202%2520Diabetes%2520Mellitus%26jtitle%3DDrugs%26date%3D2010%26volume%3D70%26issue%3D42%26spage%3D489%26epage%3D512" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit2b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Kim, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beconi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eiermann, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fisher, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hickey, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kowalchick, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leiting, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lyon, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marsilio, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCann, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petrov, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scapin, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roy, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wyvratt, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, B. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thornberry, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weber, A. E.</span><span> </span><span class="NLM_article-title">(2<i>R</i>)-4-Oxo-4-[3-(trifluoromethyl)-5,6-dihydro[1,2,4]triazolo[4,3-<i>a</i>]pyrazin-7(8<i>H</i>)-yl]-1-(2,4,5-trifluorophenyl)butan-2-amine: A Potent, Orally Active Dipeptidyl Peptidase IV Inhibitor for the Treatment of Type 2 Diabetes</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">141</span><span class="NLM_x">–</span> <span class="NLM_lpage">151</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0493156" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=141-151&issue=1&author=D.+Kimauthor=L.+Wangauthor=M.+Beconiauthor=G.+J.+Eiermannauthor=M.+H.+Fisherauthor=H.+Heauthor=G.+J.+Hickeyauthor=J.+E.+Kowalchickauthor=B.+Leitingauthor=K.+Lyonauthor=F.+Marsilioauthor=M.+E.+McCannauthor=R.+A.+Patelauthor=A.+Petrovauthor=G.+Scapinauthor=S.+B.+Patelauthor=R.+S.+Royauthor=J.+K.+Wuauthor=M.+J.+Wyvrattauthor=B.+B.+Zhangauthor=L.+Zhuauthor=N.+A.+Thornberryauthor=A.+E.+Weber&title=%282R%29-4-Oxo-4-%5B3-%28trifluoromethyl%29-5%2C6-dihydro%5B1%2C2%2C4%5Dtriazolo%5B4%2C3-a%5Dpyrazin-7%288H%29-yl%5D-1-%282%2C4%2C5-trifluorophenyl%29butan-2-amine%3A+A+Potent%2C+Orally+Active+Dipeptidyl+Peptidase+IV+Inhibitor+for+the+Treatment+of+Type+2+Diabetes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2b&amp;dbid=16384&amp;doi=10.1021%2Fjm0493156&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0493156%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DD.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DBeconi%26aufirst%3DM.%26aulast%3DEiermann%26aufirst%3DG.%2BJ.%26aulast%3DFisher%26aufirst%3DM.%2BH.%26aulast%3DHe%26aufirst%3DH.%26aulast%3DHickey%26aufirst%3DG.%2BJ.%26aulast%3DKowalchick%26aufirst%3DJ.%2BE.%26aulast%3DLeiting%26aufirst%3DB.%26aulast%3DLyon%26aufirst%3DK.%26aulast%3DMarsilio%26aufirst%3DF.%26aulast%3DMcCann%26aufirst%3DM.%2BE.%26aulast%3DPatel%26aufirst%3DR.%2BA.%26aulast%3DPetrov%26aufirst%3DA.%26aulast%3DScapin%26aufirst%3DG.%26aulast%3DPatel%26aufirst%3DS.%2BB.%26aulast%3DRoy%26aufirst%3DR.%2BS.%26aulast%3DWu%26aufirst%3DJ.%2BK.%26aulast%3DWyvratt%26aufirst%3DM.%2BJ.%26aulast%3DZhang%26aufirst%3DB.%2BB.%26aulast%3DZhu%26aufirst%3DL.%26aulast%3DThornberry%26aufirst%3DN.%2BA.%26aulast%3DWeber%26aufirst%3DA.%2BE.%26atitle%3D%25282R%2529-4-Oxo-4-%255B3-%2528trifluoromethyl%2529-5%252C6-dihydro%255B1%252C2%252C4%255Dtriazolo%255B4%252C3-a%255Dpyrazin-7%25288H%2529-yl%255D-1-%25282%252C4%252C5-trifluorophenyl%2529butan-2-amine%253A%2520A%2520Potent%252C%2520Orally%2520Active%2520Dipeptidyl%2520Peptidase%2520IV%2520Inhibitor%2520for%2520the%2520Treatment%2520of%2520Type%25202%2520Diabetes%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26issue%3D1%26spage%3D141%26epage%3D151" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Augeri, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robl, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Betebenner, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Magnin, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khanna, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robertson, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simpkins, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taunk, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Han, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abboa-Offei, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cap, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xin, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tao, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tozzo, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Welzel, G. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Egan, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marcinkeviciene, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, S. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biller, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kirby, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parker, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamann, L. G.</span><span> </span><span class="NLM_article-title">Discovery and Preclinical Profile of Saxagliptin (BMS-477118): A Highly Potent, Long-Acting, Orally Active Dipeptidyl Peptidase IV Inhibitor for the Treatment of Type 2 Diabetes</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x"> (</span><span class="NLM_issue">15</span><span class="NLM_x">) </span> <span class="NLM_fpage">5025</span><span class="NLM_x">–</span> <span class="NLM_lpage">5037</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm050261p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref3/cit3a&amp;dbid=32&amp;doi=10.1021%2Fjm4008906&amp;key=1%3ACAS%3A528%3ADC%252BD2MXlsVeltb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=5025-5037&issue=15&author=D.+J.+Augeriauthor=J.+A.+Roblauthor=D.+A.+Betebennerauthor=D.+R.+Magninauthor=A.+Khannaauthor=J.+G.+Robertsonauthor=A.+Wangauthor=L.+M.+Simpkinsauthor=P.+Taunkauthor=Q.+Huangauthor=S.+P.+Hanauthor=B.+Abboa-Offeiauthor=M.+Capauthor=L.+Xinauthor=L.+Taoauthor=E.+Tozzoauthor=G.+E.+Welzelauthor=D.+M.+Eganauthor=J.+Marcinkevicieneauthor=S.+Y.+Changauthor=S.+A.+Billerauthor=M.+S.+Kirbyauthor=R.+A.+Parkerauthor=L.+G.+Hamann&title=Discovery+and+Preclinical+Profile+of+Saxagliptin+%28BMS-477118%29%3A+A+Highly+Potent%2C+Long-Acting%2C+Orally+Active+Dipeptidyl+Peptidase+IV+Inhibitor+for+the+Treatment+of+Type+2+Diabetes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3aR"><div class="casContent"><span class="casTitleNuber">3a</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery and Preclinical Profile of Saxagliptin (BMS-477118): A Highly Potent, Long-Acting, Orally Active Dipeptidyl Peptidase IV Inhibitor for the Treatment of Type 2 Diabetes</span></div><div class="casAuthors">Augeri, David J.; Robl, Jeffrey A.; Betebenner, David A.; Magnin, David R.; Khanna, Ashish; Robertson, James G.; Wang, Aiying; Simpkins, Ligaya M.; Taunk, Prakash; Huang, Qi; Han, Song-Ping; Abboa-Offei, Benoni; Cap, Michael; Xin, Li; Tao, Li; Tozzo, Effie; Welzel, Gustav E.; Egan, Donald M.; Marcinkeviciene, Jovita; Chang, Shu Y.; Biller, Scott A.; Kirby, Mark S.; Parker, Rex A.; Hamann, Lawrence G.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">5025-5037</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Efforts to further elucidate structure-activity relationships (SAR) within the authors previously disclosed series of β-quaternary amino acid linked L-cis-4,5-methanoprolinenitrile dipeptidyl peptidase IV (DPP-IV) inhibitors led to the investigation of vinyl substitution at the β-position of α-cycloalkyl-substituted glycines.  Despite poor systemic exposure, vinyl-substituted compds. showed extended duration of action in acute rat ex vivo plasma DPP-IV inhibition models.  Oxygenated putative metabolites were prepd. and were shown to exhibit the potency and extended duration of action of their precursors in efficacy models measuring glucose clearance in Zuckerfa/fa rats.  Extension of this approach to adamantylglycine-derived inhibitors led to the discovery of highly potent inhibitors, including hydroxyadamantyl compd. BMS-477118 (saxagliptin), a highly efficacious, stable, and long-acting DPP-IV inhibitor, which is currently undergoing clin. trials for treatment of type 2 diabetes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpGrIJX7K8p67Vg90H21EOLACvtfcHk0li5kHZhAGSO3Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXlsVeltb0%253D&md5=878355880133bb0ddd6bd14ecbf1d070</span></div><a href="/servlet/linkout?suffix=cit3a&amp;dbid=16384&amp;doi=10.1021%2Fjm050261p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm050261p%26sid%3Dliteratum%253Aachs%26aulast%3DAugeri%26aufirst%3DD.%2BJ.%26aulast%3DRobl%26aufirst%3DJ.%2BA.%26aulast%3DBetebenner%26aufirst%3DD.%2BA.%26aulast%3DMagnin%26aufirst%3DD.%2BR.%26aulast%3DKhanna%26aufirst%3DA.%26aulast%3DRobertson%26aufirst%3DJ.%2BG.%26aulast%3DWang%26aufirst%3DA.%26aulast%3DSimpkins%26aufirst%3DL.%2BM.%26aulast%3DTaunk%26aufirst%3DP.%26aulast%3DHuang%26aufirst%3DQ.%26aulast%3DHan%26aufirst%3DS.%2BP.%26aulast%3DAbboa-Offei%26aufirst%3DB.%26aulast%3DCap%26aufirst%3DM.%26aulast%3DXin%26aufirst%3DL.%26aulast%3DTao%26aufirst%3DL.%26aulast%3DTozzo%26aufirst%3DE.%26aulast%3DWelzel%26aufirst%3DG.%2BE.%26aulast%3DEgan%26aufirst%3DD.%2BM.%26aulast%3DMarcinkeviciene%26aufirst%3DJ.%26aulast%3DChang%26aufirst%3DS.%2BY.%26aulast%3DBiller%26aufirst%3DS.%2BA.%26aulast%3DKirby%26aufirst%3DM.%2BS.%26aulast%3DParker%26aufirst%3DR.%2BA.%26aulast%3DHamann%26aufirst%3DL.%2BG.%26atitle%3DDiscovery%2520and%2520Preclinical%2520Profile%2520of%2520Saxagliptin%2520%2528BMS-477118%2529%253A%2520A%2520Highly%2520Potent%252C%2520Long-Acting%252C%2520Orally%2520Active%2520Dipeptidyl%2520Peptidase%2520IV%2520Inhibitor%2520for%2520the%2520Treatment%2520of%2520Type%25202%2520Diabetes%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26issue%3D15%26spage%3D5025%26epage%3D5037" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit3b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Dhillon, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weber, J.</span><span> </span><span class="NLM_article-title">Saxagliptin</span> <span class="citation_source-journal">Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">69</span><span class="NLM_x"> (</span><span class="NLM_issue">15</span><span class="NLM_x">) </span> <span class="NLM_fpage">2103</span><span class="NLM_x">–</span> <span class="NLM_lpage">2114</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2009&pages=2103-2114&issue=15&author=S.+Dhillonauthor=J.+Weber&title=Saxagliptin"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDhillon%26aufirst%3DS.%26aulast%3DWeber%26aufirst%3DJ.%26atitle%3DSaxagliptin%26jtitle%3DDrugs%26date%3D2009%26volume%3D69%26issue%3D15%26spage%3D2103%26epage%3D2114" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Villhauer, E. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brinkman, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naderi, G. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burkey, B. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dunning, B. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prasad, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mangold, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Russell, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hughes, T. E.</span><span> </span><span class="NLM_article-title">1-[[(3-Hydroxy-1-adamantyl)amino]acetyl]-2-cyano-(<i>S</i>)-pyrrolidine: A Potent, Selective, and Orally Bioavailable Dipeptidyl Peptidase IV Inhibitor with Antihyperglycemic Properties</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x"> (</span><span class="NLM_issue">13</span><span class="NLM_x">) </span> <span class="NLM_fpage">2774</span><span class="NLM_x">–</span> <span class="NLM_lpage">2789</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm030091l" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2003&pages=2774-2789&issue=13&author=E.+B.+Villhauerauthor=J.+A.+Brinkmanauthor=G.+B.+Naderiauthor=B.+F.+Burkeyauthor=B.+E.+Dunningauthor=K.+Prasadauthor=B.+L.+Mangoldauthor=M.+E.+Russellauthor=T.+E.+Hughes&title=1-%5B%5B%283-Hydroxy-1-adamantyl%29amino%5Dacetyl%5D-2-cyano-%28S%29-pyrrolidine%3A+A+Potent%2C+Selective%2C+and+Orally+Bioavailable+Dipeptidyl+Peptidase+IV+Inhibitor+with+Antihyperglycemic+Properties"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4a&amp;dbid=16384&amp;doi=10.1021%2Fjm030091l&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm030091l%26sid%3Dliteratum%253Aachs%26aulast%3DVillhauer%26aufirst%3DE.%2BB.%26aulast%3DBrinkman%26aufirst%3DJ.%2BA.%26aulast%3DNaderi%26aufirst%3DG.%2BB.%26aulast%3DBurkey%26aufirst%3DB.%2BF.%26aulast%3DDunning%26aufirst%3DB.%2BE.%26aulast%3DPrasad%26aufirst%3DK.%26aulast%3DMangold%26aufirst%3DB.%2BL.%26aulast%3DRussell%26aufirst%3DM.%2BE.%26aulast%3DHughes%26aufirst%3DT.%2BE.%26atitle%3D1-%255B%255B%25283-Hydroxy-1-adamantyl%2529amino%255Dacetyl%255D-2-cyano-%2528S%2529-pyrrolidine%253A%2520A%2520Potent%252C%2520Selective%252C%2520and%2520Orally%2520Bioavailable%2520Dipeptidyl%2520Peptidase%2520IV%2520Inhibitor%2520with%2520Antihyperglycemic%2520Properties%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2003%26volume%3D46%26issue%3D13%26spage%3D2774%26epage%3D2789" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit4b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Banerjee, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Younis, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soran, H.</span><span> </span><span class="NLM_article-title">Vildagliptin in Clinical Practice: A Review of Literature</span> <span class="citation_source-journal">Expert Opin. Pharmacother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x"> (</span><span class="NLM_issue">16</span><span class="NLM_x">) </span> <span class="NLM_fpage">2745</span><span class="NLM_x">–</span> <span class="NLM_lpage">2757</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=16&amp;doi=10.1021%2Fjm4008906&amp;key=10.1517%2F14656560903302265" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=8&amp;doi=10.1021%2Fjm4008906&amp;key=19874253" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=32&amp;doi=10.1021%2Fjm4008906&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtleksbzN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2009&pages=2745-2757&issue=16&author=M.+Banerjeeauthor=N.+Younisauthor=H.+Soran&title=Vildagliptin+in+Clinical+Practice%3A+A+Review+of+Literature"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4bR"><div class="casContent"><span class="casTitleNuber">4b</span><div class="casTitle"><span class="NLM_cas:atitle">Vildagliptin in clinical practice: a review of literature</span></div><div class="casAuthors">Banerjee, Moulinath; Younis, Naveed; Soran, Handrean</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Pharmacotherapy</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">2745-2757</span>CODEN:
                <span class="NLM_cas:coden">EOPHF7</span>;
        ISSN:<span class="NLM_cas:issn">1465-6566</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Vildagliptin is the second member of the DPP-IV inhibitor class of drugs licensed for the treatment of type 2 diabetes mellitus (T2DM).  The novel action of these drugs has promoted a new outlook in the pathobiol. of T2DM.  This review undertakes to examine the clin. studies published to date, with the aim of evaluating the position of vildagliptin among the drugs that are now available to treat this common dysmetabolic state.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGppN-1Bi-FdXLVg90H21EOLACvtfcHk0lgvXsg0NbQGcg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtleksbzN&md5=97786a0b3041e1c49278c7118f1a4948</span></div><a href="/servlet/linkout?suffix=cit4b&amp;dbid=16384&amp;doi=10.1517%2F14656560903302265&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F14656560903302265%26sid%3Dliteratum%253Aachs%26aulast%3DBanerjee%26aufirst%3DM.%26aulast%3DYounis%26aufirst%3DN.%26aulast%3DSoran%26aufirst%3DH.%26atitle%3DVildagliptin%2520in%2520Clinical%2520Practice%253A%2520A%2520Review%2520of%2520Literature%26jtitle%3DExpert%2520Opin.%2520Pharmacother.%26date%3D2009%26volume%3D10%26issue%3D16%26spage%3D2745%26epage%3D2757" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Del Prato, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barnett, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huisman, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neubacher, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woerle, H.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dugi, K. A.</span><span> </span><span class="NLM_article-title">Effect of Linagliptin Monotherapy on Glycaemic Control and Markers of β-Cell Function in Patients with Inadequately Controlled Type 2 Diabetes: A Randomized Controlled Trial</span> <span class="citation_source-journal">Diabetes Obes. Metab.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">258</span><span class="NLM_x">–</span> <span class="NLM_lpage">267</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Fjm4008906&amp;key=10.1111%2Fj.1463-1326.2010.01350.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Fjm4008906&amp;key=21205122" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Fjm4008906&amp;key=1%3ACAS%3A528%3ADC%252BC3MXjtFSgt74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2011&pages=258-267&author=S.+Del+Pratoauthor=A.+H.+Barnettauthor=H.+Huismanauthor=D.+Neubacherauthor=H.-J.+Woerleauthor=K.+A.+Dugi&title=Effect+of+Linagliptin+Monotherapy+on+Glycaemic+Control+and+Markers+of+%CE%B2-Cell+Function+in+Patients+with+Inadequately+Controlled+Type+2+Diabetes%3A+A+Randomized+Controlled+Trial"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Effect of linagliptin monotherapy on glycemic control and markers of β-cell function in patients with inadequately controlled type 2 diabetes: a randomized controlled trial</span></div><div class="casAuthors">del Prato, S.; Barnett, A. H.; Huisman, H.; Neubacher, D.; Woerle, H.-J.; Dugi, K. A.</div><div class="citationInfo"><span class="NLM_cas:title">Diabetes, Obesity and Metabolism</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">258-267</span>CODEN:
                <span class="NLM_cas:coden">DOMEF6</span>;
        ISSN:<span class="NLM_cas:issn">1462-8902</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">To assess the safety and efficacy of the potent and selective dipeptidyl peptidase-4 inhibitor linagliptin 5 mg when given for 24 wk to patients with type 2 diabetes who were either treatment-naive or who had received one oral antidiabetes drug (OAD).  This multicenter, randomized, parallel group, phase III study compared linagliptin treatment (5 mg once daily, n = 336) with placebo (n = 167) for 24 wk in type 2 diabetes patients.  Before randomization, patients pretreated with one OAD underwent a washout period of 6 wk, which included a placebo run-in period during the last 2 wk.  Patients previously untreated with an OAD underwent a 2-wk placebo run-in period.  The primary endpoint was the change in HbA1c from baseline after 24 wk of treatment.  Linagliptin treatment resulted in a placebo-cor. change in HbA1c from baseline of -0.69% (p < 0.0001) at 24 wk.  In patients with baseline HbA1c ≥ 9.0%, the adjusted redn. in HbA1c was 1.01% (p < 0.0001).  Patients treated with linagliptin were more likely to achieve a redn. in HbA1c of ≥0.5% at 24 wk than those in the placebo arm (47.1 and 19.0%, resp.; odds ratio, OR = 4.2, p < 0.0001).  Fasting plasma glucose improved by -1.3 mmol/l (p < 0.0001) with linagliptin vs. placebo, and linagliptin produced an adjusted mean redn. from baseline after 24 wk in 2-h postprandial glucose of -3.2 mmol/l (p < 0.0001).  Statistically significant and relevant treatment differences were obsd. for proinsulin/insulin ratio (p = 0.025), Homeostasis Model Assessment-percent 8 (p = 0.049) and disposition index (p = 0.0005).  There was no excess of hypoglycemic episodes with linagliptin vs. placebo and no patient required third-party intervention.  Mild or moderate renal impairment did not influence the through plasma levels of linagliptin.  monotherapy with linagliptin produced a significant, clin. meaningful and sustained improvement in glycemic control, accompanied by enhanced parameters of β-cell function.  The safety profile of linagliptin was comparable with that of placebo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp4wT5EBdmBrLVg90H21EOLACvtfcHk0lgjEtIOluRvzg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXjtFSgt74%253D&md5=eee381cf7037a84d2744fec5bbfcfd43</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1111%2Fj.1463-1326.2010.01350.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1463-1326.2010.01350.x%26sid%3Dliteratum%253Aachs%26aulast%3DDel%2BPrato%26aufirst%3DS.%26aulast%3DBarnett%26aufirst%3DA.%2BH.%26aulast%3DHuisman%26aufirst%3DH.%26aulast%3DNeubacher%26aufirst%3DD.%26aulast%3DWoerle%26aufirst%3DH.-J.%26aulast%3DDugi%26aufirst%3DK.%2BA.%26atitle%3DEffect%2520of%2520Linagliptin%2520Monotherapy%2520on%2520Glycaemic%2520Control%2520and%2520Markers%2520of%2520%25CE%25B2-Cell%2520Function%2520in%2520Patients%2520with%2520Inadequately%2520Controlled%2520Type%25202%2520Diabetes%253A%2520A%2520Randomized%2520Controlled%2520Trial%26jtitle%3DDiabetes%2520Obes.%2520Metab.%26date%3D2011%26volume%3D13%26spage%3D258%26epage%3D267" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Brigance, R. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meng, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fura, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harrity, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zahler, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kirby, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamann, L. G.</span><span> </span><span class="NLM_article-title">Synthesis and SAR of Azolopyrimidines as Potent and Selective Dipeptidyl Peptidase-4 (DPP4) Inhibitors for Type 2 Diabetes</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x"> (</span><span class="NLM_issue">15</span><span class="NLM_x">) </span> <span class="NLM_fpage">4395</span><span class="NLM_x">–</span> <span class="NLM_lpage">4398</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=4395-4398&issue=15&author=R.+P.+Briganceauthor=W.+Mengauthor=A.+Furaauthor=T.+Harrityauthor=A.+Wangauthor=R.+Zahlerauthor=M.+S.+Kirbyauthor=L.+G.+Hamann&title=Synthesis+and+SAR+of+Azolopyrimidines+as+Potent+and+Selective+Dipeptidyl+Peptidase-4+%28DPP4%29+Inhibitors+for+Type+2+Diabetes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBrigance%26aufirst%3DR.%2BP.%26aulast%3DMeng%26aufirst%3DW.%26aulast%3DFura%26aufirst%3DA.%26aulast%3DHarrity%26aufirst%3DT.%26aulast%3DWang%26aufirst%3DA.%26aulast%3DZahler%26aufirst%3DR.%26aulast%3DKirby%26aufirst%3DM.%2BS.%26aulast%3DHamann%26aufirst%3DL.%2BG.%26atitle%3DSynthesis%2520and%2520SAR%2520of%2520Azolopyrimidines%2520as%2520Potent%2520and%2520Selective%2520Dipeptidyl%2520Peptidase-4%2520%2528DPP4%2529%2520Inhibitors%2520for%2520Type%25202%2520Diabetes%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26issue%3D15%26spage%3D4395%26epage%3D4398" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit6b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Meng, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brigance, R. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chao, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fura, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harrity, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marcinkeviciene, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Connor, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tamura, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xie, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klei, H. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weigelt, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tuerdi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zahler, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kirby, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamann, L. G.</span><span> </span><span class="NLM_article-title">Discovery of 6-(Aminomethyl)-5-(2,4-dichlorophenyl)-7-methylimidazo[1,2-<i>a</i>]pyrimidine-2-carboxamides as Potent, Selective Dipeptidyl Peptidase-4 (DPP4) Inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x"> (</span><span class="NLM_issue">15</span><span class="NLM_x">) </span> <span class="NLM_fpage">5620</span><span class="NLM_x">–</span> <span class="NLM_lpage">5628</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm100634a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=5620-5628&issue=15&author=W.+Mengauthor=R.+P.+Briganceauthor=H.+J.+Chaoauthor=A.+Furaauthor=T.+Harrityauthor=J.+Marcinkevicieneauthor=S.+P.+O%E2%80%99Connorauthor=J.+K.+Tamuraauthor=D.+Xieauthor=Y.+Zhangauthor=H.+E.+Kleiauthor=C.+A.+Weigeltauthor=H.+Tuerdiauthor=A.+Wangauthor=R.+Zahlerauthor=M.+S.+Kirbyauthor=L.+G.+Hamann&title=Discovery+of+6-%28Aminomethyl%29-5-%282%2C4-dichlorophenyl%29-7-methylimidazo%5B1%2C2-a%5Dpyrimidine-2-carboxamides+as+Potent%2C+Selective+Dipeptidyl+Peptidase-4+%28DPP4%29+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6b&amp;dbid=16384&amp;doi=10.1021%2Fjm100634a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm100634a%26sid%3Dliteratum%253Aachs%26aulast%3DMeng%26aufirst%3DW.%26aulast%3DBrigance%26aufirst%3DR.%2BP.%26aulast%3DChao%26aufirst%3DH.%2BJ.%26aulast%3DFura%26aufirst%3DA.%26aulast%3DHarrity%26aufirst%3DT.%26aulast%3DMarcinkeviciene%26aufirst%3DJ.%26aulast%3DO%25E2%2580%2599Connor%26aufirst%3DS.%2BP.%26aulast%3DTamura%26aufirst%3DJ.%2BK.%26aulast%3DXie%26aufirst%3DD.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DKlei%26aufirst%3DH.%2BE.%26aulast%3DWeigelt%26aufirst%3DC.%2BA.%26aulast%3DTuerdi%26aufirst%3DH.%26aulast%3DWang%26aufirst%3DA.%26aulast%3DZahler%26aufirst%3DR.%26aulast%3DKirby%26aufirst%3DM.%2BS.%26aulast%3DHamann%26aufirst%3DL.%2BG.%26atitle%3DDiscovery%2520of%25206-%2528Aminomethyl%2529-5-%25282%252C4-dichlorophenyl%2529-7-methylimidazo%255B1%252C2-a%255Dpyrimidine-2-carboxamides%2520as%2520Potent%252C%2520Selective%2520Dipeptidyl%2520Peptidase-4%2520%2528DPP4%2529%2520Inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26issue%3D15%26spage%3D5620%26epage%3D5628" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit6c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Wang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Devasthale, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harrity, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Egan, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morgan, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cap, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fura, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klei, H. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kish, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weigelt, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levesque, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Y.-X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zahler, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kirby, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamann, L. G.</span><span> </span><span class="NLM_article-title">7-Oxopyrrolopyridine-Derived DPP4 Inhibitors—Mitigation of CYP and hERG Liabilities via Introduction of Polar Functionalities in the Active Site</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x"> (</span><span class="NLM_issue">22</span><span class="NLM_x">) </span> <span class="NLM_fpage">6646</span><span class="NLM_x">–</span> <span class="NLM_lpage">6651</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=6646-6651&issue=22&author=W.+Wangauthor=P.+Devasthaleauthor=A.+Wangauthor=T.+Harrityauthor=D.+Eganauthor=N.+Morganauthor=M.+Capauthor=A.+Furaauthor=H.+E.+Kleiauthor=K.+Kishauthor=C.+A.+Weigeltauthor=L.+Sunauthor=P.+Levesqueauthor=Y.-X.+Liauthor=R.+Zahlerauthor=M.+S.+Kirbyauthor=L.+G.+Hamann&title=7-Oxopyrrolopyridine-Derived+DPP4+Inhibitors%E2%80%94Mitigation+of+CYP+and+hERG+Liabilities+via+Introduction+of+Polar+Functionalities+in+the+Active+Site"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DW.%26aulast%3DDevasthale%26aufirst%3DP.%26aulast%3DWang%26aufirst%3DA.%26aulast%3DHarrity%26aufirst%3DT.%26aulast%3DEgan%26aufirst%3DD.%26aulast%3DMorgan%26aufirst%3DN.%26aulast%3DCap%26aufirst%3DM.%26aulast%3DFura%26aufirst%3DA.%26aulast%3DKlei%26aufirst%3DH.%2BE.%26aulast%3DKish%26aufirst%3DK.%26aulast%3DWeigelt%26aufirst%3DC.%2BA.%26aulast%3DSun%26aufirst%3DL.%26aulast%3DLevesque%26aufirst%3DP.%26aulast%3DLi%26aufirst%3DY.-X.%26aulast%3DZahler%26aufirst%3DR.%26aulast%3DKirby%26aufirst%3DM.%2BS.%26aulast%3DHamann%26aufirst%3DL.%2BG.%26atitle%3D7-Oxopyrrolopyridine-Derived%2520DPP4%2520Inhibitors%25E2%2580%2594Mitigation%2520of%2520CYP%2520and%2520hERG%2520Liabilities%2520via%2520Introduction%2520of%2520Polar%2520Functionalities%2520in%2520the%2520Active%2520Site%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D21%26issue%3D22%26spage%3D6646%26epage%3D6651" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit6d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">O’Connor, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simpkins, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brigance, R. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meng, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kirby, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weigelt, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamann, L. G.</span><span> </span><span class="NLM_article-title">Synthesis, SAR, and Atropisomerism of Imidazolopyrimidine DPP4 Inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">6273</span><span class="NLM_x">–</span> <span class="NLM_lpage">6276</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=6273-6276&author=S.+P.+O%E2%80%99Connorauthor=Y.+Wangauthor=L.+M.+Simpkinsauthor=R.+P.+Briganceauthor=W.+Mengauthor=A.+Wangauthor=M.+S.+Kirbyauthor=C.+A.+Weigeltauthor=L.+G.+Hamann&title=Synthesis%2C+SAR%2C+and+Atropisomerism+of+Imidazolopyrimidine+DPP4+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6d&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DO%25E2%2580%2599Connor%26aufirst%3DS.%2BP.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DSimpkins%26aufirst%3DL.%2BM.%26aulast%3DBrigance%26aufirst%3DR.%2BP.%26aulast%3DMeng%26aufirst%3DW.%26aulast%3DWang%26aufirst%3DA.%26aulast%3DKirby%26aufirst%3DM.%2BS.%26aulast%3DWeigelt%26aufirst%3DC.%2BA.%26aulast%3DHamann%26aufirst%3DL.%2BG.%26atitle%3DSynthesis%252C%2520SAR%252C%2520and%2520Atropisomerism%2520of%2520Imidazolopyrimidine%2520DPP4%2520Inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D6273%26epage%3D6276" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit6e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">Kirby, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, D. M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Connor, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gorrell, M. D.</span><span> </span><span class="NLM_article-title">Inhibitor Selectivity in the Clinical Application of Dipeptidyl Peptidase-4 Inhibition</span> <span class="citation_source-journal">Clin. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">118</span><span class="NLM_x">, </span> <span class="NLM_fpage">31</span><span class="NLM_x">–</span> <span class="NLM_lpage">41</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6e&amp;dbid=16&amp;doi=10.1021%2Fjm4008906&amp;key=10.1042%2FCS20090047" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6e&amp;dbid=32&amp;doi=10.1021%2Fjm4008906&amp;key=1%3ACAS%3A528%3ADC%252BD1MXht1WntbrL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=118&publication_year=2010&pages=31-41&author=M.+Kirbyauthor=D.+M.+T.+Yuauthor=S.+P.+O%E2%80%99Connorauthor=M.+D.+Gorrell&title=Inhibitor+Selectivity+in+the+Clinical+Application+of+Dipeptidyl+Peptidase-4+Inhibition"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6eR"><div class="casContent"><span class="casTitleNuber">6e</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibitor selectivity in the clinical application of dipeptidyl peptidase-4 inhibition</span></div><div class="casAuthors">Kirby, Mark; Yu, Denise M. T.; O'Connor, Steven; Gorrell, Mark D.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Science</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">118</span>
        (<span class="NLM_cas:issue">1/2</span>),
    <span class="NLM_cas:pages">31-41</span>CODEN:
                <span class="NLM_cas:coden">CSCIAE</span>;
        ISSN:<span class="NLM_cas:issn">0143-5221</span>.
    
            (<span class="NLM_cas:orgname">Portland Press Ltd.</span>)
        </div><div class="casAbstract">A review.  DPP-4 (dipeptidyl peptidase-4) degrades the incretin hormones GLP-1 (glucagon-like peptide-1) and GIP (gastric inhibitory polypeptide), decreasing their stimulatory effects on β-cell insulin secretion.  In patients with Type 2 diabetes, meal-related GLP-1 secretion is reduced.  DPP-4 inhibitors (alogliptin, saxagliptin, sitagliptin and vildagliptin) correct the GLP-1 deficiency by blocking this degrdn., prolonging the incretin effect and enhancing glucose homoeostasis.  DPP-4 is a member of a family of ubiquitous atypical serine proteases with many physiol. functions beyond incretin degrdn., including effects on the endocrine and immune systems.  The role of DPP-4 on the immune system relates to its extra-enzymic activities.  The intracytosolic enzymes DPP-8 and DPP-9 are recently discovered DPP-4 family members.  Although specific functions of DPP-8 and DPP-9 are unclear, a potential for adverse effects assocd. with DPP-8 and DPP-9 inhibition by non-selective DPP inhibitors has been posed based on a single adverse preclin. study.  However, the preponderance of data suggests that such DPP-8 and DPP-9 enzyme inhibition is probably without clin. consequence.  This review examines the structure and function of the DPP-4 family, assocd. DPP-4 inhibitor selectivity and the implications of DPP-4 inhibition in the treatment of Type 2 diabetes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqYcV4MFkHr_bVg90H21EOLACvtfcHk0lizmx4KCEmRjQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXht1WntbrL&md5=ba5650dc1c928a621aea4e30b123b27d</span></div><a href="/servlet/linkout?suffix=cit6e&amp;dbid=16384&amp;doi=10.1042%2FCS20090047&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252FCS20090047%26sid%3Dliteratum%253Aachs%26aulast%3DKirby%26aufirst%3DM.%26aulast%3DYu%26aufirst%3DD.%2BM.%2BT.%26aulast%3DO%25E2%2580%2599Connor%26aufirst%3DS.%2BP.%26aulast%3DGorrell%26aufirst%3DM.%2BD.%26atitle%3DInhibitor%2520Selectivity%2520in%2520the%2520Clinical%2520Application%2520of%2520Dipeptidyl%2520Peptidase-4%2520Inhibition%26jtitle%3DClin.%2520Sci.%26date%3D2010%26volume%3D118%26spage%3D31%26epage%3D41" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Lankas, G. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leiting, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roy, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eiermann, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beconi, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biftu, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, C.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edmondson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feeney, W. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ippolito, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lyons, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ok, H. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petrov, A. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pryor, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qian, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reigle, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woods, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zaller, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weber, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thornberry, N. A.</span><span> </span><span class="NLM_article-title">Dipeptidyl Peptidase IV Inhibition for the Treatment of Type 2 Diabetes. Potential Importance of Selectivity over Dipeptidyl Peptidases 8 and 9</span> <span class="citation_source-journal">Diabetes</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">2988</span><span class="NLM_x">–</span> <span class="NLM_lpage">2994</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2005&pages=2988-2994&author=G.+R.+Lankasauthor=B.+Leitingauthor=R.+S.+Royauthor=G.+J.+Eiermannauthor=M.+G.+Beconiauthor=T.+Biftuauthor=C.-C.+Chanauthor=S.+Edmondsonauthor=W.+P.+Feeneyauthor=H.+Heauthor=D.+E.+Ippolitoauthor=D.+Kimauthor=K.+A.+Lyonsauthor=H.+A.+Okauthor=R.+A.+Patelauthor=A.+N.+Petrovauthor=K.+A.+Pryorauthor=X.+Qianauthor=L.+Reigleauthor=A.+Woodsauthor=J.+K.+Wuauthor=D.+Zallerauthor=X.+Zhangauthor=L.+Zuauthor=A.+E.+Weberauthor=N.+A.+Thornberry&title=Dipeptidyl+Peptidase+IV+Inhibition+for+the+Treatment+of+Type+2+Diabetes.+Potential+Importance+of+Selectivity+over+Dipeptidyl+Peptidases+8+and+9"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLankas%26aufirst%3DG.%2BR.%26aulast%3DLeiting%26aufirst%3DB.%26aulast%3DRoy%26aufirst%3DR.%2BS.%26aulast%3DEiermann%26aufirst%3DG.%2BJ.%26aulast%3DBeconi%26aufirst%3DM.%2BG.%26aulast%3DBiftu%26aufirst%3DT.%26aulast%3DChan%26aufirst%3DC.-C.%26aulast%3DEdmondson%26aufirst%3DS.%26aulast%3DFeeney%26aufirst%3DW.%2BP.%26aulast%3DHe%26aufirst%3DH.%26aulast%3DIppolito%26aufirst%3DD.%2BE.%26aulast%3DKim%26aufirst%3DD.%26aulast%3DLyons%26aufirst%3DK.%2BA.%26aulast%3DOk%26aufirst%3DH.%2BA.%26aulast%3DPatel%26aufirst%3DR.%2BA.%26aulast%3DPetrov%26aufirst%3DA.%2BN.%26aulast%3DPryor%26aufirst%3DK.%2BA.%26aulast%3DQian%26aufirst%3DX.%26aulast%3DReigle%26aufirst%3DL.%26aulast%3DWoods%26aufirst%3DA.%26aulast%3DWu%26aufirst%3DJ.%2BK.%26aulast%3DZaller%26aufirst%3DD.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DZu%26aufirst%3DL.%26aulast%3DWeber%26aufirst%3DA.%2BE.%26aulast%3DThornberry%26aufirst%3DN.%2BA.%26atitle%3DDipeptidyl%2520Peptidase%2520IV%2520Inhibition%2520for%2520the%2520Treatment%2520of%2520Type%25202%2520Diabetes.%2520Potential%2520Importance%2520of%2520Selectivity%2520over%2520Dipeptidyl%2520Peptidases%25208%2520and%25209%26jtitle%3DDiabetes%26date%3D2005%26volume%3D54%26spage%3D2988%26epage%3D2994" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit7b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Kushner, P.; Gorrell, M.</span><span> </span><span class="NLM_article-title">DPP-4 Inhibitors in Type 2 Diabetes: Importance of Selective Enzyme Inhibition and Implications for Clinical Use</span> <span class="citation_source-journal">J. Fam. Pract.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span>), <a href="http://www.jfponline.com/Pages.asp?AID=8408" class="extLink">http://www.jfponline.com/Pages.asp?AID=8408</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2010&issue=2&author=P.+Kushner&author=M.+Gorrell&title=DPP-4+Inhibitors+in+Type+2+Diabetes%3A+Importance+of+Selective+Enzyme+Inhibition+and+Implications+for+Clinical+Use"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKushner%26aufirst%3DP.%26atitle%3DDPP-4%2520Inhibitors%2520in%2520Type%25202%2520Diabetes%253A%2520Importance%2520of%2520Selective%2520Enzyme%2520Inhibition%2520and%2520Implications%2520for%2520Clinical%2520Use%26jtitle%3DJ.%2520Fam.%2520Pract.%26date%3D2010%26volume%3D59%26issue%3D2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit7c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Burkey, B. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoffmann, P. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hassiepen, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trappe, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Juedes, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foley, J. E.</span><span> </span><span class="NLM_article-title">Adverse Effects of Dipeptidyl Peptidases 8 and 9 Inhibition in Rodents Revisited</span> <span class="citation_source-journal">Diabetes Obes. Metab.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">1057</span><span class="NLM_x">–</span> <span class="NLM_lpage">1061</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7c&amp;dbid=16&amp;doi=10.1021%2Fjm4008906&amp;key=10.1111%2Fj.1463-1326.2008.00860.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7c&amp;dbid=8&amp;doi=10.1021%2Fjm4008906&amp;key=18422675" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7c&amp;dbid=32&amp;doi=10.1021%2Fjm4008906&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsVeqsLfJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2008&pages=1057-1061&author=B.+F.+Burkeyauthor=P.+K.+Hoffmannauthor=U.+Hassiepenauthor=J.+Trappeauthor=M.+Juedesauthor=J.+E.+Foley&title=Adverse+Effects+of+Dipeptidyl+Peptidases+8+and+9+Inhibition+in+Rodents+Revisited"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7cR"><div class="casContent"><span class="casTitleNuber">7c</span><div class="casTitle"><span class="NLM_cas:atitle">Adverse effects of dipeptidyl peptidases 8 and 9 inhibition in rodents revisited</span></div><div class="casAuthors">Burkey, B. F.; Hoffmann, P. K.; Hassiepen, U.; Trappe, J.; Juedes, M.; Foley, J. E.</div><div class="citationInfo"><span class="NLM_cas:title">Diabetes, Obesity and Metabolism</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1057-1061</span>CODEN:
                <span class="NLM_cas:coden">DOMEF6</span>;
        ISSN:<span class="NLM_cas:issn">1462-8902</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Aim: To evaluate the assocn. between inhibition of dipeptidyl peptidase (DPP)-8 and/or DPP-9 organ toxicities and mortality in rodents.  Research Design and Methods: The relative selectivity of the DPP-4 inhibitor, vildagliptin, was detd. by comparing its KI (concn. of compd. yielding 50% inhibition of the enzyme) values for inhibition of recombinant human DPP-4, DPP-8 and DPP-9 assessed in vitro.  In expts. performed in vivo, vildagliptin was administered by gavage for 13 wk, at doses up to 1500 mg/kg/day in CD-1 mice and at doses up to 900 mg/kg/day in Wistar rats.  Plasma concns. of vildagliptin were assessed at week 12, and toxicities previously ascribed to inhibition of DPP-8 and/or DPP-9 were assessed at week 13.  Results: The KI values for vildagliptin-induced inhibition of DPP-4, DPP-8 and DPP-9 were 3, 810 and 95 nM resp.  The mean plasma concn. 24 h after dose after 12-wk daily dosing with 1500 mg/kg/day in mice was 2279 nM.  The mean plasma drug level 24 h after dose after 12-wk daily dosing with 900 mg/kg/day in rats was 5729 nM.  These high doses maintained plasma drug levels well above the KI values for DPP-8 and DPP-9 throughout a 24-h period.  At these high doses, the toxicities of a selective DPP-8/DPP-9 inhibitor that were reported previously (100% mortality in mice, alopecia, thrombocytopenia, reticulocytopenia, enlarged lymph nodes, splenomegaly and 20% mortality in rats) were not obsd.  Conclusions: Inhibition of DPP-8 and DPP-9 per se does not lead to organ toxicities and mortality in rodents.  Thus, a mechanism other than DPP-8/DPP-9 inhibition likely underlies the toxicity previously reported to be assocd. with a selective DPP-8/DPP-9 inhibitor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoY8zdsP6qpIbVg90H21EOLACvtfcHk0lh5S28REYM7DA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsVeqsLfJ&md5=0da6c4f34499ce1f558e28b877142519</span></div><a href="/servlet/linkout?suffix=cit7c&amp;dbid=16384&amp;doi=10.1111%2Fj.1463-1326.2008.00860.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1463-1326.2008.00860.x%26sid%3Dliteratum%253Aachs%26aulast%3DBurkey%26aufirst%3DB.%2BF.%26aulast%3DHoffmann%26aufirst%3DP.%2BK.%26aulast%3DHassiepen%26aufirst%3DU.%26aulast%3DTrappe%26aufirst%3DJ.%26aulast%3DJuedes%26aufirst%3DM.%26aulast%3DFoley%26aufirst%3DJ.%2BE.%26atitle%3DAdverse%2520Effects%2520of%2520Dipeptidyl%2520Peptidases%25208%2520and%25209%2520Inhibition%2520in%2520Rodents%2520Revisited%26jtitle%3DDiabetes%2520Obes.%2520Metab.%26date%3D2008%26volume%3D10%26spage%3D1057%26epage%3D1061" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit7d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Wu, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, H. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yeh, T. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, C. M</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shy, H. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chu, Y. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chien, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsai, T. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, Y. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, Y. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tseng, H. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiaang, W. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chao, Y. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, X.</span><span> </span><span class="NLM_article-title">Biochemistry, Pharmacokinetics, and Toxicology of a Potent and Selective DPP8/9 Inhibitor</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">78</span><span class="NLM_x">, </span> <span class="NLM_fpage">203</span><span class="NLM_x">–</span> <span class="NLM_lpage">210</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=78&publication_year=2009&pages=203-210&author=J.+J.+Wuauthor=H.+K.+Tangauthor=T.+K.+Yehauthor=C.+M+Chenauthor=H.+S.+Shyauthor=Y.+R.+Chuauthor=C.+H.+Chienauthor=T.+Y.+Tsaiauthor=Y.+C.+Huangauthor=Y.+L.+Huangauthor=C.+H.+Huangauthor=H.+Y.+Tsengauthor=W.+T.+Jiaangauthor=Y.+S.+Chaoauthor=X.+Chen&title=Biochemistry%2C+Pharmacokinetics%2C+and+Toxicology+of+a+Potent+and+Selective+DPP8%2F9+Inhibitor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7d&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DJ.%2BJ.%26aulast%3DTang%26aufirst%3DH.%2BK.%26aulast%3DYeh%26aufirst%3DT.%2BK.%26aulast%3DChen%26aufirst%3DC.%2BM%26aulast%3DShy%26aufirst%3DH.%2BS.%26aulast%3DChu%26aufirst%3DY.%2BR.%26aulast%3DChien%26aufirst%3DC.%2BH.%26aulast%3DTsai%26aufirst%3DT.%2BY.%26aulast%3DHuang%26aufirst%3DY.%2BC.%26aulast%3DHuang%26aufirst%3DY.%2BL.%26aulast%3DHuang%26aufirst%3DC.%2BH.%26aulast%3DTseng%26aufirst%3DH.%2BY.%26aulast%3DJiaang%26aufirst%3DW.%2BT.%26aulast%3DChao%26aufirst%3DY.%2BS.%26aulast%3DChen%26aufirst%3DX.%26atitle%3DBiochemistry%252C%2520Pharmacokinetics%252C%2520and%2520Toxicology%2520of%2520a%2520Potent%2520and%2520Selective%2520DPP8%252F9%2520Inhibitor%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2009%26volume%3D78%26spage%3D203%26epage%3D210" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Peters, J.-U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weber, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kritter, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weiss, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wallier, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zimmerli, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boehringer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steger, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loeffler, B.-M.</span><span> </span><span class="NLM_article-title">Aminomethylpyridines as DPP-IV Inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">3579</span><span class="NLM_x">–</span> <span class="NLM_lpage">3580</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2004&pages=3579-3580&author=J.-U.+Petersauthor=S.+Weberauthor=S.+Kritterauthor=P.+Weissauthor=A.+Wallierauthor=D.+Zimmerliauthor=M.+Boehringerauthor=M.+Stegerauthor=B.-M.+Loeffler&title=Aminomethylpyridines+as+DPP-IV+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPeters%26aufirst%3DJ.-U.%26aulast%3DWeber%26aufirst%3DS.%26aulast%3DKritter%26aufirst%3DS.%26aulast%3DWeiss%26aufirst%3DP.%26aulast%3DWallier%26aufirst%3DA.%26aulast%3DZimmerli%26aufirst%3DD.%26aulast%3DBoehringer%26aufirst%3DM.%26aulast%3DSteger%26aufirst%3DM.%26aulast%3DLoeffler%26aufirst%3DB.-M.%26atitle%3DAminomethylpyridines%2520as%2520DPP-IV%2520Inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2004%26volume%3D14%26spage%3D3579%26epage%3D3580" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit8b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Peters, J.-U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weber, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kritter, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weiss, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wallier, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boehringer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hennig, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuhn, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loeffler, B.-M.</span><span> </span><span class="NLM_article-title">Aminomethylpyrimidines as Novel DPP-IV Inhibitors: A 10(5)-Fold Activity Increase by Optimization of Aromatic Substituents</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">1491</span><span class="NLM_x">–</span> <span class="NLM_lpage">1493</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8b&amp;dbid=16&amp;doi=10.1021%2Fjm4008906&amp;key=10.1016%2Fj.bmcl.2004.01.019" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8b&amp;dbid=8&amp;doi=10.1021%2Fjm4008906&amp;key=15006388" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8b&amp;dbid=32&amp;doi=10.1021%2Fjm4008906&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhvV2itL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2004&pages=1491-1493&author=J.-U.+Petersauthor=S.+Weberauthor=S.+Kritterauthor=P.+Weissauthor=A.+Wallierauthor=M.+Boehringerauthor=M.+Hennigauthor=B.+Kuhnauthor=B.-M.+Loeffler&title=Aminomethylpyrimidines+as+Novel+DPP-IV+Inhibitors%3A+A+10%285%29-Fold+Activity+Increase+by+Optimization+of+Aromatic+Substituents"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8bR"><div class="casContent"><span class="casTitleNuber">8b</span><div class="casTitle"><span class="NLM_cas:atitle">Aminomethylpyrimidines as novel DPP-IV inhibitors: A 100 000-fold activity increase by optimization of aromatic substituents</span></div><div class="casAuthors">Peters, Jens-Uwe; Weber, Silja; Kritter, Stephane; Weiss, Peter; Wallier, Angelina; Boehringer, Markus; Hennig, Michael; Kuhn, Bernd; Loeffler, Bernd-Michael</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1491-1493</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">The influence of arom. substitution on a newly discovered class of inhibitors of dipeptidyl peptidase IV was investigated.  A 100,000-fold increase in potency was achieved by the optimization of arom. substituents in a parallel chem. program.  The obsd. SAR could be explained by an x-ray structure of the protein-ligand complex.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpF-3TwgQdprLVg90H21EOLACvtfcHk0lhrli28kZMz_g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhvV2itL0%253D&md5=37d4692f2c8b41de5cc1994bcfa21c58</span></div><a href="/servlet/linkout?suffix=cit8b&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2004.01.019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2004.01.019%26sid%3Dliteratum%253Aachs%26aulast%3DPeters%26aufirst%3DJ.-U.%26aulast%3DWeber%26aufirst%3DS.%26aulast%3DKritter%26aufirst%3DS.%26aulast%3DWeiss%26aufirst%3DP.%26aulast%3DWallier%26aufirst%3DA.%26aulast%3DBoehringer%26aufirst%3DM.%26aulast%3DHennig%26aufirst%3DM.%26aulast%3DKuhn%26aufirst%3DB.%26aulast%3DLoeffler%26aufirst%3DB.-M.%26atitle%3DAminomethylpyrimidines%2520as%2520Novel%2520DPP-IV%2520Inhibitors%253A%2520A%252010%25285%2529-Fold%2520Activity%2520Increase%2520by%2520Optimization%2520of%2520Aromatic%2520Substituents%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2004%26volume%3D14%26spage%3D1491%26epage%3D1493" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Sato, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shimoji, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fujita, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mizuno, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kumakura, S.</span><span> </span><span class="NLM_article-title">Synthetic Studies on Cardiovascular Agents. IV. Synthesis of Fused Dihydropyridine Derivatives (Author’s Transl)</span> <span class="citation_source-journal">Yakugaku Zasshi</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1978</span><span class="NLM_x">, </span> <span class="NLM_volume">98</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">448</span><span class="NLM_x">–</span> <span class="NLM_lpage">465</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=98&publication_year=1978&pages=448-465&issue=4&author=Y.+Satoauthor=Y.+Shimojiauthor=H.+Fujitaauthor=H.+Mizunoauthor=S.+Kumakura&title=Synthetic+Studies+on+Cardiovascular+Agents.+IV.+Synthesis+of+Fused+Dihydropyridine+Derivatives+%28Author%E2%80%99s+Transl%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSato%26aufirst%3DY.%26aulast%3DShimoji%26aufirst%3DY.%26aulast%3DFujita%26aufirst%3DH.%26aulast%3DMizuno%26aufirst%3DH.%26aulast%3DKumakura%26aufirst%3DS.%26atitle%3DSynthetic%2520Studies%2520on%2520Cardiovascular%2520Agents.%2520IV.%2520Synthesis%2520of%2520Fused%2520Dihydropyridine%2520Derivatives%2520%2528Author%25E2%2580%2599s%2520Transl%2529%26jtitle%3DYakugaku%2520Zasshi%26date%3D1978%26volume%3D98%26issue%3D4%26spage%3D448%26epage%3D465" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit9b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Southwick, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barnas, E. F.</span><span> </span><span class="NLM_article-title">4-Benzylidine-2,3-dioxopyrrolidines and 4-Benzyl-2,3-dioxopyrrolidines. Synthesis and Experiments on Reduction and Alkylation</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1962</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">98</span><span class="NLM_x">–</span> <span class="NLM_lpage">106</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo01048a026" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=1962&pages=98-106&issue=1&author=P.+L.+Southwickauthor=E.+F.+Barnas&title=4-Benzylidine-2%2C3-dioxopyrrolidines+and+4-Benzyl-2%2C3-dioxopyrrolidines.+Synthesis+and+Experiments+on+Reduction+and+Alkylation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9b&amp;dbid=16384&amp;doi=10.1021%2Fjo01048a026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo01048a026%26sid%3Dliteratum%253Aachs%26aulast%3DSouthwick%26aufirst%3DP.%2BL.%26aulast%3DBarnas%26aufirst%3DE.%2BF.%26atitle%3D4-Benzylidine-2%252C3-dioxopyrrolidines%2520and%25204-Benzyl-2%252C3-dioxopyrrolidines.%2520Synthesis%2520and%2520Experiments%2520on%2520Reduction%2520and%2520Alkylation%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1962%26volume%3D27%26issue%3D1%26spage%3D98%26epage%3D106" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit9c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Madhav, R.</span><span> </span><span class="NLM_article-title">A New Synthesis of Compounds in the 5<i>H</i>-Pyrrolo-[3,4-<i>b</i>]pyridine Series</span> <span class="citation_source-journal">Synthesis</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1973</span><span class="NLM_x">, </span> <span class="NLM_fpage">609</span><span class="NLM_x">–</span> <span class="NLM_lpage">610</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9c&amp;dbid=16&amp;doi=10.1021%2Fjm4008906&amp;key=10.1055%2Fs-1973-22266" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9c&amp;dbid=32&amp;doi=10.1021%2Fjm4008906&amp;key=1%3ACAS%3A528%3ADyaE2cXjsVSl" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1973&pages=609-610&author=R.+Madhav&title=A+New+Synthesis+of+Compounds+in+the+5H-Pyrrolo-%5B3%2C4-b%5Dpyridine+Series"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9cR"><div class="casContent"><span class="casTitleNuber">9c</span><div class="casTitle"><span class="NLM_cas:atitle">New synthesis of compounds in the 5H-pyrrolo[3,4-b]pyridine series</span></div><div class="casAuthors">Madhav, R.</div><div class="citationInfo"><span class="NLM_cas:title">Synthesis</span>
        (<span class="NLM_cas:date">1973</span>),
    <span class="NLM_cas:volume"></span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">609-10</span>CODEN:
                <span class="NLM_cas:coden">SYNTBF</span>;
        ISSN:<span class="NLM_cas:issn">0039-7881</span>.
    </div><div class="casAbstract">The pyrrolopyridine I (R = cyclohexyl, R1 = Ph, p-MeOC6H4, m-O2NC6H4; R = Me3C, PhCH2, R1 = Ph) were prepd. by cycloaddn. of pyrrolidinediones II with MeC(NH2):CHCO2Et and treatment of the product with Br-NaOAc.  The pyrrolopyridines III (R = cyclohexyl, PhCH2) were prepd. from II and phenacylpyridinium bromide.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoIkqm_VWteYLVg90H21EOLACvtfcHk0lhrli28kZMz_g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE2cXjsVSl&md5=18dab46a8214e59e6ffcfd10f5913b52</span></div><a href="/servlet/linkout?suffix=cit9c&amp;dbid=16384&amp;doi=10.1055%2Fs-1973-22266&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1055%252Fs-1973-22266%26sid%3Dliteratum%253Aachs%26aulast%3DMadhav%26aufirst%3DR.%26atitle%3DA%2520New%2520Synthesis%2520of%2520Compounds%2520in%2520the%25205H-Pyrrolo-%255B3%252C4-b%255Dpyridine%2520Series%26jtitle%3DSynthesis%26date%3D1973%26spage%3D609%26epage%3D610" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Jang, D. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, J.</span><span> </span><span class="NLM_article-title">A Mild and Efficient Procedure for the Preparation of Acid Chlorides from Carboxylic Acids</span> <span class="citation_source-journal">Tetrahedron Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">40</span><span class="NLM_x">, </span> <span class="NLM_fpage">5323</span><span class="NLM_x">–</span> <span class="NLM_lpage">5326</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=1999&pages=5323-5326&author=D.+O.+Jangauthor=D.+J.+Parkauthor=J.+Kim&title=A+Mild+and+Efficient+Procedure+for+the+Preparation+of+Acid+Chlorides+from+Carboxylic+Acids"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJang%26aufirst%3DD.%2BO.%26aulast%3DPark%26aufirst%3DD.%2BJ.%26aulast%3DKim%26aufirst%3DJ.%26atitle%3DA%2520Mild%2520and%2520Efficient%2520Procedure%2520for%2520the%2520Preparation%2520of%2520Acid%2520Chlorides%2520from%2520Carboxylic%2520Acids%26jtitle%3DTetrahedron%2520Lett.%26date%3D1999%26volume%3D40%26spage%3D5323%26epage%3D5326" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Brown, H. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Subba Rao, B. C.</span><span> </span><span class="NLM_article-title">A New Aldehyde Synthesis. The Reduction of Acid Chlorides by Lithium Tri-butoxyaluminohydride</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1958</span><span class="NLM_x">, </span> <span class="NLM_volume">80</span><span class="NLM_x">, </span> <span class="NLM_fpage">5377</span><span class="NLM_x">–</span> <span class="NLM_lpage">5380</span></span><div class="citationLinks">[<a href="/doi/10.1021/ja01553a014" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=80&publication_year=1958&pages=5377-5380&author=H.+C.+Brownauthor=B.+C.+Subba+Rao&title=A+New+Aldehyde+Synthesis.+The+Reduction+of+Acid+Chlorides+by+Lithium+Tri-butoxyaluminohydride"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1021%2Fja01553a014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja01553a014%26sid%3Dliteratum%253Aachs%26aulast%3DBrown%26aufirst%3DH.%2BC.%26aulast%3DSubba%2BRao%26aufirst%3DB.%2BC.%26atitle%3DA%2520New%2520Aldehyde%2520Synthesis.%2520The%2520Reduction%2520of%2520Acid%2520Chlorides%2520by%2520Lithium%2520Tri-butoxyaluminohydride%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1958%26volume%3D80%26spage%3D5377%26epage%3D5380" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12a"><span><span class="NLM_label">(a) </span>X-ray analysis of (<i>Sa</i>)-<b>2s</b>: PDB deposition number <span class="NLM_ext-link">4JH0</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=X-ray+analysis+of+%28Sa%29-2s%3A+PDB+deposition+number+4JH0."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit12b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Metzler, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yanchunas, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weigelt, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kish, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klei, H. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xie, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corbett, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tamura, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamann, L. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kirby, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marcinkeviciene, J.</span> <span class="citation_source-journal">Protein Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">240</span><span class="NLM_x">–</span> <span class="NLM_lpage">250</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12b&amp;dbid=16&amp;doi=10.1021%2Fjm4008906&amp;key=10.1110%2Fps.073253208" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12b&amp;dbid=8&amp;doi=10.1021%2Fjm4008906&amp;key=18227430" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12b&amp;dbid=32&amp;doi=10.1021%2Fjm4008906&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhvVOntLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Metzler%2C+W.+J.%3B+Yanchunas%2C+J.%3B+Weigelt%2C+C.%3B+Kish%2C+K.%3B+Klei%2C+H.+E.%3B+Xie%2C+D.%3B+Zhang%2C+Y.%3B+Corbett%2C+M.%3B+Tamura%2C+J.+K.%3B+He%2C+B.%3B+Hamann%2C+L.+G.%3B+Kirby%2C+M.+S.%3B+Marcinkeviciene%2C+J.Protein+Sci.+2008%2C+17%2C+240%E2%80%93250"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12bR"><div class="casContent"><span class="casTitleNuber">12b</span><div class="casTitle"><span class="NLM_cas:atitle">Involvement of DPP-IV catalytic residues in enzyme-saxagliptin complex formation</span></div><div class="casAuthors">Metzler, William J.; Yanchunas, Joseph; Weigelt, Carolyn; Kish, Kevin; Klei, Herbert E.; Xie, Dianlin; Zhang, Yaqun; Corbett, Martin; Tamura, James K.; He, Bin; Hamann, Lawrence G.; Kirby, Mark S.; Marcinkeviciene, Jovita</div><div class="citationInfo"><span class="NLM_cas:title">Protein Science</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">240-250</span>CODEN:
                <span class="NLM_cas:coden">PRCIEI</span>;
        ISSN:<span class="NLM_cas:issn">0961-8368</span>.
    
            (<span class="NLM_cas:orgname">Cold Spring Harbor Laboratory Press</span>)
        </div><div class="casAbstract">The inhibition of DPP-IV by saxagliptin has been proposed to occur through formation of a covalent but reversible complex.  To evaluate further the mechanism of inhibition, we detd. the x-ray crystal structure of the DPP-IV:saxagliptin complex.  This structure reveals covalent attachment between S630 and the inhibitor nitrile carbon (C-O distance <1.3 Å).  To investigate whether this serine addn. is assisted by the catalytic His-Asp dyad, we generated two mutants of DPP-IV, S630A and H740Q, and assayed them for ability to bind inhibitor.  DPP-IVH740Q bound saxagliptin with an ∼1000-fold redn. in affinity relative to DPP-IVWT, while DPP-IVS630A showed no evidence for binding inhibitor.  An analog of saxagliptin lacking the nitrile group showed unchanged binding properties to the both mutant proteins, highlighting the essential role S630 and H740 play in covalent bond formation between S630 and saxagliptin.  Further supporting mechanism-based inhibition by saxagliptin, NMR spectra of enzyme-saxagliptin complexes revealed the presence of three downfield resonances with low fractionation factors characteristic of short and strong hydrogen bonds (SSHB).  Comparison of the NMR spectra of various wild-type and mutant DPP-IV:ligand complexes enabled assignment of a resonance at ∼14 ppm to H740.  Two addnl. DPP-IV mutants, Y547F and Y547Q, generated to probe potential stabilization of the enzyme-inhibitor complex by this residue, did not show any differences in inhibitor binding either by ITC or NMR.  Together with the previously published enzymic data, the structural and binding data presented here strongly support a histidine-assisted covalent bond formation between S630 hydroxyl oxygen and the nitrile group of saxagliptin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp9JzGRDJ1J7rVg90H21EOLACvtfcHk0lhxZ8N7I21czA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhvVOntLo%253D&md5=d76619e8d6843e595a5bc971191a4828</span></div><a href="/servlet/linkout?suffix=cit12b&amp;dbid=16384&amp;doi=10.1110%2Fps.073253208&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1110%252Fps.073253208%26sid%3Dliteratum%253Aachs%26aulast%3DMetzler%26aufirst%3DW.%2BJ.%26aulast%3DYanchunas%26aufirst%3DJ.%26aulast%3DWeigelt%26aufirst%3DC.%26aulast%3DKish%26aufirst%3DK.%26aulast%3DKlei%26aufirst%3DH.%2BE.%26aulast%3DXie%26aufirst%3DD.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DCorbett%26aufirst%3DM.%26aulast%3DTamura%26aufirst%3DJ.%2BK.%26aulast%3DHe%26aufirst%3DB.%26aulast%3DHamann%26aufirst%3DL.%2BG.%26aulast%3DKirby%26aufirst%3DM.%2BS.%26aulast%3DMarcinkeviciene%26aufirst%3DJ.%26jtitle%3DProtein%2520Sci.%26date%3D2008%26volume%3D17%26spage%3D240%26epage%3D250" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit12c"><span><span class="NLM_label">(c) </span>X-ray analysis of <b>1e</b> (BMS-744891)/DPP4 [presumed to be (<i>Sa</i>)-<b>2f</b>/DPP4]: PDB deposition number <span class="NLM_ext-link">4LKO</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=X-ray+analysis+of+1e+%28BMS-744891%29%2FDPP4+%5Bpresumed+to+be+%28Sa%29-2f%2FDPP4%5D%3A+PDB+deposition+number+4LKO."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><div class="note"><p class="first last">BMS-538305 was used as an internal standard for relevant DPP4-related studies:</p></div><span class="NLM_contrib-group">Simpkins, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bolton, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pi, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sutton, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kwon, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Magnin, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Augeri, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gungor, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rotella, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Slusarchyk, W. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marcinkeviciene, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robertson, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robl, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Atwal, K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zahler, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parker, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kirby, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamann, L. G.</span><span> </span><span class="NLM_article-title">Potent Non-Nitrile Dipeptidic Dipeptidyl Peptidase IV Inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">6476</span><span class="NLM_x">–</span> <span class="NLM_lpage">6480</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=6476-6480&author=L.+M.+Simpkinsauthor=S.+Boltonauthor=Z.+Piauthor=J.+C.+Suttonauthor=C.+Kwonauthor=G.+Zhaoauthor=D.+R.+Magninauthor=D.+J.+Augeriauthor=T.+Gungorauthor=D.+P.+Rotellaauthor=Z.+Sunauthor=Y.+Liuauthor=W.+S.+Slusarchykauthor=J.+Marcinkevicieneauthor=J.+G.+Robertsonauthor=A.+Wangauthor=J.+A.+Roblauthor=K.+S.+Atwalauthor=R.+L.+Zahlerauthor=R.+A.+Parkerauthor=M.+S.+Kirbyauthor=L.+G.+Hamann&title=Potent+Non-Nitrile+Dipeptidic+Dipeptidyl+Peptidase+IV+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSimpkins%26aufirst%3DL.%2BM.%26aulast%3DBolton%26aufirst%3DS.%26aulast%3DPi%26aufirst%3DZ.%26aulast%3DSutton%26aufirst%3DJ.%2BC.%26aulast%3DKwon%26aufirst%3DC.%26aulast%3DZhao%26aufirst%3DG.%26aulast%3DMagnin%26aufirst%3DD.%2BR.%26aulast%3DAugeri%26aufirst%3DD.%2BJ.%26aulast%3DGungor%26aufirst%3DT.%26aulast%3DRotella%26aufirst%3DD.%2BP.%26aulast%3DSun%26aufirst%3DZ.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DSlusarchyk%26aufirst%3DW.%2BS.%26aulast%3DMarcinkeviciene%26aufirst%3DJ.%26aulast%3DRobertson%26aufirst%3DJ.%2BG.%26aulast%3DWang%26aufirst%3DA.%26aulast%3DRobl%26aufirst%3DJ.%2BA.%26aulast%3DAtwal%26aufirst%3DK.%2BS.%26aulast%3DZahler%26aufirst%3DR.%2BL.%26aulast%3DParker%26aufirst%3DR.%2BA.%26aulast%3DKirby%26aufirst%3DM.%2BS.%26aulast%3DHamann%26aufirst%3DL.%2BG.%26atitle%3DPotent%2520Non-Nitrile%2520Dipeptidic%2520Dipeptidyl%2520Peptidase%2520IV%2520Inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2007%26volume%3D17%26spage%3D6476%26epage%3D6480" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3SX4" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3SX4','PDB','3SX4'); return false;">PDB: 3SX4</a></li></ul></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm4008906&amp;pbContext=%3Barticle%3Aarticle%3A10.1021%2Fjm4008906%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2013.56.issue-18%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm4008906" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                2MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"6799a2f249733d82","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
